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1  Zusammenfassung 
Mit der Entschlüsselung des humanen Genoms stellte sich heraus, dass nur ein geringer Anteil der 
genetischen Information von ca. 2% für Proteine kodiert. Das verbleibende Genom wird aber 
größtenteils auch transkribiert und es entstehen ribosomale und transfer RNAs sowie verschiedene 
längere und kleine RNAs, von denen ein Großteil maßgeblich an der Regulation zellulärer Prozesse 
beteiligt ist. Obwohl die genaue Funktion vieler nicht-kodierender RNAs noch unklar ist, spielen 
besonders die kleinen, nicht-kodierenden RNAs eine große Rolle in der Regulation der 
Genexpression. Zur Gruppe der kleinen, nicht-kodierenden RNAs gehören die microRNAs (miRNAs). 
Die 20-25 Nukleotide langen Ribonukleinsäuren erfüllen wichtige Aufgaben bei der Steuerung 
grundlegender biologischer Prozesse wie der Entwicklung und Zelldifferenzierung. Es wird vermutet, 
dass ca. 60% der Protein-kodierenden Gene von miRNAs reguliert werden. Dementsprechend sind 
sie auch mit der Entstehung von verschiedenen Krankheiten wie Stoffwechselstörungen und Krebs 
assoziiert. Mittlerweile wurden ungefähr 2.500 verschiedene humane miRNAs gefunden, doch über 
ihren genauen Regulationsmechanismus liegen noch wenige Informationen vor. Die genomisch 
kodierten, kleinen RNAs werden als Vorläufer transkribiert und anschließend schrittweise durch die 
Enzyme Drosha und Dicer zur reifen miRNA prozessiert. Die reife miRNA bildet dann einen Komplex 
mit verschiedenen Proteinen und bindet an eine Ziel-mRNA. Dadurch kommt es im Rahmen der RNA-
Interferenz  entweder zur Degradation der mRNA oder zur Inhibition der Translation.  
Die synthetische Biologie besitzt ein hohes Potential, die direkten Zusammenhänge zwischen 
Erkrankungen und spezifischen miRNAs aufzuklären. Durch die wachsende Bedeutung dieses 
Forschungsfeldes wird die Entwicklung geeigneter Werkzeuge und Methoden immer wichtiger. Durch 
die gezielte Herstellung von RNA-basierten Werkzeugen zur Steuerung bestimmter zellulärer 
Prozesse kann beispielsweise die Interaktion einer miRNA mit einem potentiellen endogenen Ziel 
untersucht werden. Im Rahmen dieser Arbeit wurde ein RNA-Schalter basierend auf der natürlichen 
miRNA-Vorläuferstruktur der miRNA-126 designt, der die Prozessierung zur maturen miRNA durch 
Dicer steuern sollte. Zu diesem Zweck wurde der miRNA-Vorläufer modifiziert, indem die natürliche 
Endschleife entfernt und durch eine regulatorische Domäne, das TetR-bindende Aptamer, ersetzt 
wurde. Die Positionierung des TetR-bindenden Aptamers erfolgte an besagter Stelle, da hierdurch die 
Nähe zur Schnittstelle des Enzyms Dicer gewährleistet werden konnte. Somit konnte der Zugang der 
Schnittstellen durch Zugabe des Liganden TetR direkt kontrolliert werden. Zur Verknüpfung der zwei 
verschiedenen RNA-Bausteine zu einem funktionellen Schaltelement wurden verschiedene 
sogenannte Kommunikationsmodule getestet. Diese wurden am Übergang vom natürlichen Vorläufer 
zum TetR-bindenden Aptamer eingebracht und sollten zum einen die erfolgreiche Prozessierung und 
zum anderen die effektive Regulation des Vorläufer-basierten Systems ermöglichen. Mit Hilfe dieser 
strukturellen Modifikation gelang es einen Schalter zu generieren, der die Prozessierung des miRNA-
Vorläufers effektiv und in Abhängigkeit des Liganden TetR regulierte. Dadurch konnte eine 44-fache  
Inhibition der Prozessierung zur reifen miRNA erzielt werden. Die Verwendung des TetR-basierten 
Systems ermöglichte es zudem ein reversibles Schaltelement zu entwickeln, das nach der Zugabe 
von Doxyzyklin und der darauffolgenden Ablösung des Liganden vom Aptamer die Wiederherstellung 
der natürlichen Prozessierung zur maturen miRNA erlaubte. Es wurde zudem festgestellt, dass die 
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verschiedenen Kommunikationsmodule, abhängig von deren Länge und Volumen, und der Ersatz der 
natürlichen terminalen Schleife die Prozessierung in unterschiedlichem Maß beeinflussten. 
Letztendlich stellte sich heraus, dass die Verknüpfung über ein G-C Basenpaar die beste Möglichkeit 
bot, um die Prozessierung aufrecht zu erhalten und ein effektives Schaltverhalten herbeizuführen.   
Basierend auf dieser Erkenntnis konnte das Design erfolgreich auf weitere miRNA Vorläufer (miRNA-
34a und -199a) übertragen werden, die sich hinsichtlich ihrer Struktur von der miR-126 unterschieden.  
Auch hier konnte eine effektive Schaltaktivität von bis zu 400-fach nachgewiesen werden. Die 
Inhibition der Prozessierung des miRNA Vorläufers konnte durch die Zugabe von Doxyzyklin auch hier 
vollständig aufgehoben werden. Die entwickelten RNA-Schalter wurden daraufhin mit Hilfe eines 
Reportergen-Assays auf ihre Aktivität bezüglich der Regulation von miRNA Zielgenen überprüft. 
Hierzu wurden natürliche miRNA-Zielsequenzen hinter ein Reportergen eingebracht und die Bindung 
der miRNAs in Abhängigkeit von der Aktivität der Schaltelemente getestet. Es konnte gezeigt werden, 
dass der Großteil der Schaltelemente zur Regulation der Reportergenexpression geeignet war. Um 
Informationen über die Kinetik des Schalters miR-199a_2  zu gewinnen, wurden zeitaufgelöste 
Messungen zur Bestimmung der Ansprechverhaltens des Schalters auf die Zugabe von Doxyzyklin 
durchgeführt. Es konnte gezeigt werden, dass bis zu 30% der Prozessierungsaktivität bereits 1 h nach 
Doxycyklinzugabe wiederhergestellt und innerhalb von 24 h vollständig wiedergewonnen werden 
konnte. Im Anschluss wurde das regulatorische Potential der Schalter bezüglich endogener miRNA 
Ziele betrachtet. Dazu wurde die für den Schalter miR-199a_2 kodierende Sequenz entweder 
transient in die Zelle eingebracht oder in das Genom der Zelle integriert. Durch die genomische 
Integration wurde eine geringere Expression der Schalter-basierten miRNA beobachtet, was mit einer 
Verringerung des Schaltfaktors einherging. Eine Regulation der endogenen Ziel-mRNAs SMAD4, 
DDR1 und CAV1 in Abhängigkeit von Liganden- und Doxyzyklinpräsenz konnte allerdings weder im 
Fall der transienten Expression des Schaltelements noch nach der genomischen Integration des 
Konstrukts unter den vorliegenden experimentellen Bedingungen gezeigt werden.  
Zusammenfassend kann man sagen, dass das entwickelte Schalterdesign die effektive und robuste 
RNA-basierte Regulation der miRNA Biogenese ermöglichte. Die in dieser Studie generierten 
Schaltelemente besitzen ein hohes Potential, in zukünftigen Anwendungen die physiologische 
Relevanz verschiedener miRNAs aufzuklären. 
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Summary 
In recent years, the discovery of small non-coding RNAs has unveiled the essential role of RNAs for 
the regulation of gene expression. The largest group within the small non-coding RNAs is constituted 
by the class of micro RNAs (miRNAs). These 20 to 25 nucleotide long molecules fulfill important tasks 
concerning the control of fundamental biological processes like cell differentiation and development. 
This class of small non-coding RNAs impacts on post-transcriptional gene regulation in eukaryotes in 
a process called RNA interference. Acting on translation and mRNA stability, miRNAs influence the 
functionality of at least 60% of the human protein-coding genes. In this context the development of 
many diseases has been associated with miRNA dysregulation. Accounting for the importance of 
miRNAs, current research is focused on the elucidation of their exact function. 2,500 human miRNAs 
have been identified so far, but their detailed regulatory mechanism still remains elusive.  
MiRNAs are encoded in the genome and transcribed as primary precursors that are processed in a 
two-step mechanism to the mature miRNA by the enzymes Drosha and Dicer. Together with several 
protein factors, the mature miRNA builds the RNA-induced silencing complex and functions as a guide 
to target the respective mRNA. The consequence of a miRNA-target interaction is either mRNA 
degradation or translational repression.  
Synthetic biology offers various opportunities to shed light on the detailed relation between miRNA 
abundance and disease development. To deepen the knowledge about miRNAs and their respective 
function, the repertoire of existing methods and tools has to be adapted to the research objective. For 
an experimental setup it would be advantageous to make use of switchable systems which allow for 
the control over the abundance of the respective miRNA, thereby investigating its physiological 
relevance. In this study a natural miRNA precursor was modified by replacing the natural terminal loop 
with a regulatory sensor domain, the TetR-binding aptamer to enable the ligand-dependent control of 
the processing of precursor miRNA-126 (pre-miR-126) to mature miRNA-126-3p. The TetR aptamer 
was positioned in close proximity to the Dicer cleavage sites, conferring steric control over pre-miR 
processing by Dicer dependent on absence and presence of the ligand TetR. For the fusion of the two 
inherently different parts to a functional unit different communication modules were tested. These 
modules were introduced at the transition region between miRNA precursor and TetR aptamer to 
enable an adequate pre-miR cleavage as well as an effective regulation of processing. Here, switching 
factors of 44-fold could be yielded for pre-miR switch miR-126_5 in the presence of TetR that resulted 
in nearly complete inhibition of processing. The employment of the TetR-based system allowed the 
development of a completely reversible switching element, since the supplementation with doxycycline 
resulted in a dissociation of the ligand from the aptamer and the total recovery of pre-miRNA 
processing. Furthermore, the application of different communication modules turned out to essentially 
affect the processing to mature miRNA dependent on length and size of the resulting Dicer substrate. 
A single C-G base pair proved to provide an adequate connection between precursor and aptamer 
that preserved pre-miR processing und facilitated effective regulation at the same time.   
In analogy to this design concept further functional pre-miR switches were developed based on the 
precursors of miR-34a and -199a. These switches showed comparable features and regulatory factors 
of up to 400-fold as determined in qPCR assays. The addition of doxycycline resulted in the complete 
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recovery of pre-miRNA processing. The functional riboswitches were further tested for their regulatory 
activity in reporter gene assays. The natural target sites were introduced downstream of a reporter 
gene and miRNA binding to its target was investigated dependent on the regulatory performance of 
the respective switches. It could be shown that most of the switching elements were well suited to 
regulate reporter gene expression dependent on the presence of TetR and doxycycline. To gain 
information on the kinetics of the switch miR-199a_2 time-course experiments were performed to test 
the responsiveness of the switch to the presence of doxycycline. Within the hour of doxycycline 
addition already 30% of the processing activity were restored. 24 h after doxycycline addition the full 
recovery of switching activity could be observed in this experiment. At last, the regulatory potential of 
the switch to control endogenously expressed miRNA targets was investigated. Therefore, cells were 
either transiently transfected with the plasmid bearing the miR-199a_2 or a genomic integration of this 
switch was performed. As a consequence of genomic integration the expression of the switch as well 
as the regulatory factor were reduced compared to the effects obtained after transient transfection. All 
in all, the robust regulation of none of the miR-199a-5p targets SMAD4, DDR1 and CAV1 could be 
shown under the present experimental conditions.  
However, the developed design enabled the robust and effective RNA-based regulation of miRNA 
biogenesis. The generated pre-miR switches thus exhibit a high potential to contribute to the 
elucidation of the physiological relevance of different miRNAs in future applications.    
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2 Introduction 
2.1 The potential of synthetic biology 
Among various options a very simple, but appropriate definition of the term synthetic biology is “1. the 
design and construction of biological parts, devices and systems, and; 2. the redesign of existing, 
natural biological systems for useful purposes” 1.  
Based on the knowledge of molecular biology, synthetic biology unites different disciplines of science 
reaching from nanotechnology to immunology and connects concepts from engineering and biology. It 
separates itself from other disciplines like systems biology or biotechnology by the aspect of 
engineering that is to develop new properties and functions. Characterized by a “plug and play” 
mentality, the combination of various parts and devices by employing different engineering principles 
allows the rational design of novel, artificial functional frameworks and biological systems.  
Driven by the purpose of implementing new biological functions to organisms or modifying existing 
systems, the applicability of these artificial constructs is rather extensive. Reprogramming stem cells, 
the development of biosensors or the production of chemical entities in modified bacteria merely 
represent a small part of the current repertoire. A well-known example that emphasizes the high 
potential of the synthetic biology field is the production of terpenoid compounds in Escherichia coli  
and Saccharomyces cerevisiae as precursor for the development of the antimalaria drug Artemisinin 2–
4. This approach demonstrates that engineering of a metabolic pathway for employing cells as small 
factories for compound production is feasible in an applicable way. 
Providing a huge space for genetically modifying an organism, synthetic biology also has to face 
several challenges that set boundaries to the theoretically endless possibilities of manipulating 
systems by the help of artificial structures. In order to increase the researcher’s toolbox it is mandatory 
to create a variety of well-characterized functional building blocks that can be assembled to complex 
genetic circuits and expression systems. In an ideal case, these parts should be modularized as well 
as standardized for the robustly use in different organisms. Furthermore, a predictable and targeted 
modification of an organism requires detailed knowledge about the biology of the respective organism 
itself and the possible influence this modification has on cellular processes. Given that especially 
higher eukaryotic systems are rather complex and the mostly naturally derived devices often exhibit a 
strong dependence on the genetic context, the construction of robustly and predictably working 
devices is a complicated adventure. To counteract the issues stemming from interactions of artificial 
components with the deployed natural system, a valuable approach is the design of orthogonal 
biosystems. The ability to combine various independent, orthogonal parts and their implementation 
without affecting other natural processes is a basic requirement in synthetic biology and renders 
specific modifications of the organism possible.   
This doctoral thesis focuses on a special application area in the field of synthetic biology that intends 
to manipulate gene expression by using RNA-based regulators. Here, approaches are quite manifold 
with regard to the various factors involved in regulating gene expression. Over the years synthetic 
biologists have designed various synthetic tools that can be combined to achieve conditional gene 
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expression. It is a fact that there are more devices available for the usage in prokaryotes and lower 
eukaryotes than for the modification of higher eukaryotes 5. That in turn might be associated with the 
higher complexity of eukaryotic gene regulation. 
Synthetic biology is a continuously expanding field with a multitude of promising developments for 
industry and for basic research. But there is still some effort required to fully exploit the power of 
synthetic biology and to build up complex systems by the constructive combination of various synthetic 
units to predictably engineer an organism.     
2.2 Regulation of gene expression in eukaryotes 
During evolution, gene regulation of all organisms perfectly adapted to the environmental requirements 
through the development of a system that is defined by a complex interplay of various factors. 
Compared to prokaryotes, eukaryotes typically possess a much larger repertoire of genes that is 
organized into chromosomes. Although the whole genome of an organism is present in every cell, 
differentiation into single macrostructures like tissues and organs occurs during development. This 
leads to the conclusion that gene expression has to be an individual process in each cell type. To 
enable a precise temporal and spatial regulation of gene expression, eukaryotes are dependent on a 
highly sophisticated operation framework that decides about gene activation and the amount of RNA 
and protein product. The regulatory mechanisms can be classified into transcriptional and post-
transcriptional events. Transcription is regulated by adjusting the transcript amount of a gene, whereas 
regulation at the post-transcriptional level directly influences the translation of an mRNA into a protein.  
2.2.1 DNA-based control mechanisms 
A basic prerequisite for transcriptional control is the accessibility of the DNA for the RNA polymerase 
and specific regulatory factors. These factors mainly have an effect on transcription initiation. To find a 
compromise between a large genome and merely limited space in the nucleus and to coordinate 
cellular processes like transcription and replication, eukaryotic genes are arranged in an elaborate and 
highly dynamic higher order structure (Fig. 2.1). In the nucleus, the double stranded genomic DNA is 
stably coupled to histone proteins, thereby forming a complex, the nucleosome that constitutes the 
basic structural unit in chromatin. These nucleosomes are further organized into chromatin fibers 
(reviewed in 6). Metaphase chromosomes exhibit the most compact form of chromatin that occurs 
during nuclear division. The term heterochromatin describes the state of chromatin that appears to be 
relatively condensed and mainly contains genomic DNA that is not transcribed and is therefore 
referred to as inactive part of the genome. In order to grant the transcription machinery access to a 
gene, partial unpacking of the condensed heterochromatin structure is necessary to form the 
euchromatin. With its lightly packed structure, the euchromatin allows the binding of protein factors 
and RNA polymerase to the DNA to initiate transcription 7.  
The dynamic features of the nucleosomes are dependent on the intensity of interactions between DNA 
and histone and also strongly influenced by the processes of chromatin remodeling 8. By covalently 
modifying the protein structure of histones through acetylation, methylation or phosphorylation of 
 Introduction 
- 7 - 
 
specific amino acid residues, the stability of the nucleosome is changed. Another mechanism to 
influence DNA-histone contact formation is used by an ATP-dependent set of chromatin-remodeling 
enzymes that utilizes ATP-hydrolysis for targeted movement or eviction histones and restructuring 
nucleosomes (reviewed in 9).   
 
Figure 2.1 The organization of the eukaryotic genome.  
To condense the eukaryotic genome, the DNA double strand is wrapped around a core octamer of histones to 
form the core particles of the nucleosomes. These nucleosome particles are separated by a 50-70 base pair (bp) 
DNA linker and further compacted to a chromatin fiber. The secondary and tertiary structures of chromatin are 
stabilized by architectural proteins leading to higher organization of the chromatin structure. The tertiary structure 
chromatin is then spatially organized within defined territories in the nucleus. (adopted from 10) 
The presence of transcription factors (TFs), a group of sequence-specific DNA binding proteins 
mandatory for recruitment, adequate binding and the activity of the RNA-Polymerase II in eukaryotes, 
constitutes another level of regulation 11. The recognition and binding sites of TFs are either located 
directly in the promoter region or up- or downstream in a gene dependent on the family of TFs and 
their specific function. The mechanisms of these transcription regulation elements are manifold and 
often based on the recruiting of further factors to form the transcription (pre-)initiation complex, the 
promotion or repression of transcription by binding to distant-dependent (Promoter, Promoter-proximal 
elements, enhancer, silencer) and –independent (enhancer, silencer) cis regulatory elements in the 
DNA sequence and even influencing histone modification 12–14. Thus, the different transcription factor 
families significantly contribute to selective gene expression in the cell.   
2.2.1.1 Engineering and application of TFs in synthetic biology 
For the design of large synthetic networks, a well-characterized library of different parts and precise 
design principles for their assembly are required. Such parts can be promoters, terminators, reporters 
and also TFs. Eukaryotic cells use their complex network of TFs to precisely control gene expression. 
At present, the number of well-characterized and orthogonal natural TFs is limited and therefore 
restricts the application of TFs for the construction of complex synthetic networks in eukaryotes 15.  
Basically, a TF can be compartmentalized into three functional substructures for binding to DNA 
through specific protein-DNA interactions, one for recruiting or blocking RNA polymerase and 
interacting with further TFs. The modular nature of a TF enables the synthetic engineer to create 
designer TFs de novo by combining tailored DNA-binding and effector domains that execute either 
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activating or repressive function. Regarding the modifiability and adaptability of expression strength 
and specificity, the application of synthetic promoters and TFs provides a great advantage over their 
natural counterparts. 
The two main classes of engineered, site-specific DNA-binding domains are the Cys2-His2 zinc finger 
domains and the transcription activator-like effector (TALE) DNA-binding domains. Due to the 
modifiability of their binding regions, these domains can be engineered to specifically “read” virtually 
any promoter sequence of choice.  
A zinc finger-based TF usually employs a zinc finger protein domain to recognize a specific DNA 
sequence as well as an effector domain to recruit further factors for transcription initiation. A zinc finger 
domain consists of an array of finger domains and each finger domain recognizes an overlapping four 
bp sequence. That modular composition renders engineering of single finger domains for the 
recognition of specific three to four bp motifs possible (reviewed in 16). The fusion of single finger 
domains to one artificial zinc finger domain allows the design of tailored zinc finger-TFs for the binding 
to custom promoter sequences. In 2012, Collins and coworkers demonstrated that a complete 
synthetic TF could be established based on the modulation hypothesis 17. They combined an artificial 
zinc finger for DNA binding with a VP16 activator domain that regulates RNA polymerase recruitment 
and activity. A further protein-protein interaction domain was fused to the complex to allow the 
cooperative binding with adjacent TFs.  
TALE-based TFs constitute another powerful tool to selectively regulate gene expression in 
mammalian cells 18. TALE DNA-binding domains consist of multiple 34 amino acid repeats. Two 
polymorphic amino acids in position 12 and 13 of each repeat mediate the recognition of one specific 
DNA base 19. The knowledge about the unique domain organization and the DNA-recognition mode of 
such a DNA-binding domain can be exploited to engineer custom TFs for custom DNA recognition. 
TFs with activating or repressive characteristics can be designed by coupling the TF with an RNA 
polymerase interacting element. Zhang et al. have developed an activator TALE-TF by combining a 
truncated TALE scaffold with a VP46 activation domain and have shown the successful induction of 
gene expression in mammals 20. Custom TALE DNA-binding domains have also often been used for 
positive or negative transcription regulation in plants 21,22. Mercer et al. developed a ligand-dependent 
TALE-TF by inserting one or more ligand receptors between the DNA-binding and the regulatory 
domain, thereby creating a switchable synthetic TF 22.  
The dCas9-based TFs constitute a rather new class of artificial TFs that employ the catalytically 
inactivated CRISPR-Cas9 associated nuclease (dCas9) for the purpose of Clustered Regularly 
Interspaced Short Palindromic Repeats (CRISPR) RNA-guided DNA sequence recognition. The 
dCas9 protein has been fused to a VP64 activator domain and this hybrid protein has been co-
expressed with a guide RNA (gRNA) for the formation of a DNA recognition complex. That complex 
has been shown to facilitate gene activation of specific endogenous human genes 23. In contrast, 
Gilbert et al. have used a dCas9-repressor fusion protein for efficiently silencing transcription in 
eukaryotes 24. The design of dCas9-TFs offers some advantages over the ZF- and TALE-based TFs. 
Since target DNA recognition is based on a sequence-specific gRNA, dCas9-based TFs are easier to 
design. However, due to the necessity of engineering the respective ZF or TALE motifs as well as the 
related promoters, the development of ZF- and TALE-based TFs is rather laborious. Furthermore, by 
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using one dCas9-TF interacting with various specific gRNAs one may be capable of building a circuit 
with many orthogonal parts regulating multiple target genes at once.     
2.2.2 RNA-based control mechanisms 
For regulating a complex eukaryotic system further specific natural mechanisms are necessary to 
define the amount of mature mRNA designated for translation. In contrast to prokaryotes, eukaryotes 
possess a precursor (pre-) mRNA processing system that represents a unique level of gene 
expression control. Whereas the addition of a 5’-cap structure and the process of splicing out the 
intronic regions of the pre-mRNA already occurs during transcription, the modification of the transcript 
with a 3’ poly(A)-tail takes place post-transcriptionally in higher eukaryotes 25. RNA editing is also a 
common process to vary RNA nucleotide identity 26. This enzyme-based mechanism results in the 
chemical modification of RNA molecules and thereby extends the diversity of gene products. 
Altogether, these structural alterations strongly influence transcript stability, distribution in the cell`s 
compartments and the process of translation 27.   
2.2.2.1 Small non-coding RNAs and their involvement in gene regulation  
For a long time it has been assumed that mainly protein factors are relevant for gene regulation. In the 
meantime it became obvious that functional RNAs play a key role in determining differential gene 
expression and thus constitute another group of relevant trans regulators. Although the existence of 
non-coding (nc) RNAs has been known for many years, their meaning for the organism still has to be 
elucidated in large part 28. Many of these ncRNAs are transcribed at very low level and no specific 
function has been attributed to them yet. Still, there is also increasing evidence that some of them are 
strongly involved in a multitude of cellular processes 29. Due to their activity in gene expression 
regulation especially the small ncRNAs are of great interest. The 20-30 nucleotide long main 
representatives of this class have been categorized according to origin, function and associated 
effector proteins in Piwi-interacting (pi) RNAs, small interfering (si) RNAs and micro (mi) RNAs. These 
molecules are exclusively present in eukaryotes and constitute the key players of RNA interference 
(RNAi) 30. RNAi is a biological mechanism that was first discovered in 1993 in Caenorhabditis elegans, 
when Ambros and coworkers found the miRNA lin-4 to be an active endogenous regulator of 
developmental genes 31. The term “RNAi” was later defined by Mello and Conte 32. Over the years, this 
mechanism has turned out to be present in a huge variety of eukaryotic organisms, namely plants, 
fungi and animals, where it leads to the targeted silencing of specific genes during development or 
serves as defense mechanism from invasive nucleic acids 33. The small ncRNAs exhibit a common 
mode of action that is the specific binding of a ribonucleoprotein complex to its target gene (reviewed 
in 34).  
Within the group of small ncRNAs, piRNAs constitute the largest class (reviewed in 35). The piRNAs 
exhibit a size between 26 to 31 nucleotides (nt) and form complexes with piwi-proteins that are 
involved in the post-transcriptional gene silencing of transposons to guard germline cells against 
transposable elements (reviewed in 36).  
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Both, siRNAs and miRNAs, have a similar size of 20 to 25 nt (reviewed in37). Furthermore, siRNAs and 
miRNAs share that part of the processing machinery located in the cytoplasm during biogenesis. To 
perform their task as sequence-specific gene silencers, the siRNA as well as the miRNA have to be 
assembled in the RNA-induced silencing complex (RISC) 38. The RISC is composed of an RNA and 
protein compounds. The incorporated small RNA serves as a guide for the RISC by base-pairing to 
the target gene. One of the protein components is a member of the AGO protein family and acts as a 
recruiting factor for effector molecules. After binding to their target region, siRNAs and miRNAs either 
cause degradation or translational repression, dependent on the extent of complementarity between 
RNA and target sequence (reviewed in37). Whereas the precursor of a piRNA is assumed to be 
present as a single-strand (ss), siRNAs and miRNA both originate from  double-stranded (ds) 
precursors 30. A huge difference is revealed in the character of their precursors. The siRNA precursors 
distinguish themselves from miRNA precursors through perfectly-matched duplex structures. In 
contrast, miRNA precursors exhibit mismatches in their helical stem structure as well as a more 
extended terminal loop. Furthermore, siRNAs may be endogenous, arise from virus infection or are 
derived from other exogenous sources. However, miRNAs are encoded as an individual species in the 
genome (reviewed in 30,34).  
2.2.2.1.1 A class of small ncRNAs: miRNAs  
To date, there are 2500 miRNAs catalogued for humans (miRbase, release 21, http://mirbase.org/), 
but most of their targets and related functions still have to be elucidated. It is generally believed that 
miRNAs are involved in the regulation of about 60% of the protein-coding genes in humans 39. The 
transcription of a miRNA precursor is usually performed by RNA polymerase II. The miRNA precursors 
are typically encoded by independent miRNA genes or located in introns and, to a much smaller 
extent, in exons of (non)-coding genes (reviewed in 40). Some miRNAs are clustered in a polycistronic 
transcription unit and therefore co-transcribed 41. In this case, individual regulation of the single 
miRNAs from one cluster occurs at the post-transcriptional level. In mammals, the miRNA target 
sequence is usually located in the 3’ untranslated region (UTR) of the target mRNA and often present 
in multiple copies to intensify the regulatory effect (reviewed in 30).  
A typical, very promiscuous binding mode has been observed for miRNAs in mammals that enables 
one single miRNA to interact with multiple different target sequences. Perfect match binding within the 
miRNA-mRNA duplex structure occurs in the 5’ region of the miRNA through the heptamerical “seed” 
region of the miRNA (Fig. 2.2) 42. This “seed” region is the primary determinant of the binding 
specificity. The 3’ region of the miRNA is characterized by a partial, more flexible base pairing to the 
target sequence and functions as a modulator of suppression 43,44. 
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Figure 2.2 Typical miRNA-mRNA target interaction.  
The “seed” region of the miRNA consists of nucleotides 2 to 8 and is essential for miRNA-mRNA binding. The 
conserved heptameric sequence exhibits perfect complementarity to the mRNA target sequence. An A residue at 
position 1 or an A or U residue at position 9 additionally support efficient binding, although base pairing with the 
miRNA is not mandatory. Usually a bulge or a mismatch region is present in the centre of the miRNA-mRNA 
duplex. The 3’ region of the miRNA often shows imperfect binding to the mRNA. However, partial 
complementarity is a prerequisite for adequate duplex stability. ORF open reading frame (adopted from 40) 
Once bound to its target, RISC either induces mRNA degradation or translational repression. Direct 
target mRNA degradation via Argonaute 2 cleavage is quite rare in mammals (reviewed in 45). Most of 
the mRNAs seem to be degraded by the recruitment of further protein factors that in turn contribute to 
mRNA deadenylation and decapping 46,47. Although being a highly controversial topic, there is 
evidence that translational repression as the primary event followed by mRNA degradation accounts 
for the main regulatory effect for miRNAs (reviewed in 48). In order to facilitate an efficient translational 
repression, several target mRNAs exhibit multiple miRNA binding sites for either the same or a 
combination of different miRNAs (reviewed in 49).    
2.2.2.1.1.1 The miRNA processing machinery and regulation of miRNA biogenesis 
Being aware of the distinct involvement of miRNAs in gene regulation, an association of miRNA 
dysregulation with various diseases becomes evident. This highlights the importance of a tight 
regulation and accuracy of miRNA biogenesis to ensure an adequate functionality of gene regulation. 
The process of miRNA biogenesis is depicted in Fig. 2.3.  
The miRNA biogenesis starts with the transcription of the primary (pri-) miRNA from the respective 
miRNA gene in the nucleus. Due to the fact that usually RNA polymerase II is responsible for this step, 
pri-miRNAs are equipped with a cap structure at their 5’ end and a poly(A) tail at the 3’ end. The 
processing of the pri-miRNA requires the presence of the microprocessor complex consisting of the 
RNase III Drosha and the DiGeorge syndrome critical region 8 (DGCR8) 50. The microprocessor 
facilitates the processing of the pri-miRNA to the precursor (pre-) miRNA. For substrate recognition as 
well as the correct positioning of the pri-miRNA for Drosha cleavage, a basal stem ss junction is a 
prerequisite as the pri-miRNA is cleaved at a position about 11 bp distant from aforesaid junction. 
Furthermore, the features of the apical junction significantly contribute to the precise cleavage of the 
pri-miRNA 51. An accurate determination of the cleavage site by the involved RNase III is critical to 
prevent possible alterations in processing that could change abundance or miRNA target specificity. 
Besides the RNase III domains, Drosha harbors a double-stranded RNA binding domain which, 
however, is not sufficient for interacting with the substrate (Fig. 2.4). The presence of the RNA-binding 
protein DGCR8 is necessary to complement the complex with two additional double-stranded RNA 
binding domains (dsRBDs) (Fig. 2.4) 52. Further factors that influence Drosha cleavage efficiency are 
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the loop size and the stem structure of the terminal loop region of the respective precursor as well as 
the sequence of the flanking areas around the Drosha cleavage sites 50,53. The location of bulges 
within the pri-miRNA also significantly affects Drosha processing efficiency 54. Before Dicer cleavage 
can occur in cytoplasm, the pre-miRNA has to be transported out of the nucleus with the help of 
exportin 5, a Ras-related nuclear protein (Ran)-GTP dependent transporter 55. 
 
Figure 2.3 The process of miRNA biogenesis.  
The first step in miRNA biogenesis is the transcription of the miRNA gene by RNA polymerase II. After 
transcription the primary miRNA (pri-miRNA) is processed by Drosha to a hairpin-like pre-miRNA with a 2nt 3’ 
overhang. The pre-miRNA is exported from the nucleus to the cytoplasm via exportin 5 and cleaved by Dicer at 
defined positions (arrows) next to the terminal loop. The emerging miRNA-miRNA* duplex strand is then unwound 
and the guide strand (red) is integrated into the RISC which either triggers translational repression or mRNA 
degradation. ORF open reading frame, m7G cap structure  
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Figure 2.4 Schematic illustration of the structural organization of Drosha and DGCR8.  
The domain structures of Drosha and DGCR8 are delineated. Drosha consists of two RNase III domains and a C-
terminal dsRBD domain. DGCR8 shows two dsRBDs at its C terminus that significantly contribute to substrate 
binding and recognition. Furthermore, DGCR8s tryptophan-rich (WW) region is hypothesized to interact with the 
prolin-rich region (P) of the N terminus of Drosha. (adopted from 34) 
Dicer is another RNase III enzyme that slices the pre-miRNA near the terminal loop to produce a 
miRNA:miRNA* duplex consisting of the guide miRNA and the passenger miRNA*. To pose an eligible 
Dicer substrate, the pre-miRNA is typically hairpin shaped and usually exhibits a 2 nt 3’ terminal 
overhang as well as a 5’ terminal phosphate group that are relevant for recognition by the PAZ 
(Piwi/Argonaute/Zwille) domain of Dicer 56,57 (Fig. 2.5). Figure 2.6 illustrates the typical composition of 
the human Dicer. In mammals as well as in flies, the PAZ domain features two binding pockets, one 
for the 3’ hydroxyl end (3’ counting rule) and the other for the 5’ phosphate end (5’ counting rule), and 
thereby defines the distance to the cleavage sites 58,59. Thus, the region between PAZ domain and 
RNase III domain can be seen as a molecular ruler. In Drosophila, the helicase domain of Dicer-1 
recognizes the single stranded terminal loop structure and facilitates pre-miRNA recognition 60. So far, 
the exact function of the helicase domain of human Dicer has not been elucidated. Other structural 
features, such as the nature of the terminal loop (loop size, stem length) and the pre-miRNA 
sequence,  are also of importance for recognition and accurate processing by Dicer 61,62. Furthermore, 
Dicer contributes to RISC loading of the miRNA strand 63. Therefore, the enzyme possesses two 
additional binding sites, one for associating with dsRBPs as the TAR-RNA binding protein (TRBP), the 
other for binding to an Argonaute (Ago) protein 64. TRBP is supposed to be involved in modulating pre-
miR processing efficiency, in the adjustment of the mature miRNA`s length as well as in transferring 
the dsRNA from Dicer to Ago for strand selection 65–67. The Ago protein has the task to recognize the 
guide strand and to either cleave the target dependent on binding mode and Ago protein or to recruit 
other protein factors required for gene silencing (reviewed in 68).  
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Figure 2.5 Schematic secondary structure of a pre-miRNA.  
The typically hairpin-like structure of a pre-miRNA is depicted. The upper part of the pre-miRNA consists of the 
terminal loop, whereas the lower part is formed by a stem of incomplete complementarity. The 5’ arm of the pre-
miRNA harbors the miR-5p (green), the 3’ arm the miR-3p (red).  After being processed by Drosha the pre-miRNA 
features a 5’ phosphate group (circled P) and a 2 nt 3’ overhang. The arrows indicate the Dicer cleavage sites. 
 
 
Figure 2.6 (A) Domain structures of human Dicer. Depicted are the C-terminal dsRBD, the two RNase III 
domains and the PAZ domain responsible for the recognition of the pre-miRNA ends. In between the PAZ and 
RNase III domain, the anticipated ruler is located. Furthermore, a domain of unknown function (DUF) and a 
platform domain are depicted. The N-terminal helicase domain with over 600 amino acids constitutes the largest 
domain of Dicer. (B) Global architecture of human Dicer. The helicase domain (red) is shaped like a clamp and 
oriented in a suited position to navigate the incoming dsRNA substrate (black and grey coil) to the RNase active 
centre and the PAZ domain. The PAZ domain is reoriented to the catalytically active centre. The ruler is located 
between the PAZ domain and the RNases III. (adopted from 69 and modified) 
After Dicer cleavage the originated duplex structure miRNA:miRNA* is unwound by a helicase and, 
dependent on the thermodynamic stability of the respective 5’ end of the duplex, the guide strand 
(miRNA) is loaded onto the RISC to perform RNAi whereas the passenger strand (miRNA*) is 
degraded 70,71. For tightly regulating miRNA biogenesis, a control system similar to that of protein-
coding genes has evolved. This system is of the utmost importance for a precise spatiotemporal 
miRNA expression and comprises various modes of action. As such, several miRNAs are able to 
regulate their own transcription in an autoregulatory feedback-loop mechanism by binding to their 
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transcription factors 72. There are also numerous paths to control the processing to mature miRNA 
operating through the regulation of protein factors that participate in biogenesis itself or bind to the 
respective miRNA precursor thereby preventing processing 73. A well-characterized example for a 
protein-precursor miRNA interaction in the terminal loop region is the LIN-28-let-7 system that 
regulates access of both Drosha and Dicer to the two precursors pri-/ pre-let-7 74. RNA editing as well 
as methylation of the miRNA precursor also turned out to negatively influence pri-/ pre-miRNA 
processing by Drosha and Dicer due to poor substrate recognition 75.   
2.2.2.1.1.2 A selection of clinically relevant miRNAs: miR-34a, -92a, -101, -126 and -199a  
Due to their participation in the regulation of a multitude of target genes, miRNAs are involved in 
controlling lots of different processes in the organism. Altered miRNA expression is often found to be 
associated with disease development and there is strong evidence for a connection between miRNAs 
and oncogenesis, metastasis and resistance in cancer (reviewed in 76). Dependent on their role in 
cancer, miRNAs can be further classified as oncogenes or tumor-suppressor genes. Since miRNAs 
often have a causal connection with disease development and due to their tissue specificity, they also 
present themselves as ideal candidates for biomarker-related early diagnosis and treatment 77,78. Due 
to the identification of thousands of miRNAs across different species, a systematic nomenclature has 
been established. The numbering of newly identified miRNAs is sequential and the connection 
between structurally related miRNAs is indicated with lower case letters. Dependent on their origin, 
miRNAs derived from the 5’ or 3’ end are denoted with a “-5p” or “-3p” suffix. Considering their 
abundance after processing, the miRNAs derived from one precursor are referred to as miR-x for the 
main miRNA and miR-x* for the less abundant one. 
Five miRNAs have been chosen for investigation in this work because of their relevance in the 
emergence of frequently occurring diseases. One of these miRNAs is miRNA-34a that belongs to the 
highly conserved miRNA-34 family and has been shown to be a master regulator of tumor suppression 
79. It has been observed that the overexpression of miR-34a repressed several oncogenes and led to 
an increase of cell apoptosis as well as an inhibition of metastasis. Generally, miRNA-34a is 
ubiquitous in all tissues, but the highest level of expression is detectable in ovary, testes and prostate 
(reviewed in 80). An ectopic expression induces either cell cycle arrest or apoptosis and its 
dysregulation is strongly associated with cancer progression in numerous cell types 81,82. The 
transcription factor p53 has been proven to regulate the expression of the miRNA-34 family. It has 
been asserted that most targets of miRNA-34a are related to the p53 pathway. SIRT1 turned out to be 
a target of miRNA-34a and thus p53 dependent apoptosis is controlled through acetylation and 
activaton of p53 in a positive feedback loop 83,84. Another relevant target of miR-34a-5p is the proto-
oncogene receptor tyrosine kinase mRNA MET. The MET protein is associated with tumor cell 
migration and invasion and its expression was shown to be downregulated by miRNA-34a. In 
hepatocellular carcinoma (HCC), an inverse correlation between miR-34a and MET expression has 
been observed suggesting a function of miR-34a in the MET signaling pathway 85. On top of that a 
direct relationship between the E2F pathway and miR-34a has been found. The overexpression of 
miR-34a led to an immense downregulation of the E2F pathway and to an up-regulation of the p53 
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pathway activity. Through a direct interaction with E2F3, miRNA-34a seems to function as a potent 
suppressor of cell proliferation 86. 
MiRNA-92a belongs to the miRNA-17~92 family and arises from the miR-17/92 cluster. This cluster is 
composed of three highly conserved, polycistronic genes that encode for 15 miRNAs that are essential 
for development and homeostasis 87. MiRNA-92a is expressed in the majority of cells and in human 
blood plasma 88. It has been demonstrated that miRNA contributes to tumorigenesis via regulating 
tumor proliferation, apoptosis as well as tumor invasion and metastasis 89. Integrin α-5 expression was 
shown to be directly regulated through miR-92a. The expression of miR-92a resulted in a 
downregulation of Integrin α-5 expression in ovarian cancer cells resulting in the inhibition of cell 
adhesion, invasion and proliferation 90. Furthermore, miR-92a regulates the expression of the 
tropomyosin receptor kinase. The miRNA was shown to downregulate protein expression and thereby 
to promote proliferation and migration of human neuroblastoma cells 91. Furthermore, miRNA-92a 
regulates angiogenesis and viability of endothelial cells under oxidative stress 92.  
MiRNA-101 acts as a tumor suppressor in various cancer types. It belongs to a family of miRNAs that 
is involved in a series of cellular activities such as proliferation, cell invasion and angiogenesis. 
MiRNA-101 was often shown to be downregulated in prostate cancer, hepatocellular carcinomas and 
bladder cancers 93–95. This miRNA suppresses the proliferation of breast cancer cells by directing cell 
apoptosis and cell cycle arrest through the regulation of the expression of Von-Hippel-Lindau tumor 
suppressor, a negative regulator of the hypoxia-induced factor 1α 96. In cervical cancer cells, miRNA-
101 has been linked to the regulation of viability and invasion through affecting cyclooxigenase-2  
expression 97.  
Another miRNA with a distinct link to disease development is miRNA-126. MiRNA-126 is highly 
abundant in endothelial cells and hematopoietic stem cells 98. The miRNA-126 host gene is EGFL7 
which leads to transcription of both the miRNA and the EGFL7 transcript at the same time. In turn, this 
transcription is regulated by a negative feedback loop due to the presence of a miRNA-126 binding 
site in the host gene transcript itself 99. EGFL7 is a key factor in cell migration pathways and also 
associated with the process of angiogenesis 100. Being implicated in processes like inflammation and 
angiogenesis, this miRNA plays a role in the development of a multitude of cancer types (reviewed in 
101,102). With regard to this, vascular cell adhesion molecule 1 (VCAM1) expression is controlled 
through miRNA-126 103. By inhibiting the VCAM1 expression in endothelial cells, adhesion and 
infiltration of leukocytes into the vasculature wall is hampered and inflammation is interrupted. 
SPRED1 encoding for the sprout-related, EVH1 domain-containing protein-1 (SPRED1) constitutes a 
further target of miRNA-126 that has been shown to regulate vascular integrity and angiogenesis 104.   
An interesting miRNA with numerous links to different diseases is miR-199a. MiRNA-199a shows a 
strong correlation with the development of chronic obstructive pulmonary disease (COPD) due to its 
regulation of HIF-1α 105. Also the participation in various cancer types via either up- or down regulation 
dependent on the specific tissue is known (reviewed in 106). There are results that indicate that miR-
199a-5p functions via inhibition of cell proliferation and induction of cell death 107–109. Furthermore, the 
expression of the mothers against decapentaplegic homolog 4 (SMAD4) protein has also been shown 
to be directly regulated through miRNA-199a. The overexpression of miRNA-199a resulted in the 
downregulation of SMAD4 protein expression thereby demonstrating a regulatory effect on the TGF-β 
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signaling pathway 110. The discoidin domain receptor 1 (DDR1) affects human hepatocellular 
carcinoma invasion and its expression was demonstrated to depend on the presence of miR-199a-5p 
111. A strong correlation between caveolin-1 (CAV1) and miR-199a-5p expression has also been found 
112. MiR-199a-3p is also involved in disease development, as well. MiRNA-199a-3p was shown to 
regulate cell proliferation and survival by affecting caveolin-2 (CAV2) expression 113. Besides CAV2, 
MET and the transcript encoding for the cell-surface glycoprotein CD44 constitute validated targets of 
miRNA-199a-3p 114,115. 
The above mentioned functions of the miRNAs are merely a small excerpt of the huge repertoire of 
functions. However, most of their roles in the regulation of cellular processes are not known today and 
still have to be elucidated. To extend the existing knowledge on these molecules and their respective 
function, the repertoire of existing methods and tools has to be adapted to the features of the research 
objectives. Therefore, the synthetic biology poses a promising field of research that extensively 
employs artificially built systems for the purpose of investigating and controlling cellular processes. 
2.2.2.2 Synthetic riboswitches as post-transcriptional control elements 
Scientists from the field of synthetic biology have been inspired by the fact that nature extensively 
utilizes RNA to regulate gene expression through various mechanisms. Basically, RNA molecules 
consist of four bases and interact with their surroundings via a combination of intra- and intermolecular 
interactions. For the formation of a highly selective binding pocket of a RNA-based switch merely four 
types of monomers are available. Nonetheless, the resulting interactions between ligand and binding 
domain are suited to warrant highly precise and efficient gene regulation. For this reason, ribonucleic 
acids with their structural and functional diversity are predestinated to serve as basic building blocks 
for the development of engineered regulatory systems.  
A specific regulatory RNA-based mechanism to execute control over gene expression was first 
discovered by Breaker and coworkers when they found a flavin mononucleotide (FMN) binding 
riboswitch in the 5’UTR of a prokaryotic mRNA 116. Upon direct binding of the metabolite FMN, the 
premature termination of transcription is triggered to regulate genes participating in biosynthesis and 
transport of FMN. Riboswitches are defined as autonomous, cis-acting RNA elements consisting of a 
ligand sensing aptamer domain and an expression platform that undergoes a conformational change 
as a consequence to ligand binding 117. The switching event between two mutually exclusive 
structures enables the expression platform to directly intervene with gene expression. Riboswitches 
have been found to be encoded in the genome of fungi, plants, archea and bacteria 118. 
Due to their modular characteristic, synthetic riboswitches can be designed de novo in analog to their 
natural counterparts by combining RNA-based sensing modules and versatile regulatory domains. For 
that purpose, RNA aptamers are highly suitable components for the application as sensing modules. 
2.2.2.2.1 RNA aptamers and their application in conditional gene expression 
The term RNA aptamer refers to an oligonucleotide-based structure that is capable of binding a ligand 
with high affinity and specificity. Besides aptamers consisting of RNA, also DNA and peptide aptamers 
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can be developed to specifically bind to molecules with their 3D structure. In a process named 
systematic evolution of ligands by exponential enrichment (SELEX), aptamers against a variety of 
components like organic compounds, proteins, oligonucleotides as well as whole cells can be created 
119,120 (reviewed in 121). With regard to size, production, immunogenicity, thermodynamic stability and 
due to their structural versatility, RNA aptamers show significant advantages over their functional 
protein-based counterparts, the antibodies (reviewed in 122). Besides their applicability as a sensing 
unit for building synthetic riboswitches, aptamers can also be applied for therapeutic and diagnostic 
purposes or as biosensors (reviewed in 122) 123. To be classified as a riboswitch, an RNA structure has 
to possess essential features such as high affinity binding to a ligand, undergoing a conformational 
change in response to ligand binding and fast ligand association kinetic. Aptamers sometimes feature 
riboswitching activity and can therefore be used for interference with gene expression without 
employing further regulatory elements. In 1998, Werstuck and Green showed for the first time that the 
insertion of aptamers into a 5’UTR of an mRNA actually leads to translational repression upon ligand 
binding 124. Indeed, merely a small percentage of the presently selected aptamers show this behavior 
because the SELEX approach is focused on finding high affinity binders to the respective target. The 
combination of in vitro and in vivo selection methods in one approach is by far more constructive to 
obtain aptamers with adequate switching capability (reviewed in 125). The neomycin aptamer as well as 
the tetracycline aptamer are two examples of aptamers that can be employed to confer control over 
translation in yeast 126,127. Upon binding the respective ligand, a structural rearrangement resulting in 
the stabilization of the aptamer structure occurs in the 5’UTR which, in turn, inhibits binding or 
scanning of a ribosomal subunit to the mRNA (Fig. 2.7 A). Besides manipulating translation initiation, 
other mechanisms have also been exploited to control gene expression. Dependent on ligand 
presence, the positioning of an aptamer in proximity to recognition sequences relevant to the splicing 
machinery leads to the impairment of pre-mRNA splicing (Fig. 2.7 B) 128. RNAi can also be controlled 
by replacing the terminal loop of a small hairpin (sh) RNA with an aptamer (Fig. 2.7 C)129. 
Demonstrating the variability of applications for riboswitches, Wang and White used the theophylline 
aptamer to regulate virus replication (Fig. 2.7 D) 130. 
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Figure 2.7 Mechanisms of gene expression control with synthetic riboswitches.  
(A) Control of translation initiation. The aptamer is positioned either in proximity to the m7G cap or to the start 
codon AUG. In the presence of the ligand a stable secondary structure is formed that either interrupts binding of 
the small ribosomal unit to the mRNA (upper part) or alternatively the scanning process (lower part). (B) Control 
of pre-mRNA splicing. The sequestration of a recognition site of the splicing machinery through the introduction 
of an aptamer interrupts pre-mRNA splicing. (C) Control of siRNA processing. The structural modification of an 
shRNA by replacing the terminal loop with an aptamer sequence can affect Dicer processing by blocking the 
cleavage sites through the conformational change of the aptamer. (D) Control of viral replication. The 
replacement of an endogenous signal structure in the 5’UTR of an mRNA with an aptamer leads to a malfunction 
of structure recognition of the virus replication machinery which disturbs viral replication. 
(adopted from 131) 
In bacteria, synthetic riboswitches can also be utilized to gain control over translational initiation. By 
positioning an aptamer in a way, that sequesters the Shine-Dalgarno (SD) sequence, it is possible to 
regulate the accessibility of the 30S ribosome subunit to its binding sequence (Fig. 2.8 A) 132. Another 
approach employs a slippage element for removing the theophylline aptamer that functions as a steric 
hindrance for ribosome binding to the SD sequence upon ligand binding (Fig. 2.8 B) 133. 
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Figure 2.8 Mechanisms of gene expression control in bacteria.  
(A) Control of translational initiation by sequestration. The incorporation of both the SD sequence and the 
start codon into a secondary structure interferes with the binding of the small ribosomal subunit to the mRNA. This 
sequestration can be eliminated through ligand binding to the aptamer that leads to a conformational change and 
thus the release of the recognition elements. (B) Control of translation initiation by steric hindrance. 
Positioning a stable aptamer structure next to the SD sequence can result in an impairment of binding of the 
ribosomal subunit. Through ligand binding the steric hindrance can be removed from the recognition sequence 
thereby granting access to the SD sequence. (adopted from 131) 
The coupling of an aptamer to various expression platforms is possible to create versatile genetic 
manipulation devices. With a connection module that communicates ligand binding to an expression 
platform, an allosterically controllable ribozyme can be created by fusing an aptamer to a self-cleaving 
ribozyme, thus providing another RNA-based tool for gene expression regulation (reviewed in 134). 
Besides small-molecule binding systems, approaches employing protein-binding motifs and aptamers 
for the creation of protein-driven switches were established. Their high potential for the conditional 
regulation of cellular pathways was demonstrated by the Saito group that developed a protein-
responsive shRNA 135. 
2.2.2.2.1 The tetracycline (tc) repressor (TetR) and the TetR-binding aptamer 
In a combined approach of an in vitro screening for TetR-binding sequences and an in vivo screening 
for TetR-related induction of gene expression, the TetR aptamer was originally identified as an 
aptamer that is able to induce transcription in E. coli 136. The aptamer binding ligand is the TetR which 
is a 46.6 kDa homodimeric transcription factor of bacterial origin and belongs to the Tet/Cam family of 
regulators 137. Naturally, TetR exerts control over the expression of the Tn10 encoded tc resistance in 
gram-negative bacteria and equips the organism with the ability to actively export the antibiotic tc from 
the cell (reviewed in 138). In the absence of tc, TetR occupies the operator tetO and prevents the 
transcription of tetA that encodes for the tc antiporter. The presence of tc results in binding of a 
[tc∙Mg]+ complex to the TetR binding pocket located in the core region and induces a conformational 
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change in the homodimer. This conformational change is accompanied by the reorientation of the DNA 
reading heads that are directly connected to the protein binding core 139. The rearrangement leads to 
dissociation of TetR from the operator sequence and enables the expression of the resistance 
conferring transport protein 140. 
Tc-dependent regulation is an often used mechanism to control gene expression in a variety of 
organisms since the TetR system provides a high binding affinity and specificity as well as good 
pharmacokinetic properties 141,142. The small molecules tc and doxycycline (dox), which is an analog of 
tetracycline (Fig. 2.9), are often applied in combination with the TetR system. With 109 M-1 and 1010 M-1 
respectively, they exhibit very high affinities to TetR 140. The binding of two molecules of [tc∙Mg]+ to 
each TetR monomer (Fig. 2.10) reduces the affinity of TetR to the operator by nine orders of 
magnitude 140. This characteristic and the good permeability of the compounds facilitate the use of very 
low amounts of tc and dox in experiments, thereby preventing an effect on other cellular processes. 
Another advantage of the original system is its modularity and the concomitant potential to fuse TetR 
to eukaryotic regulation domains 143.  
Nowadays, the TetR system is often used for regulation of gene expression in eukaryotes. The first 
published application of this system in eukaryotes using the features of the unmodified TetR showed 
the regulation of transcription by employing TetR as a steric roadblock for RNA polymerase binding 
144. Furthermore, the Tet-Off and the Tet-On system have been established through the modification of 
TetR and its binding mode. For the Tet-Off system, the tc-controlled transactivator (tTA) hybrid protein 
was built by fusing a VP16 activator domain to TetR. Applied in combination with the Tet operator 
placed upstream of a promoter, the stimulation of an ensuing gene can be accomplished. Upon the 
addition of tc or dox to the system, tTA dissociates from the operator and gene expression is 
abolished. In contrast, the Tet-On system employs a VP16 activator domain coupled with the reverse 
TetR (rtTA) that has been created through a point mutation within the protein. In that case, the 
modified TetR binds to the operator sequence in presence of tc and induces gene expression 145,146. 
 
Figure 2.9 Molecular structures of (A) tc and (B) dox. 
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Figure 2.10 Crystal structure of the TetR-[tc∙Mg]+2  complex.  
The TetR homodimer is illustrated as a ribbon with one monomer in grey and the other monomer substructured by 
utilizing the following color code: the DNA binding helix is highlighted in magenta. The connecting helix α4 that is 
located between the DNA binding helix and the protein core is displayed in green. The protein core is shown in 
blue and tc depicted as space-filling model in yellow. (adopted from 140) 
The discovery of the TetR aptamer creates new opportunities to apply the TetR system. Comparable 
to the original TetR system, binding of tc to TetR results in the dissociation of TetR from the aptamer. 
It has been demonstrated that the achievable in vivo activity of the RNA-based system is comparable 
to that of the original inducer tc 136. The aptamer folds into a stem loop structure harboring a highly 
conserved internal loop structure that was shown to constitute the ligand binding site (Fig. 2.11 A). The 
thermodynamic stability of the stem and the terminal loop structure are of the utmost importance 
because they were shown to directly affect the induction efficiency and therefore the functionality of 
the aptamer 136. Suess and coworkers shed light on the mechanistic basis of the TetR aptamer-based 
induction and revealed that the aptamer interacts with amino acids from both monomers of the TetR 
homodimer by binding to the DNA reading heads (Fig. 2.11 B) 147. This observation is strongly linked 
to another finding, namely the capability of the aptamer to actively compete with the operator for TetR 
binding. Besides the observed competition, the active displacement of the operator by the TetR 
aptamer was determined in further experiments147. A prerequisite for this feature is that tetO and the 
aptamer possess similar binding affinities for TetR, as demonstrated by Steber et al. 147. The detailed 
characterization and the special features of the TetR aptamer system render it a well suited 
component for its employment in the synthetic biology. 
The universal applicability as well as the genetic modularity of the TetR aptamer in different organisms 
have already been confirmed in various experimental approaches. Demonstrating the functional 
independence of the system from the organism, Niles and coworkers illustrated the portability of the 
E.coli derived TetR aptamer system to the protozoon Plasmodium falciparum and also to the lower 
eukaryote S. cerevisiae 148,149. With their ligand-dependent intramer, Fussenegger and coworkers 
added an additional layer of regulation to the TetR aptamer based system and designed a small-
molecule responsive switch functional in mammals 150.  
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Figure 2.11 (A) Secondary structure of the TetR aptamer. The aptamer is predicted to fold into a stem loop 
structure. The internal loop is responsible for ligand binding, whereas the surrounding structural elements stabilize 
the binding structure. (B) Illustration of the TetR-aptamer interaction. The DNA binding site, recognition helix 
α3 of TetR (yellow) and the aptamer recognition epitope (blue) are illustrated. (partly adopted from 147 and 
modified) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
- 24 - 
 
2.3 Scope of the study  
Due to the variety of synthetic building blocks and devices as well as a continuously growing 
knowledge about biological systems, the opportunities to genetically manipulate an organism are 
seemingly infinite. In the last years, several studies have focused on the significance of small ncRNAs 
for eukaryotic gene regulation and revealed their important role for various biologically relevant 
processes (reviewed in 151). To deepen the knowledge about these molecules and their respective 
function, the repertoire of existing methods and tools has to be adapted to the features of the research 
objectives. 
One very promising and simultaneously complex target for synthetic engineering represents RNAi with 
miRNAs as the key components of the mechanism. The direct involvement of miRNAs in the 
regulation of gene expression offers the possibility to control the expression of specific target genes by 
affecting miRNA abundance. MiRNA abundance, in turn, is dependent on a magnitude of factors. A 
relevant process determining miRNA levels is the regulation of miRNA biogenesis, which therefore 
poses an attractive interference point for manipulation.  
Thus, the scope of this study was the design and implementation of an RNA-based device to create a 
switchable unit, consisting of a synthetic aptamer component functioning as a ligand sensing module 
coupled to a natural miRNA precursor structure, to enable ligand-controlled miRNA abundance. In 
order to control pre-miRNA processing in a ligand-dependent fashion, the TetR aptamer should be 
connected to the miRNA precursor, intending to directly control the access of Dicer to its cleavage 
sites by the presence of the ligand. Concerning the special interest in miRNA function and its 
involvement in pathogenesis, a specific and transferable design for regulating the biogenesis of 
various miRNAs was sought to be established to provide a useful tool for the investigation of cellular 
malfunctions caused by different miRNAs. To prove the functionality, applicability and robustness of 
the designed pre-miR switches, their ligand-dependent regulatory activity should be demonstrated at 
the protein level. 
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3 Results  
3.1 Design and functionality of a reversible pre-miR switch 
Accounting for the strong correlation between miRNA dysregulation and human disease, the 
development of a specific device to regulate miRNA levels in a ligand-dependent way provides a 
useful tool for investigating the impact of specific miRNAs on cellular malfunction. One approach to 
systematically control miRNA levels is constituted by the direct interference with the processing 
machinery. Although miRNA precursors display high structural variability like different extents of stem 
complementarity and varying loop size, most of these precursors are recognized by the same miRNA 
processing machinery. Thus, the processing machinery seems to feature a certain structural tolerance 
with regard to substrate recognition that can be exploited for the modification of a precursor molecule. 
Due to the current knowledge about substrate recognition features and specific cleavage positions of 
Dicer, a pre-miRNA molecule can be modified to allow the controlled and directed processing to a 
specific miRNA. Such an adjustable precursor tool could be realized by the integration of a regulatory 
synthetic component into the natural precursor structure. 
In this study, the TetR aptamer was chosen as a regulatory sensor domain for the development of a 
pre-miR switch to conditionally control miRNA maturation 136. The application of this TetR-based 
system provides several advantages over other small molecule- and protein-based systems. TetR is 
bound as a homodimer of 46.6 kDa to the aptamer and thus functions as a sterically demanding 
protein ligand that is theoretically eligible to block the binding of Dicer or other cofactors to the 
processing sites 137,147. Since one characteristic of the TetR-based system is reversibility, TetR and its 
aptamer constitute an ideal basis for the design of a reversible pre-miR switch. Additionally, the 
supplementation with a low concentration of dox is sufficient to efficiently relieve TetR from the 
aptamer. Furthermore, as TetR originates from bacteria, it is not endogenously expressed in mammals 
and therefore well suited to be applied as a regulatory protein. Two critical aspects had to be 
considered for the design with respect to the sensor domain. (i) TetR aptamer functionality turned out 
to be strongly dependent on the stability of its closing stem, whereas the exact nucleotide identity was 
negligible 136. (ii) For the purpose of directly regulating miRNA processing through ligand presence, the 
aptamer had to be introduced in direct proximity to the cleavage sites of Dicer.  
Besides, an appropriate communication module had to be established to connect the two inherently 
different parts, the aptamer and the miRNA precursor, to a functional unit. This module was sought to 
be designed in order to retain pre-miRNA processing and contemporaneously to enable efficient 
control over pre-miRNA cleavage. Therefore, the optimal distance between the ligand binding site and 
the cleavage sites had to be determined to satisfy both requirements. Figure 3.1 schematically 
illustrates the proposed mechanism of the TetR-controlled regulation of pre-miRNA processing. In the 
absence of TetR the Dicer processing sites are supposed to be readily accessible for the processing 
machinery and the precursor is converted into mature miRNA. In contrast, the expression of TetR 
followed by binding to the aptamer theoretically leads to a blockage of the processing sites and inhibits 
processing of the pre-miRNA. The addition of dox reverses the maturation stop as the inducer 
 Results 
- 26 - 
 
molecule binds to TetR and induces a conformational change that relieves the pre-miRNA from the 
steric hindrance and the precursor is processed to mature miRNA, again. 
 
Figure 3.1 TetR aptamer dependent regulation of Dicer processing. As the sensor domain of the pre-miR 
switch, the TetR aptamer replaces the terminal loop region. In the absence of the TetR homodimer, Dicer cleaves 
the pre-miRNA at the indicated processing sites (arrows) leading to the emergence of mature miRNA. Upon 
expression of the protein, the TetR homodimer binds to the aptamer and blocks the cleavage sites. This in turn 
results in an impairment of Dicer cleavage. The addition of dox to the medium causes the dissociation of TetR 
from the aptamer leading to an unblocking of the processing sites. Thus, the pre-miRNA can be processed to 
mature miRNA, again.   
The first pre-miR switches miR-126_NL, _2, _5 and _5l were designed based on the natural miR-126 
precursor (Fig. 3.2 A). The aptamer was inserted into the miRNA precursor, replacing the natural 
terminal loop. To find an appropriate communication module, stem length and flexibility in the shared 
region between the aptamer and the precursor were varied. For the design of construct miR-126_NL 
the lower part of the natural terminal loop structure was retained in the transition area to mimic the 
precursor structure as close as possible. An additional C-G bp was attached to the natural structure to 
connect the aptamer to the precursor to further stabilize the aptamer closing stem. For a stepwise 
increase of stem stability the constructs miR-126_2, _5 and _5l were designed. Construct miR-126_2 
was built with a shortened transition region to decrease the distance between the Dicer cleavage sites 
and the TetR binding site and nearly complete strand complementarity with the exception of one 
mismatched bp. For the generation of miRNA-126_5 stem stability was further enhanced, as the 
transition area displayed complete base pairing. The communication module was shortened by two bp 
to decrease the distance of the TetR binding site to the Dicer cleavage sites. Construct miR-126_5l 
represented the elongated form of miR-126_5 and was designed to further explore the influence of the 
proximity of the TetR binding site and the Dicer cleavage sites on the inhibitory capacity.    
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Figure 3.2 (A) Design scheme for the miR-126-based pre-miR switches. The predicted secondary structures 
of a part of the natural pri-miR-126 (left) and the modified pre-miR switches miR-126_5, _5l, _2 and _NL are 
shown. The TetR aptamer highlighted in blue replaces the natural terminal loop of the precursor. The 
communication modules between precursor stem and TetR aptamer were varied with regard to stem stability and 
length. The resulting differences in the transition areas between pre-miRNA and the aptamer are highlighted in 
boxes. In the precursor stem miRNA-126-5p is indicated in green, whereas red designates miRNA-126-3p. 
Arrows indicate the Dicer cleavage sites. (B) TetR and dox-dependent regulation of mature miRNA-126 
levels. 1.4 x 105 HeLa cells were seeded into 12-well plates and transfected with a plasmid either harboring the 
natural miRNA precursor or the respective pre-miR switch and the TetR expression plasmid. 1 µg/ml dox was 
supplemented to the medium 3 h after transfection. The amount of mature miRNA-126 produced from the 
respective pre-miR switch was assessed in a quantitative PCR (qPCR) assay 24 h after transfection and 
normalized to the miRNA-126 amount derived from natural miRNA precursor construct. The measurements were 
performed in duplicates (n=3). (C) Expression levels of mature miRNA-126. 1.4 x 105 HeLa cells were seeded 
into 12-well plates and transfected with a plasmid either harboring the natural miRNA precursor or the respective 
pre-miR switch. 1 µg/ml dox was supplemented to the medium 3 h after transfection. The graph reveals the 
amount of mature miR-126 produced from the respective pre-miR switch normalized to the miRNA-126 amount 
derived from natural pre-miRNA processing determined in a qPCR assay 24 h after transfection. The 
measurements were performed in duplicates (n=2). 
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Figure 3.3 Plasmid map of pCMV-miR-126_5.  
The plasmid map schematically shows the construction of the pre-miR switch miR-126_5 expression plasmid. The 
pre-miR switch construct is surrounded by 100 nt of natural context up- and downstream (grey) and expressed 
from a CMV promoter (blue). Within this natural context the miR-126 stem loop that harbors miR-126-5p (=miR-
126*) highlighted in green and miR-126-3p (=miR-126) illustrated in red is located. In between the two miRNAs 
the TetR aptamer resides fused to the precursor through a communication module for the purpose of controlling 
miRNA processing in a ligand-dependent fashion. (Maps were created with SnapGene®) 
To analyze the influence of the modification of the natural precursor on processing and the switching 
efficiency of the designed constructs, they were cloned into a plasmid pCMV-MS framed by 100 nt of 
the natural context up- and downstream to preserve precursor folding and putative recognition 
features essential for Drosha processing and expressed from a CMV promoter. The plasmid map 
pCMV-miR-126_5, depicted in Figure 3.3, exemplifies the composition of the plasmids used for the 
expression of the natural precursor and the pre-miR switch. TetR was co-expressed from the plasmid 
pCMV-TetR by a CMV promoter to accomplish high expression of the ligand of the TetR aptamer. For 
the experimental setup HeLa cells were used because of their low endogenous expression of almost 
all tested miRNAs with the exception of miRNA-92a that exhibits a relative strong endogenous 
expression profile in HeLa cells.  
HeLa cells were transfected with the plasmids harboring the constructs or the natural miRNA 
precursors as a positive control for Dicer processing together with the TetR expression plasmid. 1 
µg/ml dox was added to the medium 3 h after transfection to test the reversibility of TetR-induced 
inhibition of pre-miRNA processing. Total RNA was isolated 24 h after transfection and reversely 
transcribed with the respective stem loop primers. The amount of mature miRNA was then assessed 
by qPCR using the TaqMan method. In all TaqMan-based qPCR measurements the amount of mature 
miRNA of the predominant miRNA species after Dicer processing was assessed with the exception of 
miR-199a. For miR-199a the amount of both species, miR-199a-5p and -3p, was determined due to 
their biological interest.    
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The results of the qPCR measurements are depicted in Figure 3.2 B. In the absence of TetR and dox, 
the amount of mature miRNA-126 processed from construct miR-126_5 was detected at about 23% 
related to the amount of mature miR-126 naturally processed from the unmodified precursor. Co-
expression of TetR resulted in a 44-fold reduction of mature miRNA, whereas the additional 
supplementation with dox allowed the total reversibility of the inhibitory effect. No significant influence 
on pre-miRNA-126_5 processing could be detected upon addition of exclusively dox. In contrast to 
miR-126_5, the maximal amount of mature miRNA of constructs miR-126_5l, _2 and _NL constituted 
merely 3% relative to the expression of mature miRNA derived from the unmodified precursor (Fig. 3.2 
C).   
Basically, the replacement of the terminal loop with the aptamer and the connection through a C-G bp 
attached to a completely complementary miRNA precursor stem negatively affected pre-miRNA 
processing. Nevertheless, processing was retained to a viable extent of 23% relative basal expression 
allowing the measurement of an effective and reversible switching activity of the pre-miR switch miR-
126_5. Thus, the proximity of the aptamer as well as the resulting stem stability appeared to be suited 
to efficiently compromise processing by Dicer. However, the relative basal expression of the other 
constructs miR-126_5l, _2 and _NL turned out to be very weak. Due to the fact that the differences 
between these constructs and miR-126_5 consisted in variations of the transition area, the reasons for 
the strong reduction of pre-miRNA processing could be ascribed to either the stem length 
(communication module of three bp) or the stem flexibility (bulge, mismatch) of the respective 
constructs. According to their low processing efficiency the respective constructs were discarded from 
further analysis.  
All in all, it can be concluded from the results that variations in the communication module affected 
processing as well as switching efficiency of the pre-miR switches. Using a short C-G bp 
communication module seemed to provide an adequate processing activity in the absence of TetR and 
efficient inhibition of miRNA processing in the presence of TetR.  
3.2 Transfer of the pre-miR switch design to further miRNA precursors  
To explore the involvement of miRNAs in cellular processes, the development of a universally 
applicable tool is desirable to confer control over the maturation of different miRNAs. For an 
assessment of the transferability of the design concept, the miRNA precursors of miR-34a, -199a, -92a 
and -101 were selected according to their structural variety as well as their clinical relevance and 
modified with the TetR aptamer. Due to the superior expression level provided by miR-126_5, its 
communication module was utilized to design further pre-miR switches. The communication module 
was further varied by either a removal of the connecting bp (Fig. 3.4, A, B, C, D miR-x_2 (con)) or an 
exchange of the C-G with an A-U bp (Fig. 3.4, A miR-34a_1) to test the flexibility of the communication 
module. 
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Figure 3.4 Transfer of the design concept for pre-miR switch miR-126_5 to the miRNA precursors of (A) 
miR-34a, (B) miR-199a, (C) miR-92a and (D) miR-101-1 and -2. The predicted secondary structures of parts of 
the natural pri-miRNAs (left) and the modified pre-miR switches (right) are shown. The TetR aptamer highlighted 
in blue replaces the natural terminal loop of the precursor. The communication modules between precursor stem 
and TetR aptamer were slightly varied. The resulting differences in the transition areas between miRNA precursor 
and aptamer are highlighted in boxes. In the precursor stem miRNAs-5p are indicated in green, whereas red 
designates miRNAs-3p. Arrows indicate the Dicer cleavage sites. 
To analyze the miRNA expression levels as well as the switching efficiency of the novel pre-miR 
switch constructs, the same experiments were performed as for the miR-126-based constructs. 
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The results of the qPCR measurements testing the engineered miR-34a and -199a precursors are 
presented in Figure 3.5. Independent of the respective communication module, constructs based on 
the modified miR-34a precursor exhibited a comparable relative expression level of about 13% of 
mature miRNA compared to the unmodified precursor in the absence of TetR and dox. Furthermore, 
all construct designs for miR-34a displayed high dynamic ranges upon TetR expression. Whereas 
miR-34a_1 and _2 conferred a 33- and 41-fold reduction of miRNA processing, miR-34a_3 exhibited 
an outstandingly high dynamic range of about 400-fold. In contrast, only the former two designs of 
miR-34a enabled complete reversibility of the inhibitory effect by the supplementation with dox. The 
structural feature of miR-34a_3, distinguishing it from the other two constructs, is the C-G bp that 
served to couple the aptamer to the precursor structure. The additional stabilization of the stem turned 
out to be advantageous for aptamer functionality or to have an effect on the positioning of TetR in its 
bound state leading to the optimal proximity relative to the Dicer cleavage sites. As a consequence, an 
efficient inhibition of miRNA processing could be observed, since nearly no mature miRNA-34a 
accumulated in the presence of TetR.  
In contrast to the pre-miR switches miR-34a_1, _2 and _3, the variations in the communication module 
of the modified precursors of miR-199a resulted in a different processing behavior. Construct miR-
199a_2 that features a direct fusion of the aptamer to the miRNA precursor showed a distinct increase 
of about 10% of mature miRNA expression for both miRNAs compared to miR-199a_1 in the absence 
of ligand and inducer molecule. In that case, a direct connection of the aptamer to the precursor 
seemed to enhance pre-miRNA processing. Constructs miR-199a_1 and _2 revealed a 38- and 67-
fold reduction of mature miRNA-199a-5p in the presence of TetR. Here, the increase of the dynamic 
range observed for miR-199a_2 could be mainly attributed to the higher expression level of mature 
miRNA in the absence of TetR, since the reduced level of mature miRNA-199a-5p was almost equal 
for both constructs upon TetR expression. Analyzing the dynamic ranges for processing regulation of 
miR-199a-3p, much higher repression factors were yielded, as it is displayed in Figure 3.5 B. This 
could be ascribed to the fact, that the relative reduction of mature miRNA in the presence of TetR was 
more distinct for miR-199a-3p compared to miR-199a-5p, in turn resulting in a much higher dynamic 
range. The addition of dox completely reactivated pre-miRNA processing for both constructs (Fig. 3.5). 
Compared to the miR-34a based pre-miR switches, the pre-miR switches of miR-199a exhibited an 
inherently more stable closing stem that possibly rendered the additional C-G bp dispensable for an 
efficient inhibition of pre-miR processing. Accordingly, miR-199a_2 could afford a higher expression 
level of mature miRNA-199a-5p and -3p and very efficient TetR-related inhibition of processing at the 
same time. 
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Figure 3.5 TetR- and dox-dependent regulation of mature miRNA-34a (A) and miR-199a (B) levels.  
1.4 x 105 HeLa cells were seeded into 12-well plates and transfected with a plasmid either harboring the 
respective natural miRNA precursor or the pre-miR switch and the TetR expression plasmid. 1 µg/ml dox was 
supplemented to the medium 3 h after transfection. The amount of mature miRNA produced from the respective 
pre-miR switch was assessed in a qPCR assay 24 h after transfection and normalized to the miRNA amount 
derived from processing of the natural pre-miRNA. The measurements were performed in duplicates (n=3).  
Figure 3.6 shows the overexpression factors of miRNA-92a-3p as well as the expression levels of 
mature miRNA-101-3p. As it is apparent from Figure 3.6 A, even the expression of the unmodified 
miR-92a precursor resulted in a merely 6-fold overexpression of the miRNA compared to the high 
background expression level of miRNA-92a in HeLa cells. Because an extensive structural 
modification is often paralleled with a reduction of expression, no overexpression was observed for the 
modified precursors miR-92a_1 and _2. Consequently, the amount of switchable miRNA-92a covered 
an extremely small percentage of total intracellular miRNA-92a concentration rendering the application 
of the miR-92a-based pre-miR switches useless in HeLa cells. 
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The expression level of mature miR-101-3p appeared to be very low with about 4% expression related 
to the unmodified miRNA-101 precursor for both designed constructs (Fig. 3.6 B). Similarly, for 
construct miR-101_2 con that was designed based on the miR-101-2 precursor structure, but gave 
rise to the identical sequence of miR-101-3p, no overexpression could be detected. Here, the 
modification of the miRNA precursors nearly abolished miRNA-101-1 and -2 precursor processing. 
Due to their low processing efficiency, the switching characteristic of these constructs was not further 
analyzed.  
 
Figure 3.6 (A) Overexpression of the unmodified miR-92a precursor and pre-miR switches miR-92a_1, _2. 
1.4 x 105 HeLa cells were seeded into 12-well plates and transfected with a plasmid either harboring the natural 
miRNA-92a precursor or the respective pre-miR switches. The graph shows the overexpression factor of mature 
miR-92a, resulting from overexpression of the respective pre-miR switch or the unmodified precursor, related to 
endogenous miR-92a expression in HeLa cells assessed in a qPCR assay 24 h after transfection. The 
measurements were performed in duplicates (n=2). (B) Expression levels of mature miR-101-3p. 1.4 x 105 
HeLa cells were seeded into 12-well plates and transfected with a plasmid either containing the natural miRNA-
101-1 precursor or the respective pre-miR switches. The graph reveals the amount of mature miR-101 produced 
from the respective pre-miR switch related to the miRNA-101 amount derived from natural pre-miRNA processing 
determined in a qPCR assay 24 h after transfection. The measurements were performed in duplicates (n=2). 
In summary, the design concept proved to be transferable to the miRNA precursors of miRNA-34a and 
miRNA-199a. Here, the design yielded robust pre-miR switches that were able to efficiently inhibit 
miRNA processing and to reactivate miRNA biogenesis upon supplementation with dox. The 
endogenous expression of miRNA-92a in HeLa cells turned out to be too high to achieve a sufficient 
overexpression that in turn leaves room for an observable regulation. Processing to mature miRNA-
101-3p was found to be nearly abrogated after replacing the natural terminal loop of the miR-101-1 
and -2 precursors with the aptamer.  
3.3 Proof of the functionality of the pre-miR switches in a reporter gene 
assay 
The successful application of a pre-miR switch requires not only a robust functionality with regard to 
the control of mature miRNA levels, but also an efficient interaction with the miRNA target genes and 
regulatory function. Generally, a frequently used method to investigate the downstream effects of 
miRNA expression at the protein level is western blotting. However, it is not possible to distinguish 
between primary or secondary miRNA targets. Therefore, usually the predicted miRNA target sites of 
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the 3’UTR or the complete 3’UTR of a gene are used and introduced downstream of a firefly luciferase 
to elucidate the direct interaction of a regulatory miRNA with its target mRNA. In addition to the natural 
target sequences the perfect match target sites representing the perfect complement of the respective 
miRNA and therefore a positive control for miRNA binding and mRNA degradation are employed in 
such assays. Regardless of the mode of action of the respective miRNA, binding of the miRNA to the 
target sites can be visualized through a specific inhibition of reporter gene expression. Consequently, 
the level of luciferase expression also provides information about the intracellular level of mature 
miRNA.  
In the reporter gene assays, the regulatory performance of the functional pre-miR switches miR-
126_5, miR-34a_2 and miR-199a_2 was examined. A perfect match target site, the triplicate of a 
natural binding site or a full/ larger part of the 3’UTR of the respective target mRNA were cloned 
downstream of the firefly luciferase gene. The plasmid map of pMIR-perfect match miR-126 is 
presented in Figure 3.7. This map shows the perfect match target site for miR-126 that was inserted 
into the plasmid by the restriction sites for SacI and SpeI. Comparably, the triplicates of the natural 
miRNA binding site as well as the (part of the) 3’UTR of a target mRNA were inserted into the multiple 
cloning site (MCS) of the plasmid using the restriction sites for XhoI, SpeI, SacI and HindIII.  
 
Figure 3.7 Plasmid map of pMIR-perfect match miR-126.  
The plasmid map schematically shows the construction of a plasmid used for the reporter gene assay testing the 
binding of miR-126 to its perfect match target site (ts, light green) with regard to TetR and dox-dependent 
regulation. The firefly luciferase (green) is expressed under control of a CMV promoter (blue). The multiple 
cloning site (MCS, grey) of the plasmid was used to insert the perfect match target site for miR-126 using the 
restriction sites SacI and SpeI.   
The respective targets of the miRNAs were selected according to a preceding validation by other 
groups. One known validated target of miRNA-126-3p is SPRED1 that harbors three predicted binding 
sites for miRNA-126-3p 104. For the analysis of the influence of miR-126_2 regulation on reporter gene 
expression, one predicted binding sequence was introduced as a triplicate downstream of the firefly 
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luciferase gene. To investigate the regulatory effect of pre-miR switch miR-34a_2 and miR-199a_2, a 
triplicate of one predicted miRNA target sequence of the 3’UTR of E2F3, a target of miR-34a-5p, of the 
3’UTR of DDR1, constituting a target of miR-199a-5p and of the 3’UTR of CAV2 validated as a target 
of miR-199a-3p, were cloned downstream of the reporter gene, respectively 79,111,113.   
For the purpose of further investigating the influence of the pre-miR switches on luciferase gene 
expression, the complete natural 3’UTR of the miR-34a-5p target MET with three predicted binding 
sites was employed 85. A larger part of the 3’UTR of the miR-199a-5p target DDR1 with four predicted 
binding sites was used. Furthermore, a part of the 3’UTR of the miR-199a-3p target CAV2 harboring 
two predicted miRNA binding sites as well as the two complete 3’UTRs of MET and CD44 with three 
predicted miRNA binding sites for miR-199a-3p were used for the experiments 115.  
HeLa cells were co-transfected with the plasmid containing the respective modified reporter gene and 
the plasmid bearing the pre-miR switch. In addition to this, the TetR expression plasmid and a plasmid 
harboring a Renilla luciferase that served to normalize the firefly luciferase values to the respective cell 
count as well as to account for experimental variations due to differences in transfection efficiency 
were co-transfected. The luminescence values were normalized to the respective controls that showed 
the reporter gene expression in the absence of the particular miRNA. To exclude off-target effects, 
control constructs were generated with a single or a triplicate random sequence. 1 µg/ml dox was 
added 3 h after transfection and luminescence values were measured 24 h after transfection.  
The data of the reporter gene assay are presented in Figure 3.8 to Figure 3.11. Generally, the 
inhibition of pre-miRNA processing through TetR binding is reflected by an increase in reporter gene 
expression. The experiments that employed the perfect match binding sites of the miRNAs 
downstream of the reporter gene revealed an increase of relative reporter gene expression between 
2.5- and 3.1-fold for the pre-miR switches miR-126_5 and miR-199a_2, whereas the increase of 
relative expression for construct miR-34a_2 with 1.7-fold turned out to be comparably moderate in the 
presence of TetR (Fig. 3.8). This difference in regulation efficiency could be ascribed to the lower 
expression level of mature miRNA-34a-5p compared to that of miR-126-3p and miR-199a-5p/-3p. 
Furthermore, all of the tested pre-miR switches appeared to nearly completely restore the relative 
expression value of one in the presence of dox. Accordingly, the dissociation of TetR from the aptamer 
resulted in a resumption of pre-miRNA processing that, in turn, diminished reporter gene expression. 
The random controls did not show an effect on relative expression due to the presence of the 
respective pre-miR switch, excluding either unspecific binding or a TetR- or dox-based effect.  
The examination of the influence of the pre-miR switch-controlled miRNA expression on reporter gene 
regulation after insertion of the triplicates of the natural target sites showed an increase of expression 
of 1.5- to 1.9-fold that could be observed for miR-126-3p, miR-34a-5p and miR-199a-5p upon TetR 
expression (Fig. 3.9). A direct interaction of miR-199a-3p with the predicted target site of CAV2 could 
not be detected, as no change in relative reporter gene expression occurred (Fig. 3.11 A). Possibly, 
the tested miRNA binding site is either falsely designated as a binding site of miR-199a-3p or it the 
merely contributes weakly to the regulation of gene expression.  
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Figure 3.8 Effect of aptamer-controlled miRNA processing on reporter gene expression.  
The respective perfect match binding site for testing miR-126-3p/ -34a-5p and miR-199a-3p/-5p binding were 
introduced downstream of a firefly luciferase gene. 0.55 x 105 HeLa cells were seeded into 24-well plates and 
transfected with a reporter gene plasmid either harboring the respective miRNA target sites or a random control 
site. Furthermore, the plasmids with the natural miRNA precursor or the pre-miR switch, a TetR expression 
plasmid as well as a Renilla luciferase expression plasmid for normalization were co-transfected (ratio of reporter 
gene plasmid:miRNA precursor or pre-miR switch expression plasmid:TetR expression plasmid:Renilla 
expression plasmid 4:7:7:2). 1 µg/ml dox was added to the medium 3 h after transfection. The luminescence 
measurements were performed in duplicates 24 h after transfection (n=3). The measured values related to Renilla 
luciferase expression were normalized to reporter gene expression in the absence of the respective miRNA 
expression plasmid followed by a second normalization to reporter gene expression in presence of the respective 
miRNA expression plasmid devoid of TetR or dox. Thus, graphs display the relative expression values as x-fold 
increase. Above the graphs the respective target sites are depicted that were introduced downstream of the firefly 
luciferase gene. The miRNA target sequences are shown in green, the miRNA sequences are highlighted in red. 
RLU Relative luminescence unit. 
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Figure 3.9 Effect of aptamer-controlled pre-miRNA processing on reporter gene expression.  
The respective triplicate of one binding site derived from a natural target gene for testing miR-126-3p/ -34a-5p 
and miR-199a-5p binding were introduced downstream of a firefly luciferase gene. 0.55 x 105 HeLa cells were 
seeded into 24-well plates and transfected with a reporter gene plasmid either harboring the respective miRNA 
target sites or random control sites. Furthermore, the plasmids with the natural miRNA precursor or the pre-miR 
switch, a TetR expression plasmid as well as a Renilla luciferase expression plasmid for normalization were co-
transfected (ratio of reporter gene plasmid:miRNA precursor or pre-miR switch expression plasmid:TetR 
expression plasmid:Renilla expression plasmid 4:7:7:2). 1 µg/ml dox was added to the medium 3 h after 
transfection. The luminescence measurements were performed in duplicates 24 h after transfection (n=3). The 
measured values related to Renilla luciferase expression were normalized to reporter gene expression in the 
absence of the respective miRNA expression plasmid followed by a second normalization to reporter gene 
expression in presence of the respective miRNA expression plasmid devoid of TetR or dox. Thus, graphs display 
the relative expression values as x-fold increase. Above the graphs the respective target sites are depicted that 
were introduced downstream of the firefly luciferase gene. The miRNA target sequences are shown in purple, the 
miRNA sequences are highlighted in red. RLU Relative luminescence unit.  
The insertion of the complete 3’UTR of MET, harboring three different miRNA binding sites for miR-
34a led to an increase of relative expression of 1.4-fold (Fig. 3.10 left), whereas the incorporation of a 
part of the 3’UTR of DDR1 resulted in a 1.8-fold elevation of relative expression due to miR-199a-5p 
binding (Fig. 3.10 right). The reversibility of that effect was also observed upon the addition of dox. 
Comparing the effect resulting from insertion of the triplicate of a single miR-199a-5p binding 
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sequence derived from DDR1 with that of the insertion of a larger part of the 3’UTR with several 
binding sites for one miRNA, it can be asserted that the interplay of the four predicted target sites in 
the 3’UTR led to a more effective inhibition of firefly luciferase expression. 
 
Figure 3.10 Effect of aptamer-controlled pre-miRNA processing on reporter gene expression.  
A complete or a larger part of 3'UTR of a respective targets MET or DDR1 for testing miR-34a-5p and miR-199a-
5p binding were introduced downstream of a firefly luciferase gene. 0.55 x 105 HeLa cells were seeded into 24-
well plates and transfected with a reporter gene plasmid harboring the respective (part of the) 3’UTR. 
Furthermore, the plasmids with the natural miRNA precursor or the pre-miR switch, a TetR expression plasmid as 
well as a Renilla luciferase expression plasmid for normalization were co-transfected (ratio of reporter gene 
plasmid: miRNA precursor or pre-miR switch expression plasmid:TetR expression plasmid:Renilla expression 
plasmid 4:7:7:2). 1 µg/ml dox was added to the medium 3 h after transfection. The luminescence measurements 
were performed in duplicates 24 h after transfection (n=3). The measured values related to Renilla luciferase 
expression were normalized to reporter gene expression in the absence of the respective miRNA expression 
plasmid followed by a second normalization to reporter gene expression in presence of the respective miRNA 
expression plasmid devoid of TetR or dox. Thus, graphs display the relative expression values as x-fold increase. 
Above the graphs the respective target sites within the target gene 3’UTR are depicted that were introduced 
downstream of the firefly luciferase gene. The miRNA target sequences are shown in purple, the miRNA 
sequences are highlighted in red. RLU Relative luminescence unit.  
Although the complete 3’UTRs of the validated targets CAV2, MET and CD44 were inserted 
downstream of the reporter gene, no regulatory effect hinting at a direct interaction of miR-199a-3p 
with these 3’UTRs could be inferred (Fig. 3.11). In consent with these findings, also no change in 
firefly luciferase gene expression could be determined when the miRNA was naturally processed from 
the unmodified precursor. It can be assumed that either the expression levels of miR-199a-3p were 
generally not sufficient to affect gene expression or the cellular context was not appropriate to facilitate 
a miRNA-target site interaction.  
For all of the tested miRNAs with the exception of miR-199a-3p, a regulation of reporter gene 
expression based on pre-miR switch performance could be demonstrated dependent on the presence 
of TetR and dox. Thus, the results confirmed that the expression levels of the miRNAs as well as the 
regulation efficiency of the respective pre-miR switches notably influenced reporter gene expression 
and hence supported the data previously obtained by qPCR. The different extents of regulation were 
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constituted by the different amounts of mature miRNA dependent on the pre-miR switch as well as the 
various binding sites that all display individual interaction characteristics with the respective miRNAs. 
 
Figure 3.11 Effect of aptamer-controlled miR-199a-3p presence on reporter gene expression.  
(A) A triplicate of one binding site of miR-199a-3p derived from the natural target CAV2, (B) a larger part of the 
3’UTR of CAV2 harboring two predicted miRNA binding sites and (C) the two complete 3’UTRs of MET and CD44 
featuring three predicted miRNA binding sites for miR-199a-3p were introduced downstream of a firefly luciferase 
gene. 0.55 x 105 HeLa cells were seeded into 24-well plates and transfected with a reporter gene plasmid either 
harboring the respective miRNA target sites or random control sites. Additionally, the plasmids with the natural 
miRNA precursor or the pre-miR switch, a TetR expression plasmid as well as a Renilla luciferase expression 
plasmid for normalization were co-transfected (4:7:7:2 ratio of reporter gene plasmid: miRNA precursor or pre-
miR switch expression plasmid:TetR expression plasmid:Renilla expression plasmid). 1µg/µl Dox was added to 
the medium 3 h after transfection. The luminescence measurements were performed in duplicates 24 h after 
transfection (n=2). The measured values related to Renilla luciferase expression were normalized to reporter 
gene expression in the absence of the respective miRNA expression plasmid followed by a second normalization 
to reporter gene expression in presence of the respective miRNA expression plasmid devoid of TetR or dox. 
Thus, graphs display the relative expression values as x-fold increase. Above the graphs the respective target 
sites (within the target gene 3’UTR) are depicted. The miRNA target sequences are shown in purple, the miRNA 
sequences are highlighted in red. RLU Relative luminescence unit.    
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3.4 Determination of the pre-miR switch miR-199a_2 onset kinetics 
The in vivo application of a pre-miR switch requires its operation at biological relevant time scales. 
Thus, a closer characterization of the onset kinetics of one pre-miR switch was pursued. With regard 
to the developed pre-miR switches the onset kinetics provided information on the time needed to 
respond to dox by a dissociation of TetR from the aptamer. Therefore the measured parameter was 
the continuation of miRNA processing that was constituted by the amount of mature miRNA.  
Accordingly, time-course experiments were performed to elucidate the potential of pre-miR switch 
miR-199a_2. For that purpose, HeLa cells were transfected with the pre-miR switch miR-199a_2 
containing plasmid and the TetR expression plasmid. The cells were treated with dox 24 h after 
transfection. To exclude effects arising from transient transfection, control cells were concomitantly 
transfected with the plasmid containing the pre-miR switch, omitting the TetR expression plasmid and 
dox supplementation, to monitor the processing of the pre-miRNA switch in the course of the 
experiment. The levels of mature miR-199a-5p were measured at 0, 2, 4, 8, 16 and 24 h after dox 
addition by qPCR. The results were shown normalized to the respective controls, because a reduction 
of absolute processing to the mature miRNA was observed over time that was probably caused by cell 
division (Fig. 3.12 B).  
Figure 3.12 A displays the results of the time course experiments. A rapid increase of miRNA 
expression was recorded already after 1 h, restoring pre-miRNA processing to about 30%. 
Furthermore, a steep digressive expression profile between 0 to 4 h suggested a preceding 
accumulation of pre-miRNA that has been shielded from degradation probably due to an occupation 
with TetR protein before dox addition led to a dissociation of TetR from the aptamer. That effect might 
have superimposed the natural kinetics of the pre-miR switch resulting in the observed curve 
progression. Once, excess pre-miRNA was processed by Dicer, miRNA expression kinetics resumed 
a constant expression profile climaxing in the highest miRNA amount of 80% measured at about 16 h 
after dox addition.  
From the experiment it can be deduced that pre-miR switch miR-199a_2 features fast onset kinetics. 
An almost complete restoration of miRNA processing was accomplished within 24 h. Hence, the 
developed pre-miR switch operates at biological relevant time scales highlighting its applicability as a 
robust and efficient regulator of miRNA biogenesis. 
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Figure 3.12 (A) Onset kinetics of pre-miR switch 199a_2. 1.4 x 105 HeLa cells were seeded into 12-well plates 
and transfected with a plasmid harboring pre-miR switch miR-199a_2 and the TetR expression plasmid. 24 h after 
transfection, 1 µg/ml dox was added to the medium and cells were harvested after 0, 2, 4, 8, 16 and 24 h after 
dox addition. The qPCR-based measurement was performed in duplicates for detection of mature miRNA-199a-
5p (n=3). Shown is the amount of mature miRNA-199a-5p produced from the pre-miR switch related to the 
miRNA levels derived from controls transfected with the pre-miR switch in the absence of TetR or dox (shown in 
B). (B) Pre-miR switch miR-199a_2 processing over 24h. 1.4 x 105 HeLa cells were seeded into 12-well plates 
and transfected with a plasmid harboring pre-miR switch miR-199a_2. 24 h after transfection growth medium was 
exchanged and cells were harvested after 0, 2, 4, 8, 16 and 24 h after medium exchange. The qPCR-based 
measurement was performed in duplicates for detection of mature miRNA-199a-5p (n=3). Shown is the amount of 
mature miRNA-199a-5p normalized to the amount of mature miRNA-199a-5p present at time point 0 (=100%) in 
the absence of TetR or dox. 
3.5 Regulatory function of the pre-miR switches targeting endogenous 
genes 
3.5.1 Transient transfection of pre-miR switch miR-199a_2 
MiRNAs are known to confer regulation of gene expression through degradation of mRNA or inhibition 
of translation. In most cases the mode of action of a certain miRNA-target pair has not been elucidated 
so far and therefore it is not predictable, whether the interaction leads to a change at the mRNA level, 
a visible effect at the protein level, or both. To detect potential regulatory effects on endogenous 
miRNA targets caused by the pre-miR switch application, qPCR as well as western blotting were 
performed. Based on previously published studies, that identified SMAD4 and DDR1 as target genes 
of miR-199a-5p, these two endogenous targets were screened for regulation by the pre-miR switch 
miR-199a_2 110,111.  
For qPCR measurements, HeLa cells were transfected with the plasmid harboring the pre-miR switch 
miR-199a_2 or the natural miRNA precursor as a positive control for Dicer processing together with a 
TetR expression plasmid. 1 µg/ml dox was added to the medium 3 h after transfection. 24 h after 
transfection total RNA was isolated and transcribed with random hexamers. The amount of respective 
target mRNA was then assessed using cDNA-specific primers in a qPCR assay. For the examination 
of the protein level by western blotting, cells were transfected with 1,000 ng of the empty plasmid 
pCMV-MS (MS), 500 ng of pCMV-MS together with 500 ng of the natural precursor harboring 
construct (MS+miR-199a) or 1,000 ng of the natural precursor (miR-199a) alone, to test for a general 
response to miR-199a presence. Cells were lysed 24 h after transfection and 20 µg of total protein 
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analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). Then, total 
protein was blotted onto a PVDF membrane. The target proteins SMAD4 (60 kDa) and DDR1 (100 
kDa: non-glycosylated; 125 kDa: glycosylated) were visualized using horseradish peroxidase (HRP)-
conjugated secondary antibodies with a chemiluminescence substrate. As a loading control β-actin 
was used. 
 
Figure 3.13 Influence of mature miR-199a levels on mRNA and protein level of (A) SMAD4 and (B) DDR1 
after transient transfection. Shown are either the results from mRNA level determination using qPCR or the 
protein levels of the respective miR-199a target in a western blot. For qPCR assays, 1.4 x 105 HeLa cells were 
seeded into 12-well plates and transfected with the plasmid containing the natural miR-199a precursor or pre-miR 
switch miR-199a_2 and the TetR expression plasmid. 1 µg/ml dox was supplemented 3 h after transfection. Total 
RNA was isolated and the mRNA level measurements were performed in duplicates 24 h after transfection (n=2). 
The mRNA levels are shown normalized to the mRNA amount of HeLa cells transfected with empty plasmid. For 
the visualization of the target proteins SMAD4 and DDR1 in a western blot, 1.4 x 105 HeLa cells were seeded into 
12-well plates and transfected with the either empty plasmid (MS), the natural miR-199a precursor bearing 
plasmid (miR-199a) or a 1:1 mixture of both (MS+miR-199a) in duplicates. Cells were lysed 24 h after transfection 
and 20 µg of total protein analyzed by an SDS-PAGE. Then total protein was blotted onto a PVDF membrane and 
the target proteins SMAD4 (60 kDa) and DDR1 (100 kDa, 125 kDa) were visualized using HRP-conjugated 
secondary antibodies with a chemiluminescence substrate. β-actin (42 kDa) was used as loading control. Protein 
sizes are indicated in kDa.  
As it becomes evident from Figure 3.13 A, no relevant regulation of the mRNA level of SMAD4 neither 
in the presence of miR-199a-5p derived from the natural precursor nor by miR-199a-5p stemming from 
the pre-miR switch miR-199a_2 was identifiable. In contrast to that, the presence of miR-199a 
processed from the unmodified precursor slightly diminished the mRNA amount of DDR1 for about 
30% compared to the mRNA expression in the absence of miR-199a (Fig. 3.13 B). In comparison, the 
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reduction of DDR1 mRNA that could be associated with the pre-miR switch processing emerged to be 
less intense. Furthermore, a significant response of the mRNA levels to the presence of TetR or dox 
could not be deduced from the results.  
Looking at the western blots of SMAD4 and DDR1, no changes at the protein level of both potential 
miR-199a-5p targets appeared due to miR-199a presence independent of the source of the miRNA. 
Also other cells (A549, HEK-293) were tested for a change at the protein level due to miR-199a 
presence but they equally yielded no visible regulation.  
To sum up, for SMAD4 no regulation at the mRNA or protein level was observed. The small effect 
appearing at the DDR1 mRNA level allowed the deduction of a small tendency regarding a response 
to the presence of the miRNA but was still far away from being significant. In case of DDR1, the 
detected decrease of the mRNA amount did not result in an apparent change at the protein level. 
Thus, it could not be excluded that the amount of miRNA-199a-5p provided by transient transfection 
was too weak to evoke significant changes on both, mRNA and protein level.  
3.5.2 Genomic integration of pre-miR switch miR-199a_2 
A genomic integration constitutes a valid approach to overcome an irregular distribution of the plasmid 
used for miRNA precursor expression within the cell population due to moderate transfection 
efficiencies and the capability of a cell to take up varying numbers of the transfected plasmid. Without 
a preceding selection the examination of the total RNA or the total protein after transient transfection 
implies mRNA and protein from both transfected as well as non-transfected cells. In contrast to that, 
genomic integration allows an assay performance with cells exhibiting a uniform genotype and thus 
comparable levels of miRNA.  
For this reason, a stable integration of the pre-miR switch construct miR-199a_2 and the natural miR-
199a precursor into the genome of HF1-3 cells was performed using the Flip-in® system. A plasmid 
was established for this purpose that harbored the respective constructs under control of an hCMV 
promoter and the Flp Recombination Target (FRT)-site that served as a recognition as well as 
cleavage site for the applied recombinase (Fig. 3.14). This FRT-site was located upstream of a 
hygromycin resistance conferring gene that lacked a promoter and a start codon. The promoter and 
the start codon were, in turn, integrated into the HF1-3 host cell genome and brought into correct 
proximity and frame with the hygromycin resistance gene upon genomic integration of the created 
plasmid at the FRT-site. Successful integration then conferred hygromycin resistance to the cells and 
enabled selection of the cells bearing the integrated constructs.  
The respective plasmids containing either the natural miRNA precursor or the pre-miR switch and a 
plasmid for Flp recombinase expression were co-transfected into the HF1-3 host cells. Following 
transfection with the plasmids, cells were selected with 150 µg/µl hygromycin B for an integration of 
the constructs. After selection, cells with the integrated construct were additionally transfected with the 
TetR expression plasmid and 1 µg/ml dox was supplemented 3 h after transfection. To explore the 
expression level as well as switching characteristic of the chromosomally integrated pre-miR switch, 
total RNA was isolated, miR-199a-5p transcribed into cDNA and the amount of the mature miRNA-
199a-5p was determined 24 h and 72 h after dox addition by qPCR. Concomitantly, the levels of 
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mRNA expression of SMAD4 and DDR1 were determined after 24 h in the presence of miR-199a 
derived from both the natural and the TetR aptamer-modified precursor in a qPCR assay.  
To complete the dataset, a western blot was performed to reveal a possible regulation of DDR1 
protein expression by miR-199a-5p. Therefore, a change from the previously used gradient SDS-
PAGE gel to a 7.5% SDS-PAGE gel was conducted to obtain a better resolution of the two DDR1 
bands.    
 
Figure 3.14 Plasmid map of pFRT-miR-199a.  
The plasmid map schematically shows the construction of plasmid pFRT-miR-199a used for the genomic 
integration of the natural miRNA-199a precursor or pre-miR switch miR-199a_2. The constructs were expressed 
under control of an hCMV promoter (blue). BamHI and SacI restriction sites were employed for the insertion of the 
(un-)modified miRNA precursor surrounded by 100 nt of natural context up- and downstream (grey). The FRT-site 
(orange) for genomic integration is located upstream of the hygromycin B resistance gene (Hygro(R)\(no\ATG), 
red) that lacks a promoter and a start codon.    
As Figure 3.15 A reveals, after 24 h the genomic integration of pre-miR switch miR-199a_2 resulted in 
17% expression of mature miRNA-199a-5p compared to the natural precursor that was comparatively 
lower than for transient transfection. Unfortunately, the efficient inhibition of miRNA processing 
appeared to be strongly reduced to a factor of 1.4-fold. The addition of dox completely restored pre-
miRNA processing to the primarily seen expression value. The measurements of the level of mature 
miR-199a-5p after 72 h revealed a reduction of miRNA expression to 10% compared to the natural 
precursor in the absence of TetR and dox, but the presence of TetR resulted in a slightly enhanced 
inhibitory effect compared to the results obtained after 24 h leading to a 3.2-fold reduction of pre-
miRNA processing. Also here, a reversion of the inhibitory effect could be observed upon the 
supplementation with dox.  
In summary, the qPCR measurements after 24 h uncovered a clear loss of efficient suppression of 
miRNA processing by TetR that was slightly improved after a longer incubation for 72 h. Possibly, this 
phenomenon can be ascribed to the genomic integration of the pre-miR switch without a parallel TetR 
integration that led to a continuous production of miRNA over a long period of time. As a consequence 
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of constitutive miRNA expression, preceding TetR expression, mature miR-199a-5p seemed to be 
accumulated in the cell. Thus, although the presence of TetR prevented the cell from processing new 
mature miR-199a through binding to the pre-miR switch, the measurements were falsified by the 
previously matured miRNA amount that therefore diminished the inhibitory effect. In that case, the 
effect caused by TetR binding might have been masked by the strong miRNA-199a background that 
persisted in the cell until miRNA degradation occurred. This theory was further supported by the 
results obtained from the 72 h measurements. They displayed a slightly improved dynamic range with 
regard to the suppression of pre-miR processing that hinted at the possibility that after a longer time of 
TetR induced suppression, the reduction of the miRNA amount became apparent due to the absence 
of de novo pre-miRNA processing. To exclude problems resulting from a defective expression of TetR, 
the presence of TetR (24 kDa) in the samples after 24 h and 48 h after transfection was verified in a 
western blot (Fig. 3.16 A). Regarding the cellular amount of TetR protein and the ratio of pre-miR 
switch and TetR no statements could be made. 
 
Figure 3.15 (A) TetR- and dox-dependent regulation of mature miRNA-199a after genomic integration of 
pre-miR switch miR-199a_2. To examine the switching efficiency after genomic integration, 0.9 x 105 HF1-3 cells 
exhibiting the natural miR-199a precursor or pre-miR switch miR-199a_2 integrated in their genome were seeded 
into 12-well plates, transfected with the TetR expression plasmid and 1 µg/ml dox was supplemented 3 h after 
transfection. Either 24 h (left) or 72 h (right) after transfection total RNA was isolated and the amount of mature 
miRNA-199a-5p determined in duplicates in a qPCR assay (n=3). The miR-199a-5p levels are presented 
normalized to the miRNA amount derived from natural pre-miRNA processing. (B) Influence of miR-199a 
expression on mRNA level of SMAD4 and DDR1 after genomic integration. To examine the effect of 
genomically expressed miR-199a on SMAD4 and DDR1 mRNA levels, 0.9 x 105 HF1-3 cells expressing the 
natural miR-199a precursor or pre-miR switch miR-199a_2 were seeded into 12-well plates and incubated for 24 
h. Afterwards, total RNA was isolated and mRNA levels of the miR-199a target SMAD4 and DDR-1 were 
assessed in qPCR. The mRNA levels are shown normalized to the mRNA amount of non-integrated HF1-3 cells. 
The measurements were performed in duplicates (n=2).   
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Regardless of the loss of the efficient switching characteristic, the impact of a constant miRNA-199a 
overexpression on the mRNA level of SMAD4 and DDR1 in the cell was determined. The graph in 
Figure 3.15 B clearly shows that no decrease of the SMAD4 mRNA level arose due to miR-199a 
presence for the control with the natural miRNA precursor (miR-199a), whereas miR-199a presence 
derived from the pre-miR switch (miR-199a_2) evoked a strong decline of the mRNA level to about 
40% compared to the mRNA level provided by the untreated HF1-3 cells. In contrast to the 
inconsistent behavior seen for SMAD4, the chromosomal expression of miR-199a-5p from both 
integration HF1-3 cell lines elicited a comparable reduction of DDR1 mRNA ranging from 50% to 40% 
of the mRNA level of the non-integrated cells. 
It may be assumed, that SMAD4 mRNA regulation was influenced by other unexpected factors. Since 
the expression level of miR-199a based on natural precursor processing usually excelled the miR-
199a level derived of the pre-miR switch, a comparable or even stronger reduction of the mRNA level 
was to be expected. The expectations were met in case of DDR1 where at least a similar decline of 
the mRNA level could be observed for miRNAs-199a-5p independent of the origin. Due to the 
emergence of that unknown factor that influenced SMAD4 regulation, this miRNA target was 
abrogated from further analyses.  
The western blot in Figure 3.16 B shows the DDR1 protein amount derived from the non-integrated 
HF1-3 cells (HF) and the cells harboring the natural precursor (199a) and the pre-miR switch (199a_2) 
chromosomally integrated into their genome, after 24 and 48 h. After 24 h a reduction of band intensity 
could be observed for the samples subjected to miR-199a-5p expression, supporting the findings from 
the measurement of DDR1 mRNA levels. This effect was more distinct for the samples expressing 
miR-199a from the natural precursor. But also in sample 199a_2 the intensity of the DDR1 bands still 
exhibited a comparably lower band intensity compared to the untreated HF cells after 24 h. That 
tendency was also reflected in the western blot performed after 48 h. At least the protein amount in 
miR-199a-5p presence derived from the natural precursor seemed to be reduced, whereas the protein 
amount for the cells with the integrated pre-miR switch exhibited a DDR1 protein amount comparable 
to that of the HF cells despite of miR-199a-5p attendance. 
These findings indicated a presumable interaction of miR-199a-5p, processed from both, the 
unmodified and the modified precursor, with DDR1. Considering the results from mRNA measurement 
and western blotting of DDR1, it could be deduced that the genomic integration accompanied by a 
constitutive expression of miR-199a was advantageous with regard to DDR1 target regulation.     
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Figure 3.16 (A) TetR expression after transient transfection of HF1-3 cells. For the visualization of TetR in a 
western blot, 0.9 x 105 HF1-3 cells either carrying no construct (HF), the natural miR-199a precursor (miR-199a) 
or the pre-miR switch miR-199a_2 (miR-199a_2) integrated in the genome were seeded into 12-well plates and 
transiently transfected with the TetR expression plasmid. Cells were lysed 24 h or 48 h after transfection and 40 
µg of total protein was analyzed in an SDS-PAGE. Total protein was blotted onto a PVDF membrane and TetR 
(24 kDa) visualized using HRP-conjugated secondary antibodies with a chemiluminescence substrate. β-actin (42 
kDa) was used as loading control. Protein sizes are indicated in kDa. (B) Influence of miR-199a construct 
integration on DDR1 protein level. To test the influence on DDR1 protein expression, 0.9 x 105 of the non-
integrated (HF) and the stably integrated HF1-3 cells (199a, 199a_2) were seeded into 12-well plates and 
incubated for either 24 h or 48 h. Afterwards, cells were lysed, 40 µg of total protein analyzed in an SDS-PAGE 
and blotted onto a PVDF membrane. DDR1 (100 kDa, 125 kDA) was visualized using HRP-conjugated secondary 
antibodies with a chemiluminescence substrate. HSP-60 (60 kDa) was used as a loading control. Protein sizes 
are indicated in kDa.    
3.5.3 Genomic integration of pre-miR switch miR-199a_2 and TetR 
A second genomic integration was performed where the natural precursor or the pre-miR switch were 
integrated together with TetR into the genome of HF1-3 cells. This approach aimed to prevent the 
constitutive expression followed by an accumulation of miR-199a-5p through a concurrent expression 
of the aptamer ligand TetR and the pre-miR switch miR-199a_2. Additionally, the cell was not under 
permanent influence of an endogenously absent miRNA that possibly changes cellular processes 
through unpredictable primary and secondary effects.   
Genomic integration was performed as described earlier. The only variation consisted in the 
composition of the transfected integration plasmid that now additionally harbored the TetR expression 
gene under control of a SV40 promoter (Fig. 3.17). After selection, first, the dynamic range of the pre-
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miR switch was examined after 24 h, 48 h and 5 d of dox incubation. Therefore, the selected and the 
control HF1-3 cells were seeded into 12-well plates and incubated with dox after 24 h. Cells were 
harvested after 24 h, 48 h and 5 d of dox incubation and total RNA was isolated, miRNA-199a-5p  was 
reversely transcribed and qPCR measurements were performed to assess the amount of mature miR-
199a-5p. In case of the 5 d incubation the medium was changed after two days and freshly 
supplemented with 1 µg/ml dox.  
Furthermore, the expression of TetR was tested after genomic integration and visualized in a western 
blot. For this purpose, the cells expressing the natural miRNA-199a precursor (199a) or the pre-miR 
switch miR-199a_2 (199a_2) and non-integrated HF1-3 cells (HF) were seeded into 12-well plates and 
incubated for 24 h or 48 h at 37°C. Then, cells were lysed and 40 µg of total protein analyzed in an 
SDS-PAGE. Afterwards, total protein was blotted onto a PVDF membrane and TetR was detected 
using HRP-conjugated secondary antibodies with a chemiluminescence substrate. As a loading 
control β-actin was used. 
 
Figure 3.17 Plasmid map of pFRT-miR-199a-TetR.  
The plasmid map schematically shows the composition of plasmid pFRT-miR-199a-TetR used for the genomic 
integration of the natural miRNA-199a precursor or pre-miR switch miR-199a_2 together with TetR. The 
constructs were expressed under control of an hCMV promoter (blue), whereas TetR expression was driven by an 
SV40 promoter (darker blue). The FRT-site (orange) for genomic integration is located upstream of the 
hygromycin B resistance gene (Hygro(R)\(no\ATG), red) that lacks a promoter and a start codon. 
Figure 3.18 A clearly shows an efficient suppression of pre-miRNA processing to 1.4% of mature 
miRNA compared to the natural precursor-based miR-199a-5p expression according to the 
simultaneous expression of miR-199a_2 and TetR after genomic integration. The supplementation 
with dox resulted in a 12-fold increase of the amount of mature miRNA-199a-5p after 24 h up to 17%. 
This 17% of expression exactly agreed with the value obtained after the first genomic integration. The 
elevated miRNA expression level was also conserved after 48 h of dox incubation. Even after 5 d of 
incubation, a 9-fold elevation of the amount of the mature miRNA-199a-5p up to 15% in comparison to 
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the natural precursor appeared (Fig. 3.18 A right). These findings corresponded with the results 
obtained from time course experiments and confirmed that pre-miRNA processing was completely 
reconstituted within 24 h of incubation with dox. The western blot for TetR detection confirmed the 
successful integration and expression of TetR in the samples that derived from HF1-3 cells either 
harboring the natural precursor or the pre-miR switch integrated in their genome (Fig. 3.18 B). 
Basically, the genomic integration including TetR restored the efficient switching characteristic of the 
pre-miR switch. Thus, repression due to TetR binding was reversible upon dox addition and found to 
be stable for at least 5 d. Supporting this observation, it could also be verified that TetR was present in 
all cells that were subject to genomic integration. But the genomic integration of the pre-miR switch 
resulted in a lower pre-miR switch expression and a strong loss of dynamic range compared to the 
effects seen after transient transfection. 
 
Figure 3.18 (A) TetR- and dox-dependent regulation of mature miRNA-199a after genomic integration of 
pre-miR switch miR-199a_2 and TetR. For identifying the switching efficiency after genomic integration of the 
constructs and TetR, 0.9 x 105 HF1-3 cells possessing the natural miR-199a precursor or pre-miR switch miR-
199a_2 integrated in their genome were seeded into 12-well plates and treated with 1 µg/ml dox for either 24 h, 
48 h (left) or 5 d (right). Then, total RNA was isolated and the amount of mature miRNA-199a-5p assessed in 
duplicates in a qPCR assay (n=3). The miR-199a-5p levels are presented normalized to the miRNA amount 
derived from natural pre-miRNA processing. (B) TetR expression after genomic integration. For verifying the 
successful integration of TetR into the genome at the protein level a western blot was performed. 0.9 x 105 HF1-3 
cells harboring no construct (HF), the natural miR-199a precursor (miR-199a) or the pre-miR switch miR-199a_2 
(miR-199a_2) together with TetR integrated in the genome were seeded into 12-well plates and incubated for 24 
h or 48 h. Then, the cells were lysed and 40 µg of total protein analyzed in an SDS-PAGE. Total protein was 
blotted onto a PVDF membrane and TetR (24 kDa) visualized using HRP-conjugated secondary antibodies with a 
chemiluminescence substrate. β-actin (42 kDa) was used as loading control. Protein sizes are indicated in kDa. 
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After ascertaining that the pre-miR switch and TetR expression were functional after genomic 
integration, the effect of dox supplementation on DDR1 protein level was examined. Additionally, 
CAV1 that constitutes another validated target of miR-199a-5p, was adjoined to explore the impact of 
pre-miR switch-controlled processing on CAV1 protein (22 kDa) expression. HF1-3 cells, either without 
integration (HF), expressing the integrated natural precursor (199a) or the pre-miR switch (199a_2) 
were treated with dox for 24 h, 48 h or 5 d. Then, cells were harvested, lysed and 40 µg of total protein 
were analyzed in an SDS-PAGE. Afterwards, total protein was blotted onto a PVDF membrane and 
DDR1 and CAV1 were detected using HRP-conjugated secondary antibodies with a 
chemiluminescence substrate. As loading controls either HSP-60 or β-actin were employed. 
Basically, the western blots showing protein DDR1 revealed no significant reduction of the protein 
amount due to miR-199a-5p presence. For the samples 199a that expressed miR-199a-5p from the 
natural precursor, a weak reduction of the intensity of the upper band was observed in Figure 3.19 A 
and B compared to sample HF. This detected change at the protein level was completely abolished for 
the samples 199a_2 (A)/ _2 (B) with miR-199a-5p derived from the pre-miR switch miR-199a_2 hinting 
at too little amounts of mature miRNAs being processed under the present conditions. Comparing the 
band intensity of 199a_2 and 199a_2 24 h, no noticeable alteration of DDR1 protein levels was 
determined after 24 h of dox incubation. The western blot showing the samples after 48 h of dox 
incubation allowed no clear conclusion with regard to a potential dox effect due to the low band 
intensity revealed by the samples that were not treated with dox. The western blot, displayed in Figure 
3.18 B, showed no relevant alteration in DDR1 protein amount as response to dox presence for 
samples _2 5 d.  
Considering the results from the CAV1 protein expression, another interesting phenomenon was 
uncovered in Figure 3.20. The constitutive overexpression of miR-199a from the natural miRNA 
precursor consistently yielded a strong increase of CAV1 protein expression visible in samples 199a 
compared to all HF samples. Integration of the pre-miR switch, entailing a lower amount of mature 
miRNA-199a, showed a comparably weak increase of the amount of CAV1 protein for the samples _2 
after 5 d. Equally to DDR1, no response to dox addition in form of an accompanying increase of 
miRNA-199a amount was reflected at CAV1 protein level neither after 24 h, 48 h nor even 5 d of 
incubation. Actually, the western blot for the samples after 5 d of incubation with dox was repeated 
four times with independently prepared samples, but for sample _2 and _2 5 d strong fluctuations in 
band intensity were determined prohibiting a clear statement to a potential, dox-related effect.    
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Figure 3.19 Influence of dox-dependent regulation of pre-miR switch miR-199a on DDR1 protein levels 
after 24 h and 48 h (A) or 5 d (B) of incubation. For monitoring the effect of pre-miR switch based regulation of 
miR-199a processing at the DDR1 protein amount a western blot was performed. 0.9 x 105 HF1-3 cells either 
carrying no construct (HF), the natural miR-199a precursor (miR-199a) or the pre-miR switch miR-199a_2 (miR-
199a_2, (B) _2) together with the TetR expression sequence in the genome were seeded into 12-well plates and 
incubated with 1 µg/ml dox for 24 h, 48 h and 5 d. Subsequently, the cells were lysed and total protein was 
analyzed in an SDS-PAGE. Then, total protein was blotted onto a PVDF membrane and DDR1 (100 kDa, 125 
kDa) was visualized using HRP-conjugated secondary antibodies with a chemiluminescence substrate. HSP-60 
(60 kDa) was used as loading control. Protein sizes are indicated in kDa. 
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Figure 3.20 Influence of dox-dependent regulation of pre-miR switch miR-199a on CAV1 protein levels 
after 24 h and 48 h (A) or 5 d (B) of incubation. To check for an effect at the CAV1 protein level after genomic 
integration of the constructs and TetR a western blot was performed. 0.9 x 105 HF1-3 cells either featuring no 
construct (HF), the natural miR-199a precursor (miR-199a) or the pre-miR switch miR-199a_2 (_2) together with 
the TetR expression sequence in the genome were seeded into 12-well plates and incubated with 1 µg/ml dox for 
24 h, 48 h and 5 d. Subsequently, the cells were lysed and 40 µg of total protein analyzed in an SDS-PAGE. 
Then, proteins were blotted onto a PVDF membrane and CAV1 (22 kDa) visualized using HRP-conjugated 
secondary antibodies with a chemiluminescence substrate. β-actin (42 kDa) was used as loading control. Protein 
sizes are indicated in kDa.  
In parallel to the determination of protein levels, the mRNA levels of the miR-199a-5p targets DDR1 
and CAV1 mRNA levels were monitored by qPCR (Fig. 3.21). Concordant with the results from 
western blotting, a weak diminishment of the amount of mRNA by 10-20% could be measured for 
DDR1 in sample 199a after 24 h and 48 h of dox incubation (Fig. 3.21 A left). In contrast, the mRNA 
amount determination of the samples stably expressing pre-miR switch 199a_2 disclosed a weak 
increase of 10-20% in all measurements. After 5 d of dox incubation the mRNA levels of DDR1 were 
comparable for the HF1-3 cells without integration, whereas the expression after the integration of pre-
miR switch miR-199a_2 was elevated for about 40% compared to the expression of HF1-3 cells (Fig. 
3.21 A right).  
The assessment of CAV1 mRNA level supported the results obtained at the protein level (Fig. 3.21 B). 
The presence of miR-199a-5p derived from the natural miRNA precursor led to a 2-fold increase after 
24 h and 48 h and an up to 4-fold increase in mRNA observed after 5 d of dox incubation. No change 
of the mRNA amount of CAV1 was present for the sampled expressing the pre-miR switch miR-
199a_2 after 24 h and 48 h. Merely, a weak increase of the mRNA level of about 10% became 
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obvious for the samples that genomically expressed the pre-miR switch miR-199a_2. Also CAV1 
mRNA levels remained unaffected by the presence of dox.  
 
Figure 3.21 Influence of stable miR-199a expression on mRNA level of DDR1 (A) and CAV1 (B) after 24 h, 
48 h and 5 d of dox incubation. To explore the effect of genomically expressed miR-199a at the DDR1 and 
CAV1 mRNA level, 0.9 x 105 HF1-3 cells harboring the natural miR-199a precursor or pre-miR switch miR-199a_2 
were seeded into 12-well plates and incubated for 24 h, 48 h or 5 d with 1 µg/ml dox. Afterwards, total RNA was 
isolated and mRNA levels of the miR-199a target DDR1 and CAV1 were assessed in qPCR. The mRNA levels 
are shown normalized to the mRNA amount of DDR1 and CAV1 of non-integrated HF1-3 cells. The 
measurements were performed in duplicates (n=3, n=2 for (A) right and (B) left).   
At last, an experiment was performed to check whether a relation between a constitutive expression of 
miR-199a and the strongly elevated mRNA and protein level of CAV1 exists. For that purpose, a 
transient co-transfection of HeLa cells with either an empty plasmid (MS), the natural miRNA precursor 
(199a) or pre-miR switch miR-199a_2 (199a_2) together with the TetR expression plasmid was 
performed. 1 µg/ml dox was supplemented 3 h after transfection. Cells were harvested 24 h after 
transfection, lysed and 40 µg of total protein was analyzed in an SDS-PAGE. Then, proteins were 
blotted onto a PVDF membrane and the protein amount of CAV1 visualized on a western blot using 
HRP-conjugated secondary antibodies with a chemiluminescence substrate. β-actin was used as 
loading control. 
Looking at the western blot presented in Figure 3.22, no relevant alteration of the CAV1 protein level 
regardless of the presence of miR-199a-5p, TetR or dox occurred 24 h after transient transfection. 
This, in turn, strengthened the assumption that the strong increase of CAV1 mRNA and CAV1 protein 
arose as a consequence of the long-time exposure to miR-199a-5p.  
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To come to a conclusion for the experiments after genomic integration, the results hinted at a very 
weak response of DDR1 and an intense, but unexpected response of CAV1 to miR-199a-5p presence 
at both, the protein and the mRNA level. Apart from that, primarily the expression level of mature miR-
199a-5p processed from the pre-miR switch seemed to be too low to cause a significant effect at the 
mRNA or/ and the protein level. Consequently, the efficient regulation of the miRNA-199a-5p level 
provided by the pre-miR switch could not be demonstrated in the present experimental setup.    
 
Figure 3.22 Influence of TetR-dependent regulation on CAV1 protein levels after transient transfection of 
the pre-miR switch miR-199a and TetR. For the visualization of a potential effect at the regulation of CAV1 
protein level due to transient transfection of the pre-miR switch miR-199a_2 and the TetR expression plasmid, a 
western blot was prepared. Therefore, 1.4 x 105 HeLa cells were seeded into 12-well plates and transfected with 
either the empty plasmid (MS) or a plasmid containing the natural miR-199a precursor (199a) or the pre-miR 
switch miR-199a_2 (199a_2). Also, the TetR expression plasmid was co-transfected and 1 µg/ml dox was added 
3 h after transfection. 24 h after transfection, the cells were lysed and total protein was analyzed in an SDS-
PAGE. Afterwards, proteins were blotted onto a PVDF membrane and CAV1 (22 kDa) detected using HRP-
conjugated secondary antibodies with a chemiluminescence substrate. β-actin (42 kDa) was used as loading 
control. Protein sizes are indicated in kDa. 
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4 Discussion 
The elucidation of miRNA-related phenotypes requires an understanding of the particular cellular 
function of a certain miRNA. A disease-dependent, aberrant tissue-specific expression of a miRNA 
may yield first insights into its involvement in a specific disease pattern. In various cancer types and 
other human diseases, a distinct miRNA expression profile can often be observed that is directly linked 
to disease development (reviewed in 152). The correlation between the potential target protein 
abundance and the respective miRNA level is investigated to get more detailed information about 
miRNA participation. Such experiments constitute a passive way to shed light on possible miRNA-
target interactions and merely allow assumptions about how a given miRNA affects the cellular 
function, neglecting the detailed knowledge about the exact mode of miRNA action and the specific 
target.  
A distinct exploration of miRNA function may be achieved through the directed overexpression or 
knockdown of the implied miRNA to observe the associated effects on cellular processes. A “gain-of-
function” study is often implemented by using miRNA mimics, whereas a “loss-of-function” study is 
usually performed with modified antisense oligonucleotides that inhibit miRNA-target interactions 
through the sequestration of the miRNA. These chemically modified RNA-based oligonucleotides are 
easily to handle, but due to their modifications conferring enhanced stability, their half-life is often 
longer than the half-life of the naturally derived miRNAs, leading, in turn, to a non-physiological 
persistence and putative side effects. 
In this work, a specific synthetic tool was developed that was intended to exploit controlled miRNA 
processing to explore miRNA function under more physiological conditions, bypassing the issues 
summarized previously. As such, a design concept for an RNA-based switch was pursued that would 
account for the structure of the natural precursor and the substrate recognition features of the cellular 
machinery required for miRNA maturation. The design was thus focused on the modification of the 
pre-miRNA to render its processing dependent on a reversible, external effector system. Ultimately, 
the miRNA precursor was linked to the TetR aptamer, restricting access to the Dicer cleavage sites in 
presence of its cognate ligand, TetR. Dox was then used to prevent TetR binding to the aptamer and, 
hence, to restore miRNA processing to the original activity. 
4.1 Evaluation of design and functionality of the pre-miR switches 
A design concept based on the direct or one bp fusion of the aptamer to the miRNA precursor stood 
out due to its characteristics of adequate precursor processing, efficient processing inhibition and 
complete reversibility. The design of pre-miR switch miR-126_5 turned out to be completely 
transferable to another two miRNA precursors, yielding comparable results with regard to the 
performance of the switch.  
Evaluating the basic strategy of the pre-miR switch design and the selection of the insertion site for the 
TetR aptamer into the natural precursor, the Dicer cleavage sites could be successfully occupied in 
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the presence of TetR, leading to a nearly complete inhibition of processing. Consequently, the stability 
of the respective closing stem of the aptamer that was formed by the communication module and the 
stem region of the natural precursor seemed to be sufficient to serve as stabilizing scaffold for the 
TetR binding pocket and, thus, to facilitate ligand binding for all functional pre-miR switches. In a 
comparable approach to manipulate Dicer processing of shRNAs, Saito and coworkers exploited 
either protein-binding motifs for the human U1A protein and the snoRNA binding protein L7Ae or the 
p50-binding aptamer integrated into the loop region of the shRNA for regulating Dicer cleavage 153. 
Similar to the present study, they chose the terminal loop to introduce their sensor elements into the 
shRNA and were able to regulate shRNA processing by imposing steric hindrance on the processing 
machinery. Although they employed different proteins and binding modes compared to the presented 
system, they demonstrated that the interference with the processing machinery poses a valuable 
opportunity to control small ncRNA levels. Furthermore, the protective binding of human Dicer to the 
terminal loop was demonstrated in an enzymatic probing experiment with the S1 nuclease 154. The fact 
that Dicer seems to directly interact with the terminal loop further supports the basic idea of the design 
approach developed in this study.  
In this context it should be noted that the modifications intended to regulate Dicer processing may 
have also influenced Drosha processing. Several substrate recognition features relevant for Drosha 
activity are known to reside in the terminal loop structure that was removed and replaced by the TetR 
aptamer in this study 54. Here, northern blotting experiments could help to determine the amounts of 
present miRNA and pri-/pre-miRNA species and, thus, poses an adequate measure to provide 
evidence for a selective inhibition of Dicer processing as a consequence of TetR binding. 
Generally, the replacement of the natural terminal loop structure with the TetR aptamer was observed 
to result in a distinct reduction of processing in comparison to the natural precursor, dependent on the 
used communication module. The variation of the communication module for coupling the miR-126 
precursor with the TetR aptamer revealed that the replacement of the terminal loop was merely 
tolerated in combination with a very short C-G bp bridging the area between the aptamer and the 
precursor stem. It is a well-known effect in synthetic biology that the presence of a stable secondary 
structure like an aptamer strongly influences the level of gene expression (reviewed in 125). Zeng and 
coworkers mutated the natural terminal loop of several miRNAs with regard to size and flexibility and 
found that Dicer prefers large flexible loop structures for processing 62. As confirmed in an in-line 
probing by Hunsicker et al., the TetR aptamer constitutes a stable secondary structure that was 
inserted into the into the loop position of the precursor and therefore affected Dicer processing 136. 
Furthermore, the terminal loop structure was shown to be highly conserved for some miRNAs and to 
harbor essential recognitions sites relevant for processing by Drosha and Dicer 155. Michlewski et al. 
demonstrated that 14% of all pri-miRNAs possess terminal loops, which were well conserved 
throughout evolution 156. In their experiments they identified a binding site of the heterogeneous 
nuclear ribonucleoprotein A1 (hnRNP A1) in the terminal loop region of pri-miR-18a. The interaction of 
hnRNP A1 with the miR-18a precursor loop was proven to cause a relaxation at the stem region that, 
in turn, creates a more favorable substrate structure for the processing by Drosha. What is more, the 
presence of a binding site for hnRNP A1 was also found to be located in the terminal loop of pri-miR-
101-1 and a mutation analysis of the critical loop region appeared to almost completely abrogate 
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processing. A conserved terminal loop was also found to be existent in pri-miR-101-2. In this study, 
the replacement of the terminal loop structures of both miR-101 precursors also led to an abolishment 
of processing. Given this background, it is not surprising that a modification within a significant part of 
a natural miRNA precursor causes a reduction of processing efficiency. 
Thus, the mentioned aspects could be related to the decrease or even the loss of precursor 
processing. Consequently, a restriction of modification to a particular set of miRNA precursors, 
including the precursors that are not reliant on their terminal loop structure for miRNA maturation, is 
conceivable.  
The functionality of hybrid constructs, such as the pre-miR switch, strongly depends on the linker 
domains between the inherently different parts. According to this, one of the most challenging aspects 
in the design of a pre-miR switch was constituted by the adequate fusion of the TetR aptamer and the 
natural miRNA precursor through a communication module in a way that facilitated aptamer 
functionality and preserved miRNA biogenesis at the same time. Therefore, communication modules 
varying in length and stability were tested for the design of a pre-miR switch based on the miR-126 
precursor. With the exception of a simple C-G bp, all communication modules impacted pre-miR 
switch processing to similar extents. Their introduction led to the abolishment of processing as they 
created non-cognate Dicer substrates either due to an improper stem length (three bp stem) or 
structural elements like mismatches or bulges. Considering the various structures of Dicer substrates, 
including miRNA precursors, it can be assumed that Dicer is very flexible with regard to its processing 
activity, but negative effects on Dicer cleavage due to lengthy or bulky structures have already been 
observed. Zhang and coworkers proposed a relation between Dicer processing efficiency and 
precursor stem length 155. The Kay group demonstrated the dependence of Dicer cleavage accuracy 
on the position of loop structures in the precursor stem 157. Taylor et al. also supported the hypothesis 
that the precursor length influences Dicer cleavage efficiency, since overlong substrates were 
supposed to disturb necessary conformational rearrangements of single domains within Dicer 
indispensable for adequate processing 158. Nevertheless, due to the fact that the detailed Dicer 
mechanism still remains to be elucidated, a definitive correlation between miRNA precursor structure 
and enzyme activity cannot be stated yet. 
During the design of further constructs based on the miR-34a and miR-199a precursors, the direct or 
one bp fusion of the aptamer to the precursor stem yielded an appropriate processing efficiency and 
pre-miR switch performance. Thus, the design concept revealed to be completely transferable to 
another two miRNA precursors. Similar to the findings presented in this work, Yokobayashi and 
coworkers designed a hybrid molecule composed of a theophylline aptamer and an shRNA with the 
purpose to control Dicer processing and observed that a direct fusion resulted in the best regulation of 
eGFP expression 129. 
4.2 Regulation of reporter gene expression dependent on TetR and dox 
Reporter gene assays are a frequently used method to investigate the direct interaction of a miRNA 
with the respective binding site of a target mRNA. In this work, the results obtained from reporter gene 
assays confirmed that the miRNA expression levels as well as the regulatory efficiency arising from 
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the pre-miR switch application are capable to notably influence reporter gene expression and thereby 
support the observations from qPCR.  
The binding of a miRNA to its perfect complement does not resemble the natural mechanism in 
mammals and is therefore merely used as a positive control to confirm miRNA presence and binding 
to the sequences located downstream of the reporter gene. In the perfect match binding assay, the 
binding of all miRNAs derived from the respective pre-miR switch was shown to efficiently regulate 
gene expression. Due to perfect binding of the miRNA to the complementary target sequence, the 
maximal inhibitory effect under the given experimental conditions can be assessed. Thus, the 
regulatory factors exceeded the factors seen for their natural counterparts. Still, the interactions of all 
miRNAs originating from the processing of the pre-miR switch, except miR-199a-3p, with the natural 
target sites were successfully demonstrated. Considering the raw data with respect to regulatory 
activity, it is remarkable that the presence of TetR in parallel to the pre-miR switches resulted in firefly 
luciferase expression that was comparable with the reporter gene expression in the absence of the 
respective miRNA. This hints at a complete inhibition of the miRNA-target interaction by TetR and 
shows that the pre-miR switch is capable of tapping the full potential under the given conditions. 
Another interesting fact is that the regulatory efficiency of the miR-126 and -199a-derived pre-miR 
switches was 70-90% of the maximal, theoretical switching performance that could have been 
achieved with the miRNA amount obtained from the processing of the natural precursor. In contrast, 
about 45-50% of the maximal performance was observed for the miR-34a-dependent pre-miR 
switches. This can be attributed to the reduced processing efficiency (~12%) compared to the 
unmodified miR-34a precursor.  
In general, a comparison between the dynamic ranges of different synthetic systems is often drawn to 
assess the value of the developed device. Here, a direct comparison of the performance of the 
developed pre-miR switches with other published regulatory tools is rather difficult due to alterations in 
the experimental setups. The Beckebaum group inserted a comparable part of the 3’UTR of DDR1 
also containing all four predicted target sites for miR-199a-5p downstream of a reporter gene and 
transfected HepG2 cells with chemically modified pre-miRNAs 111. This arrangement yielded a 2.5-fold 
change of relative expression, which covers a similar range of efficiency as the factor determined for 
the DDR1 3’UTR insertion, testing the regulatory activity of pre-miR switch miR-199a_2. However, the 
particular results were obtained under a completely different experimental setup. Generally, the 
regulatory efficiency in a reporter gene assay strongly depends on factors concerning the experimental 
environment and target site selection itself. The transfection efficiency as well as the transfected 
amount of plasmid used for reporter gene and miRNA expression are crucial for the experimental 
outcome, as they directly determine the ratio of the miRNA and the cognate target site and, thus, also 
stochasticity of the miRNA-target interaction. With regard to this, the total number of plasmids used to 
transfect the cells is also essential for the same reason as mentioned before. Furthermore, the 
employed cell type and its transcriptional program are decisive and can affect specific miRNA-target 
interactions. Often, cancer cells reveal unexpected target modifications like point mutations or 
shortened 3’UTRs that can be accompanied by a loss of miRNA binding 159,160.  
Additionally, the methods for miRNA target validation per se have to be seen critical. Most 
experiments are performed utilizing chemically modified miRNA mimics or precursors, often leading to 
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supra-physiological concentrations of miRNAs that is followed by non-specific alterations in gene 
expression and a saturation of the miRNA system 161. A dramatic overexpression of a miRNA might 
directly influence the stoichiometric ratio of the miRNA-target site interaction and, thus, result in an 
occupation of not only all high- , but also many low-affinity binding sites. Consequently, false-positive 
results could be generated due to a shift of interaction that causes an inclusion of low-affinity binding 
sites normally not considered under natural conditions. Consequently, the currently applied methods 
are often far away from mirroring the naturally occurring miRNA-target interactions.  
To gain confidence about the authenticity of a miRNA target and the exact target sites, a combination 
of functional assays and biochemical validation methods reflecting the physiological interactions 
between miRNA and target mRNA should be considered. An example of a powerful method to provide 
information about miRNA-target interaction under physiological conditions is a cross-linked 
immunoprecipitation followed by high-throughput sequencing (HITS-CLIP). This way, direct binding of 
the miRNA-RISC to a specific part of the target mRNA can be confirmed by cross-linking both 
components followed by sequencing analysis 162.    
Although the miRNA-199a-3p targets CAV2, MET and CD44 were validated by at least reporter gene 
assays, western blotting and RT-qPCR, a direct interaction with miR-199a-3p could not be confirmed 
in the reporter gene assays in this work. The presence of the mature miR-199a-3p was shown by 
qPCR and a regulatory effect on reporter gene expression was detected for the positive control. 
Analyzing the raw data obtained from the reporter gene assay, also no regulatory activity based on the 
naturally derived miRNA-199a-3p became apparent, although natural pre-miRNA processing led to 
demonstrably higher intracellular levels of mature miRNA than pre-miR switch processing. 
Accordingly, the reason for the missing regulation remains elusive.  
As mentioned above, miRNA-target interactions can be strongly dependent on the cellular context and 
the experimental setup. Thus, the source and the quality of the 3’UTR bearing the respective miRNA 
binding sites could also be pivotal for miRNA binding. Due to the fact that the 3’UTRs were cloned 
from genomic HeLa DNA, it cannot be excluded that cell line-related point mutations or deletions have 
rendered the predicted target sites inactive. The importance of the employed cell type was highlighted 
by experiments from the Nares group that demonstrated the dependence of miRNA regulation 
strength on the respective cell line, thereby suggesting that different cell lines also exhibit varying 
levels of regulation 163. Even the usually applied cell lines HEK-293 and HeLa revealed strong 
differences with regard to gene regulation in their experiments. Since all of the published luciferase 
assays investigating the interaction of miRNA-199a-3p and the respective target genes have been 
performed using either modified pre-miRNAs or miRNA mimics and different cell lines than HeLa, the 
experimental outcome may not show the same effect with regard to miRNA targeting.  
At that point, evidence for the integrity of the HeLa cell-derived 3’UTR utilized in this work could be 
provided by conducting specific amplification and sequencing of the respective target sites. To exclude 
a potential influence of the cellular context, an alteration of the cell system should be considered to 
reassess the interaction between miR-199a-3p and the targets. 
 
 Discussion 
- 60 - 
 
4.3 Regulation of endogenous miRNA-199a-5p targets with miR-199a_2 
In a luciferase assay, the interaction between a miRNA und its potential target sequences is explored 
under unnatural conditions. Therefore, a positive outcome of such an assay can only serve as a 
positive indicator and the regulation has to be further investigated under more authentic cellular 
conditions. For testing the endogenous regulatory activity of pre-miR switch miR-199a_2, it was either 
expressed transiently or integrated into the genome. The validated targets SMAD4, DDR1 and CAV1 
were employed to analyze the influence of the miR-199a_2 activity on regulating their mRNA and 
protein levels after different time points. 
Although the first tested target, SMAD4, harbors three predicted target sites in its 3’UTR, no regulation 
either at the mRNA or the protein level that hints at a direct correlation between miR-199a presence 
and SMAD4 could be observed 164. Until today, evidence of SMAD4 being a direct target of miRNA-
199a has only been provided by one group that conducted luciferase assays in NIH-3T3 cells to 
demonstrate the interaction between miRNA and SMAD4 3’UTR 110. The performance of a luciferase 
assay, in which the natural precursor was transiently expressed from a CMV promoter, resulted in a 
regulation factor of about 1.3-fold, thereby demonstrating the suppression of the luciferase expression 
due to miRNA-199a presence. Furthermore, a reduction of SMAD4 protein expression as a 
consequence of transient transfection of miRNA-199a mimics could be visualized in a western blot in 
their experiments. However, the authors did not discuss why the suppression of the SMAD4 protein 
level was tested with miRNA mimics instead of the previously applied plasmid-based miRNA precursor 
expression. Possibly, the plasmid-derived level of miRNA expression was not sufficient to affect the 
SMAD4 protein amount. Alternatively, the distribution of the transfected miRNA mimics among the 
cells achieved by transient transfection could have been more homogenous compared to the miR-
199a overexpression plasmid, thus leading to effective target regulation. Since the study presented in 
this work was also performed using plasmid-based miRNA expression under the control of a CMV 
promoter, the level of miRNA-199a-5p, derived from either the natural precursor or the pre-miR switch, 
might have been insufficient to cause an effect at the SMAD4 protein level. It is also conceivable that 
the conduction of transient transfection with Lipofectamine® 2000 led to an inhomogeneous miRNA 
expression profile within the HeLa cell population, which could have contributed to mask the miRNA-
related regulatory effect.   
As mentioned above, the regulatory effect of a miRNA often heavily depends on the cellular context. 
To rule out systematic errors caused by the use of the HeLa cell line and possibly shortened or 
mutated target sequences for miR-199a, RNA was isolated and the presence of the target regions was 
verified by sequencing. Nevertheless, the variation of the experimentally used cell line would be useful 
to gain more information about the suitability of the previously employed cell system.   
Besides the miR-199a-based regulation of SMAD4, also the influence of miR-199a on DDR1 mRNA 
and DDR1 protein level was examined, since an interaction of miR-199a-5p with the 3’UTR of DDR1 
has already been revealed in a reporter gene assay in this study. Further evidence for the direct 
relation between miRNA-199a-5p presence and DDR1 targeting was provided by Shen et al. 111.  
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After transient transfection, a slight reduction of 30% of DDR1 mRNA level in the presence of miR-
199a from the natural precursor could be seen, but nearly no regulation dependent on pre-miR switch 
processing. The apparent reduction at the mRNA level appeared to be too weak to demonstrably 
affect the DDR1 protein level.  
To implement a consistent overexpression of miR-199a in the complete cell population, a genomic 
integration, omitting or including the simultaneous integration of TetR, was performed. The first 
genomic integration resulted in a strong reduction of 50% of DDR1 mRNA level for HF1-3 cells, 
bearing either the integrated pre-miR switch or the natural miRNA precursor in comparison to the HF1-
3 cells with an unmodified genome. This effect at the mRNA level led to a detectable reduction of 
DDR1 protein that was quite distinct for cells expressing the natural precursor and weak for the pre-
miR switch expressing cells. Although unaltered basal levels of mature miRNA-199a-5p and DDR1 
mRNA were produced after the second genomic integration, the mRNA level as well as the protein 
amount of DDR1 merely showed a slight reduction in the presence of naturally processed miR-199a. 
In contrast to the results obtained after the first genomic integration, the significant reduction at the 
mRNA level due to the presence of the pre-miR switch was fully abolished.  
The phenomenon observed after the second genomic integration might be directly linked to the 
selection procedure. Whereas the cells tested after the first integration originated from one single 
clone with a unique genotype, the second generation of cells was derived from a mixed pool of up to 
ten single clones. Thus, it cannot be excluded that the deterioration of regulation activity can be 
attributed to a mixture of genotypes, leading to varying gene expression profiles that possibly masked 
the effect caused by miR-199a. A re-selection of the second generation cells followed by a seeding for 
single cells should be performed to confirm this hypothesis. 
Generally, the experimental conditions could also have influenced the results. Cell type specific effects 
on the regulation of DDR1 mRNA levels through miR-199a expression were observed by Shen et al.  
111. In their study, they saw a differential regulation of the mRNA level of DDR1 dependent on the cell 
type. A 5-fold reduction of the mRNA level was detected in HepG2 cells, whereas SNU-182 did not 
respond to the transfection of pre-miRNA at all, again underlining the influence of cell type specific 
effects. Thus, also in this case testing of the pre-miR switch in another cellular context could provide a 
good opportunity to assess the regulatory function of the tool developed in this study. At least, a lack 
of adequate miR-199a-5p target sites could be ruled out, as evidence for the presence of all of the 
predicted miRNA target sites was provided through sequencing and a response to miRNA-199a-5p 
presence was seen in the reporter gene assay.  
In contrast to the results obtained for the regulation of endogenous DDR1 during this study, the 
publication of Shen et al. demonstrated a great impact of miR-199a-5p on DDR1 regulation. However, 
it must be considered that the effects seen in their experiments were based on the transfection with a 
chemically modified precursor. This presumably led to a more effective miR-199a-5p overexpression, 
exceeding the plasmid-based overexpression employed in this work. Thus, the concentration of miR-
199a-5p resulting from plasmid expression of the pre-miR switch simply might have been too low to 
achieve a significant regulation of the DDR1 target. Consequently, the pre-miR switching activity could 
not be demonstrated with regard to regulation of the endogenously expressed DDR1.  
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With CAV1 a target of miR-199a-5p was selected that was validated using various methods according 
to the miRTarBase database 164. After genomic integration a pronounced, yet unexpected increase of 
CAV1 protein as well as mRNA was detected for the cells with a persistently present miRNA-199a 
derived from the processing of the natural precursor. Such a distinct effect was not observed as a 
consequence of pre-miR switch miR-199a_2 expression due to a constitutive co-expression of TetR 
and the generally lower expression due to a modification of the miRNA precursor. So it can be 
assumed that the long-term expression of miR-199a-5p could be responsible for the observed effect, 
since transient transfection with the plasmid bearing the natural precursor or the pre-miR switch did 
not cause an increase at the CAV1 protein level. An effect related to the integration locus per se can 
be excluded since the pre-miR switch has been integrated at the same site as the natural miRNA 
precursor. Since miRNA-199a-5p is known to target many endocytosis-related proteins, the apparent 
increase could either be linked to an interference with factors related to the CAV1 pathway or other 
secondary effects caused by the constitutive miR-199a expression 165. 
Regarding the publications of Cardenas et al. and Aranda et al., a reduction of CAV1 mRNA and 
CAV1 protein expression was to be expected as a response to miR-199a-5p 165,166. In their works, they 
used chemically modified pre-miRNAs or miR-199a-5p mimics and demonstrated a regulation in 
reporter gene assays, RT-qPCR and western blotting in either HEK-293, hFL1, Huh7 or also HeLa 
cells. Accordingly, a correlation between the employed cell system and the failed regulation of CAV1 
mRNA and CAV1 protein can be ruled out. Considering also the results of the other tested 
endogenous targets of miR-199a, it can be assumed that the absence of CAV1 regulation by miR-
199a-5p after transient transfection is the consequence of either inhomogeneous transfection within 
the cell population or a comparably low amount of mature miRNA-199a-5p provided by plasmid-based 
miRNA expression.  
4.4 Comparison between transient and genomic expression 
Generally, transient transfection based on the uptake of lipoplexes suffers from two significant 
disadvantages that play a relevant role for the investigation of device activity on endogenous target 
regulation. On the one hand, not all cells of a population were comparably transfected with the miRNA 
expression plasmids. Thus, the target expression of non-transfected cells remains unaffected due to a 
lack of miR-199a and therefore falsifies the regulatory effect measured as an average from the overall 
cell population. On the other hand, different amounts of plasmid were probably incorporated into the 
cells with the applied method, resulting in varying levels of miRNA within the cells. The regulation of a 
miRNA target heavily depends on the amount of miRNA, target mRNA and the respective target sites 
167. Thus, the induced changes could be quite heterogeneous and cell-to-cell variations might have 
masked the efficiency of the miRNA-based regulatory performance.  
Genomic integration was performed to gain independency of transfection efficiencies and to work with 
a homogenous cell population exhibiting narrowly distributed expression profiles with regard to the 
miRNA precursor. Also a contemporaneous integration of TetR turned out to be necessary, since the 
first integration led to a dramatic reduction of switching efficiency that was presumably caused by a 
high background of miRNA-199a produced before TetR expression.  
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Furthermore, the opportunity to extend the exposure to miR-199a in the system could have served to 
reveal a potential regulatory effect. All in all, a long-term persistence of miR-199a-5p did not achieve 
the desired effect for e.g. DDR1 target regulation and significantly influenced the natural expression 
pattern of CAV1. Accounting for CAV1 regulation, even an adverse effect arose as a consequence of 
genomic integration that recalls the fact that the endogenous miRNA-target interaction relies on 
complex fine tuning which cannot be simulated under the present experimental conditions.  
Accounting for a lower copy number of the integrated constructs, their expression resulted in lower 
miR-199a-5p levels after genomic integration. Besides, also a deterioration of the pre-miR switch-
based miRNA-199a-5p expression relative to natural precursor-based expression was assessed that 
was accompanied by a significant reduction of switching efficiency compared to transient transfection. 
Also after an incubation with dox for 5 d the observed effect remained stable and no further increase 
of relative miRNA expression could be achieved. As both the natural precursor and the pre-miR switch 
were expressed from the same hCMV promoter, differences concerning their relative abundance could 
be ruled out. Locus-specific effects are also not accountable for a switching factor reduction, since the 
same insertion site was employed for both constructs. The regulatory efficiency of the pre-miR 
switches is calculated by the ratio of the values obtained under active and inhibited processing states. 
Transiently transfected cells exhibited mature miRNA levels of 0.5% in the presence of TetR. In 
contrast, genomic integration yielded a value of 1.4% in the presence of constitutively expressed TetR, 
thus changing the regulatory factor for about 3-fold. The slightly lower inhibitory efficiency appearing 
after genomic integration could be related to a change of the CMV promoter to an SV40 promoter to 
drive TetR expression since the ratio of TetR and pre-miR switch are of the utmost importance for pre-
miR switch functionality. A titration of the involved components dependent on promoter strength 
should be considered to optimize the performance of the pre-miR switch miR-199a_2 not only for 
transient transfection, but also for genomic integration.  
4.5 Evaluation of the experimental setup to investigate endogenous 
regulation  
As discussed earlier, the influence of the selected cell system is an important point to be considered. 
The experiments were performed in HeLa cells that do not endogenously express miR-199a. A lot of 
cancer cells are known to ectopically express specific miRNAs (reviewed in 152). Often, the level of 
oncogenic miRNAs is increased in cancer cells and defects in miRNA biogenesis as well as global 
downregulation are often seen mechanisms. Also, several pathways are deregulated in cancer cell 
lines 168. Another important requirement to the system used for the investigation of miRNA activity is 
that low endogenously expressed amounts of the examined miRNA are present to enable efficient 
switching of miRNA processing dependent on the developed construct. 
In order to test a tool for the regulation of miRNA processing, the miRNA target should be chosen 
carefully. As demonstrated, the interaction of one specific miRNA with the 3’UTR of a potential target 
does not necessarily lead to a detectable outcome, since many transcripts are targeted by several 
miRNAs concertedly regulating target expression 168. Besides, many different factors concerning the 
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experimental setup, mentioned before, play an important role and significantly influence the formation 
of a miRNA-target interaction.   
The investigation of a whole cell population can also be seen problematic. By conducting single-cell 
measurements, Mukherji et al could show a high cell-to-cell variability of reporter gene expression 
although all targets were regulated by the same miRNA 167. Theses variations are usually obscured in 
bulk measurements. Also pre-miR switch performance could have been masked due to large cell-to-
cell variations. Therewith, single-cell studies that investigate the miRNA-target interaction and its effect 
based on an individual cell might be advantageous to test the influence of pre-miR switch regulation 
on a defined target.  
Considering the expression system, transient transfection should be further enhanced by an alteration 
of the transfection method to achieve higher transfection efficiencies. Also, a pre-selection of 
transfected cells, e.g. by using FACS, could be advisable to exclude non-transfected cells from the 
measurements. Generally, to increase the amount of mature miRNA generated by the processing of 
the pre-miR switch, an exchange of promoter strength for construct expression is considerable, too. 
4.6 Synthetic regulatory tools for controlling RNAi in mammals  
Realizing the potential of RNAi as a general means for studying mammalian gene function, the first 
synthetic RNA-based tools were developed to control the abundance of small ncRNAs. So far, the 
majority of designs for RNAi-mediated gene silencing and functional studies concentrated on artificially 
modified shRNAs for tool development and implementation. The main differences between shRNA 
and miRNA-based tools lie in their targeting capabilities and the structural complexity of their 
precursors. Whereas siRNA activity is restricted to the regulation of one specific target site, a single 
miRNA is capable of targeting various mRNAs, facilitated by the tolerance of imperfect hybridization to 
their target sequences. In contrast to miRNA, shRNA precursors feature a perfectly hybridized stem 
connected by a short loop. This simple secondary structure is readily accessible to (i) a specific 
redesign matching virtually any target sequence and to (ii) an in silico prediction of the Dicer cleavage 
sites. Thus, issues accompanying the engineering of complex natural structures can be bypassed, 
because the modification of an shRNA structure does not require following the strict processing rules 
that apply to a miRNA precursor.    
In an approach that also intended to interfere with Dicer processing, Yokobayashi and coworkers 
presented a fusion molecule composed of an in vitro selected theophylline aptamer inserted in the 
terminal loop of an shRNA 129. Their construct design featured the integration of the Dicer cleavage 
sites into the aptamer structure. Consequently, theophylline binding resulted in the stabilization of the 
aptamer structure that masked the cleavage sites to prevent Dicer processing. With the shRNA-based 
construct they were able to control GFP silencing in mammalian cells with a regulatory factor of 2.7-
fold in a ligand-dependent fashion. In an ensuing publication, the group demonstrated the adaptability 
of the developed shRNA technology in an approach to target endogenous human albumin in 
mammalian cells 170. In their experiment they showed the specific modulation of the level of human 
serum albumin yielding a regulation factor of about 3.8-fold in the presence of 2 mM theophylline. The 
Smolke group modified an shRNA loop structure and integrated various aptamers as well as 
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competing strands affecting Dicer mediated processing of the shRNA 171. Also a co-transfection with 
two engineered shRNAs either harboring a hypoxanthine- or a theophylline-binding aptamer was 
performed and the ligand-dependent regulating of processing to a GFP-binding siRNA resulted in a 
~4-fold change of GFP expression in the simultaneous presence of both ligands. As mentioned before, 
Saito and coworkers inserted either protein-binding motifs for the human U1A protein and L7Ae or the 
p50-binding aptamer into the shRNA loop region for the purpose of controlling Dicer cleavage by 
employing protein-based sensor domains 135. After exploring the optimal length of the modified shRNA 
with regard to the orientation of the U1A protein, a 4-fold regulation of eGFP expression could be 
achieved due to regulation of the siRNA amount. The introduction of the p50-binding aptamer resulted 
in a 3-fold regulation of eGFP expression. Also, miRNA precursors have been considered as valuable 
modification platforms for the integration of aptamers to enable ligand-dependent processing. Smolke 
and coworkers designed a synthetic precursor bearing an siRNA that targets GFP and integrated 
small molecule- or protein-binding aptamers into its basal segment. Mimicking a pri-miRNA, they 
targeted Drosha processing resulting in a genetic system that facilitated ligand control over the 
miRNA-mediated silencing of GFP expression. 2.4-fold regulation was observed for a theophylline-
binding construct in the presence of 0.1 mM theophylline.  
Since RNA interference experiences an increasing popularity as the method of choice for gene-
silencing and functional analysis, there is also an increasing need for robustly working interference 
tools. So far, no modification of a natural miRNA precursor that resulted in an effective regulation of 
mature miRNA levels has been demonstrated. The RNA-based device developed in this study 
constitutes a flexible, reversible switching unit consisting of a synthetic aptamer as the ligand sensing 
domain coupled to a natural miRNA precursor and enables the efficient, ligand-controlled regulation of 
miRNA abundance. In contrast to the previously mentioned devices for controlling RNAi, the novel pre-
miR switches are the first to provide a three-level regulatory system allowing the active reversion of 
inhibition of pre-miR processing. 
4.7 Conclusion and perspectives 
In this work, a robust pre-miR switch design was presented that allows the control of miRNA 
processing in a ligand-dependent fashion. Testing various communication modules revealed that 
either the direct fusion or the connection through a one base-pair communication module yields the 
best results with regard to miRNA precursor processing. The functionality of the designed pre-miR 
switches was asserted in qPCR and reporter gene assays, where the RNA-based tools led to the 
efficient regulation of luciferase expression. The regulation of validated endogenous targets of miR-
199a could not be shown presumably due to an insufficient concentration of miRNA-199a present 
under the experimental conditions. To encounter the problem of the absence of endogenous target 
regulation, a revision of the experimental setup, including the adaptation of promoter strength to 
increase construct expression, should be taken into consideration. To exclude effects arising from 
large cell-to-cell variabilities, single-cell measurements could provide an adequate approach to gain 
information on the regulatory nature of the pre-miR switches concerning the endogenous regulation. 
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Whereas other publications demonstrated “one-way” switching devices for controlling the biogenesis 
of small ncRNAs, the design concept for the development of pre-miR switches is the first to enable the 
creation of a reversible and transferable system that accounts for ligand-dependent regulation of 
miRNA biogenesis. Thus, the system developed during this work poses the perfect basis for the 
generation of a robust RNA-based tool to investigate the physiological function of specific miRNAs.  
In conclusion, dedicated design guidelines for the successful development of a pre-miR switch can be 
deduced from this work. But, in order to assess the scope of the universality of the design rules, the 
investigation of a further set of modified miRNA precursors should be taken into consideration to 
confirm the robustness and universal transferability of the pre-miR switch design strategy.  
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5 Material and Methods  
The materials and instruments that were utilized in this work are listed below. The following section 
contains the lists for chemicals and reagents (Table 5.1), instrumentation (Table 5.2), kits and 
commercially available systems (Table 5.3), enzymes and proteins (Table 5.4), protein standards and 
DNA ladders (Table 5.5), consumables (Table 5.6), antibodies (Table 5.7), cell strains (Table 5.8), 
buffers and solutions (Table 5.9), oligonucleotides (Table 5.10) and plasmids (Table 5.11).  
All buffers and solutions were produced using ultrapure water. If necessary, buffers and solutions were 
autoclaved at 121°C and 2 bar for 20 min. Oligonucleotides were ordered from Sigma-Aldrich, Munich 
(desalted or RP1 purified).  
5.1 Chemicals, instrumentation and consumables 
Table 5.1 List of employed chemicals and reagents. 
Chemicals and reagents Manufacturer 
2-Mercaptoethanol Roth, Karlsruhe 
Acetic acid Roth, Karlsruhe 
Agar Oxoid, Heidelberg 
Agarose peqGold Universal Peqlab, Erlangen 
Ammonium sulfate Roth, Karlsruhe 
Ampicillin Roth, Karlsruhe 
Bovine serum albumin  New England Biolabs, USA 
Bromophenol blue Roth, Karlsruhe 
Chloroform, p.a. Roth, Karlsruhe 
Clarity™/ Clarity Max™ Western ECL Blotting Substrates Bio-Rad, Munich 
Deoxynucleotide triphosphate (dNTP) Peqlab, Erlangen 
Dimethyl sulfoxide Peqlab, Erlangen 
Doxycycline hydrochloride Sigma-Aldrich, USA 
Dulbecco’s Modified Eagle Medium (DMEM)  Sigma-Aldrich, USA 
Dulbecco’s Phosphate buffered Saline (PBS)  Life Technologies, USA 
ECL Prime Blocking Reagent  Amersham, USA 
Ethanol absolute, p.a. Merck, Darmstadt 
Ethanol, denatured VWR, Darmstadt 
Ethidium bromide  Roth, Karlsruhe 
Ethylenediaminetetraacetic acid (EDTA) Roth, Karlsruhe 
Fetal Bovine Serum (FBS) Biochrom, Berlin 
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Formamide  Roth, Karlsruhe 
Glycerol, p.a. Roth, Karlsruhe 
Glycine Roth, Karlsruhe 
GlycoBlue™ Invitrogen, USA 
Hydrochloric acid (HCl) Roth, Karlsruhe 
Hygromycin B Invivogen, France 
IGEPAL CA-630 Sigma-Aldrich, USA 
Isopropylic alcohol, p.a.  VWR, Darmstadt 
Lipofectamine® 2000 Life Technologies, USA 
MgCl2 solution Applied Biosystems, USA 
Opti-MEM® Life Technologies, USA 
Penicillin/ Streptomycin  Life Technologies, USA 
Protein Assay Dye Reagent Concentrate (5x) Bio-Rad, Munich 
Proteinase-inhibitor-cocktail (PIC) Sigma-Aldrich, USA 
RiboLock RNase inhibitor Thermo Fisher Scientific, USA  
Sodium carbonate Roth, Karlsruhe 
Sodium chloride (NaCl) Roth, Karlsruhe 
Sodium dodecyl sulfate (SDS), pellets Roth, Karlsruhe 
SYBR Green PCR Master Mix Life Technologies, USA 
TaqMan® Universal PCR Master Mix Applied Biosystems, USA 
Tris Roth, Karlsruhe 
TRIzol®  reagent Thermo Fisher Scientific, USA 
Trypan blue Bio-Rad, Munich 
Trypsin/ EDTA (10x) Life Technologies, USA 
Tryptone Oxoid, Heidelberg 
Tween® 20 Roth, Karlsruhe 
Universal ProbeLibrary #21 Roche, Switzerland 
Urea Roth, Karlsruhe 
Xylene cyanole Roth, Karlsruhe 
Yeast extract Oxoid, Heidelberg 
Zeocin Invivogen, France 
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Table 5.2 List of utilized instruments. 
Instrument Manufacturer 
Accuracy weighing machine Acculab, USA 
Centrifuges Heraeus Christ, Osterode 
Electroporator MicroPulser™ Bio-Rad, Munich 
Gel documentation with UV screen INTAS, Göttingen 
Heating block  VWR, Darmstadt 
Incubation Shaker Multitron Infors AG, Bottmingen 
Incubator Heraeus Christ, Osterode 
Infinite® M200 plate reader  Tecan Trading AG, Switzerland 
Magnetic stirrer IKA RET basic IKA, Staufen 
Milli-Q® water purification system with RNase filter EMD Millipore, France 
Mini-PROTEAN Tetra Cell electophoresis chamber  Bio-Rad, Munich 
NanoDrop® ND-1000 spectral photometer Peqlab, Erlangen 
StepOnePlus Real-Time PCR cycler Thermo Fisher Scientific, USA 
Scale Acculab, USA 
T100™ Thermal Cycler  Bio-Rad, Munich 
TC-10™ Automated Cell Counter Bio-Rad, Munich 
Thermomixer comfort   Eppendorf AG, Hamburg 
Trans-Blot®Turbo™ Transfer System Bio-Rad, Munich 
 
Table 5.3 List of kits and commercially available systems. 
Kits and commercially available systems Manufacturer 
DNeasy® Blood & Tissue Kit QIAGEN, Hilden 
Dual-Glo® Luciferase Assay System Promega, USA 
ECL Primer Blocking Reagent Amersham, USA 
Flp-In™ System Life Technologies, USA 
Mini-PROTEAN® TGX™ Precast Gel, any Kd and 7.5% Infors AG, Bottmingen 
QIAprep® Spin Miniprep Kit QIAGEN, Hilden 
QIAquick PCR Purification Kit  VWR, Darmstadt 
Trans-Blot® Turbo™ Transfer Pack Mini, 0.2 µm PVDF Heraeus Christ, Osterode 
Zymoclean™ Gel DNA Recovery Kit  Zymo Research, USA 
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Table 5.4 List of employed enzymes and proteins. 
Enzymes and proteins Manufacturer 
MuLV Reverse Transcriptase [50 U/µl] Applied Biosystems, USA 
Q5 High-Fidelity DNA Polymerase [2 U/µl] New England Biolabs, USA 
RiboLock™ RNase Inhibitor [40 U/ml] Fermentas, USA 
SuperScript II Reverse Transcriptase [200 U/µl] Life Technologies, USA  
T4 DNA Ligase [400 U/µl] New England Biolabs, USA 
T4 Polynucleotide kinase [10 U/µl] New England Biolabs, USA 
Taq DNA Polymerase [5 U/µl] New England Biolabs, USA 
TURBO DNase [2 U/µl] Life Technologies, USA 
Restriction endonucleases 
BamHI [20 U/µl] New England Biolabs, USA 
ClaI [10 U/µl] New England Biolabs, USA 
DpnI [20 U/µl] New England Biolabs, USA 
HindIII [20 U/µl]  New England Biolabs, USA 
SacI-HF [20 U/µl] New England Biolabs, USA 
SpeI-HF [20 U/µl] New England Biolabs, USA 
XbaI [20 U/µl] New England Biolabs, USA 
XhoI [20 U/µl] New England Biolabs, USA 
Table 5.5 List of used protein standards and DNA ladders. 
Protein standards/ DNA ladders Manufacturer 
peqGold Ultra Low Range DNA ladder II PeqLab, Erlangen 
peqGold 1 kB DNA ladder PeqLab, Erlangen 
Precision Plus Protein™ All Blue Prestained Protein 
Standard  
Bio-Rad, Munich 
Table 5.6 List of utilized consumables. 
Consumables Manufacturer 
Cell culture flasks Greiner, Nürtingen 
Cellstar® cell culture plates, 12-well/ 24-well Greiner Bio-One, Austria 
Cuvettes, acrylic  Sarstedt, Nürnbrecht 
Dispenser tips Greiner, Nürtingen 
Micro Pulser Electroporation Cuvettes, 0.1 cm gap Bio-Rad, Munich 
MicroAmp® Fast 96-Well reaction plate Applied Biosystems, USA 
MicroAmp™ optical adhesive film Applied Biosystems, USA 
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Nitrile Gloves  Starlab, Hamburg 
Nunc™ MicroWell™ white 96-well plates, polystyrene Thermo Fisher Scientific, USA 
Petri dishes, plastic Greiner, Nürtingen 
Pipette tips, plastic 
Greiner, Nürtingen 
Starlab, Hamburg 
Nerbe Plus, Winsen 
Pipettes, plastic Nerbe Plus, Winsen 
Polyethylene tubes Sarstedt, Nürnbrecht 
Reaction tubes (1.5 ml, 2 ml) Greiner, Nürtingen 
Syringes Becton Dickinson, Heidelberg 
Table 5.7 List of employed antibodies. 
Primary antibodies Host Dilution Manufacturer 
Anti-CAV1, sc-894  Rabbit 1:1,000 Santa Cruz Biotechnology, USA 
Anti-DDR1, sc-532  Rabbit 1:1,000 Santa Cruz Biotechnology, USA 
Anti-HSP60, ab-6530 Rabbit 1:2,000 Abcam, UK 
Anti-SMAD4, sc-7154 Rabbit 1:1,000 Santa Cruz Biotechnology, USA 
Anti-β-actin, AC-74 Mouse 1:7,000 Sigma-Aldrich, USA 
Anti-TetR Rabbit 1:5,000 Dr. Chris Berens, FAU Erlangen 
Secondary antibodies Host Dilution Manufacturer 
Anti-mouse IgG (H+L) Rabbit 1:7,000 Jackson Immunoresearch, USA 
Anti-rabbit IgG (H+L) Goat 1:7,000 Jackson Immunoresearch, USA 
5.2 Prokaryotic and eukaryotic cell strains 
Table 5.8 List of employed cell strains. 
Cells Genotype/ Description Reference 
Bacterial strains 
E. coli Top10 
F- mcrA Δ( mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ 
lacX74 recA1 araD139 Δ( araleu)7697 galU galK 
rpsL (StrR) endA1 nupG 
Invitrogen, USA 
Eukaryotic cell lines 
HeLa  
Human epithelial cells derived from an epidermoid 
carcinoma of the cervix 
DSMZ (ACC 57) 
HeLa HF1-3 
HeLa cell line with integrated FRT-site for a Flp-In™ 
system-based genomic integration 
C. Berens 172 
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5.3 Buffers and solutions 
Table 5.9 List of buffers and solutions and their composition. 
Buffer/ solution Ingredients Concentration 
10x running buffer  
(SDS-PAGE) 
Tris 
Glycine 
SDS 
pH 8.3 
250 mM 
1.9 M 
1% (w/v) 
 
10x TBS 
 
 
For 1x TBST 
Tris 
NaCl 
pH 7.6 
Tween™ 20 
200 mM 
1.5 M 
 
0.1% (v/v) 
2x RNA loading dye 
EDTA 
Bromophenol blue 
Xylene cyanole  
In formamide (deionized)  
25 mM 
0.1% (w/v) 
0.1% (w/v) 
 
4x protein loading dye 
Glycerol 
SDS 
2-Mercaptoethanol 
Bromophenol blue 
50% (v/v) 
4% (w/v) 
15% (v/v) 
0.1% (w/v) 
50x TAE 
Tris 
Acetic acid 
EDTA 
pH 8.3 
2 M 
1 M 
50 mM 
 
6x DNA loading dye 
Tris-HCl pH 7.6 
EDTA 
Acetic acid 
Glycerol 
Bromophenol blue 
Xylene cyanole 
40 mM 
1 mM 
20 mM 
50% (v/v) 
Spatula point 
Spatula point 
Ampicillin, stock solution 
Ampicillin 
In 70% (v/v) EtOH 100 mg/ml 
LB medium 
 
 
For LB-Amp plates 
Tryptone 
Yeast extract 
NaCl 
Agar 
Ampicillin  
1% (w/v) 
0.5% (w/v) 
1% (w/v) 
2% (w/v) 
100 µg/ml 
Lysis buffer 
Tris-HCl, pH 8.0 
EDTA 
NaCl 
20 mM 
2 mM 
137 mM 
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Glycerol 
IGEPAL CA-630 
PIC 
10% (v/v) 
1% (v/v) 
0.5% (v/v) 
SOC-medium 
Yeast Extract 
Tryptone 
NaCl 
KCl 
MgCl2 
MgSO4 
Glucose 
0.5% 
0.2% 
10 mM 
2.5 mM 
10 mM  
10 mM 
20 mM 
5.4 Oligonucleotides 
Table 5.10 List of oligonucleotides employed for reverse transcription, qPCR and cloning. 
Oligonucleotide 
name 
Sequence (5’ → 3’) 
Reverse transcription 
Stem loop U48  
GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACGGTC
AG 
Stem loop miR-126 
GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACCGCA
TT 
Stem loop miR-92a 
GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACACAG
GC 
Stem loop miR-199a-
5p  
GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACGAAC
AG 
Stem loop miR-199a-
3p 
GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACTAAC
CT 
Stem loop miR-34a 
GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACACAA
CC 
Stem loop miR-101-1 
GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACTTCA
GT 
qPCR, TaqMan assay 
Universal primer GTGCAGGGTCCGAGGT 
qPCR U48 fwd GAGTGATGATGACCCCAGGTAA 
qPCR miR-126 fwd CGCGGTCGTACCGTGAGTAAT 
qPCR miR-92a fwd GCGGTATTGCACTTGTCCCG 
qPCR miR-199a-5p 
fwd 
GCGGCCCAGTGTTCAGACTAC 
qPCR miR-199a-3p CGGCGGACAGTAGTCTGCACAT 
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fwd 
qPCR miR-34a fwd GCGTGGCAGTGTCTTAGCT 
qPCR miR-101-1 fwd GCGGTACAGTACTGTGATA 
qPCR, SYBR Green assay 
SMAD4-qPCR_ 
1130-1220-f 
CCAGCTCTGTTAGCCCCATC 
SMAD4-qPCR_ 
1130-1220-r 
TACTGGCAGGCTGACTTGTG 
DDR1-qPCR_ 
231-301-f 
GAGAGGTGTCTGAAGGTGGC 
DDR1-qPCR_ 
231-301-r 
GGCAGCATCTCTTGGCATTC 
CAV1- qPCR 1_ 
294-419-f 
TACGTAGACTCGGAGGGACA 
CAV1-qPCR_ 
294-419-r 
GGTTGACCAGGTCGATCTCC 
Cloning 
CMV prom fwd TAAGCAGAGCTCGTTTAGTG 
SV40 polyA rev CACTGCATTCTAGTTGTGG 
pri-miR-34a_XhoI-f cttctcCTCGAGTGCATCCTTTCTTTCCTCCCCAC 
pri-miR-34a_XbaI-r cttctcTCTAGACTTTCCCAGCCGCCCTCAC 
pri-miR-101-1_XhoI-f cttctcCTCGAGAGAAGGTGATCTTTTAGTCCTTCACTTCATGG 
pri-miR-101-1_XbaI-r cttctcTCTAGAGTAAGAGGGTTTCTGGGTCCCAGC  
TetR5 p1-r 
TCTGGTCTGTGATGACCCATAACATGCTGCCCGTACCAAAAGTAATAAT
G 
TetR5 p2-f TATGGGTCATCACAGACCAGAGAAAAGCTCGTACCGTGAGTAATAATGC 
TetR2 p1-r 
TCTGGTCTGTGATGACCCATAACATGCTGTCCGCGTACCAAAAGTAATA
ATG 
TetR2 p2-f 
TATGGGTCATCACAGACCAGAGAAAAGTCTTCGTACCGTGAGTAATAAT
GC 
TetR5l p1-r  
TCTGGTCTGTGATGACCCATAACATGCTGCGCCCGTACCAAAAGTAATA
ATGTCC 
TetR5l p2-f  
TATGGGTCATCACAGACCAGAGAAAAGCGCTCGTACCGTGAGTAATAAT
G 
TetR NL1 p1-r TCTGGTCTGTGATGACCCATAACATGCTGCACAGCGCGTACCAAAAG 
TetR NL1 p2-f 
TATGGGTCATCACAGACCAGAGAAAAGCAAACTCGTACCGTGAGTAATA
ATG 
miR-199a-2-#1-1-r TGGTCTGTGATGACCCATAACATGCTGGAACAGGTAGTCTGAACAC 
miR-199a-2-#2-1-r TGGTCTGTGATGACCCATAACATGCTGAACAGGTAGTCTGAACAC 
miR-199a-2-#1-2-f 
GTTATGGGTCATCACAGACCAGAGAAAAGGAACAGTAGTCTGCACATTG
G 
miR-199a-2-#2-2-f GTTATGGGTCATCACAGACCAGAGAAAAGAACAGTAGTCTGCACATTGG 
miR-92a-1-#1-1-r CTGGTCTGTGATGACCCATAACATGCTGAGCATTGCAACCGATCC 
miR-92a-1-#2-1-r CTGGTCTGTGATGACCCATAACATGCTAGCATTGCAACCGATCC 
miR-92a-1-#1-2-f TGGGTCATCACAGACCAGAGAAAAGAGTATTGCACTTGTCCCGGC 
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miR-92a-1-#2-2-f TGGGTCATCACAGACCAGAGAAAAAGTATTGCACTTGTCCCGGC 
miR-34a-#1_1-r 
TTTTCTCTGGTCTGTGATGACCCATAACATGCTAACAACCAGCTAAGACA
C 
miR-34a-#2_1-r 
TTTTCTCTGGTCTGTGATGACCCATAACATGCTACAACCAGCTAAGACA
C 
miR-34a-#3_1-r 
TTTTCTCTGGTCTGTGATGACCCATAACATGCTGACAACCAGCTAAGAC
AC 
miR-34a-#1_2-f 
GCATGTTATGGGTCATCACAGACCAGAGAAAAAGCAATCAGCAAGTATA
CTGCC 
miR-34a-#2_2-f 
CATGTTATGGGTCATCACAGACCAGAGAAAAGCAATCAGCAAGTATACT
GCC 
miR-34a-#3_2-f 
GCATGTTATGGGTCATCACAGACCAGAGAAAAGGCAATCAGCAAGTATA
CTGCC 
miR-101-1-#1_1-r 
TTTTCTCTGGTCTGTGATGACCCATAACATGCTGAGCATCAGCACTGTG
ATAAC 
miR-101-1-#2_1-r 
TTTTCTCTGGTCTGTGATGACCCATAACATGCTAGCATCAGCACTGTGAT
AAC 
miR-101-1-#1_2-f 
TGTTATGGGTCATCACAGACCAGAGAAAAGGGTACAGTACTGTGATAAC
TGAAG 
miR-101-1-#2_2-f 
GTTATGGGTCATCACAGACCAGAGAAAAGGTACAGTACTGTGATAACTG
AAG 
miR-101-2-con_1-r 
TTTTCTCTGGTCTGTGATGACCCATAACATGCTAGCATCGGTACCATGAT
AAC 
miR-101-2-con_2-f 
TGTTATGGGTCATCACAGACCAGAGAAAAGGTACAGTACTGTGATAACT
G  
perfectmatch-miR-
199a-3p-f 
AGCTTACAGTAGTCTGCACATTGGTTAGAGCT 
perfectmatch-miR-
199a-3p-r 
CTAACCAATGTGCAGACTACTGTA 
perfectmatch-miR-
199a-5p-f 
AGCTTCCCAGTGTTCAGACTACCTGTTCGAGCT 
perfectmatch-miR-
199a-5p-r 
CGAACAGGTAGTCTGAACACTGGGA 
perfectmatch-miR-
34a-5p-f 
AGCTTTGGCAGTGTCTTAGCTGGTTGTGAGCT 
perfectmatch-miR-
34a-5p-r 
CACAACCAGCTAAGACACTGCCAA 
3xseed-miR-126_I-f AGCTTTCGTACCTTACATTTAGTTAAAGAGCT 
3xseed-miR-126_I-r CTTTAACTAAATGTAAGGTACGAA 
3xseed-miR-126_II-f CTCGTACCTTACATTTAGTTAAAA 
3xseed-miR-126_II-r CTAGTTTTAACTAAATGTAAGGTACGAGAGCT 
3xseed-miR-126_III-f CTAGTTCGTACCTTACATTTAGTTAAACATCAC 
3xseed-miR-126_III-r TCGAGTGATGTTTAACTAAATGTAAGGTACGAA 
3xseed-miR-199a-
5p_I-f 
AGCTTTCCAGTGTCTATCCTATATTTCTGAGCT  
3xseed-miR-199a-
5p_I-r 
CAGAAATATAGGATAGACACTGGAA 
3xseed-miR-199a-
5p_II-f 
CTCCAGTGTCTATCCTATATTTCTA 
3xseed-miR-199a-
5p_II-r 
CTAGTAGAAATATAGGATAGACACTGGAGAGCT 
3xseed-miR-199a-
5p_III-f 
CTAGTTCCAGTGTCTATCCTATATTTCTCATCAC 
3xseed-miR-199a-
5p_III-r 
TCGAGTGATGAGAAATATAGGATAGACACTGGAA 
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3xseed-miR-199a-
3p_I-f 
AGCTTTACAGTAAAATGAAACATCTTGTTAGAGCT 
3xseed-miR-199a-
3p_I-r 
CTAACAAGATGTTTCATTTTACTGTAA 
3xseed-miR-199a-
3p_II-f 
CTACAGTAAAATGAAACATCTTGTTAA 
3xseed-miR-199a-
3p_II-r 
CTAGTTAACAAGATGTTTCATTTTACTGTAGAGCT 
3xseed-miR-199a-
3p_III-f 
CTAGTTACAGTAAAATGAAACATCTTGTTACATCAC 
3xseed-miR-199a-
3p_III-r 
TCGAGTGATGTAACAAGATGTTTCATTTTACTGTAA 
3xseed-miR-34a- 
5p_I-f 
AGCTTTGGCAGTGTTTACAAATTAAGAGCT  
3xseed-miR-34a- 
5p_I-r 
CTTAATTTGTAAACACTGCCAA 
3xseed-miR-34a-
5p_II-f 
CTGGCAGTGTTTACAAATTAAA 
3xseed-miR-34a-
5p_II-r 
CTAGTTTAATTTGTAAACACTGCCAGAGCT 
3xseed-miR-34a-
5p_III-f 
CTAGTTGGCAGTGTTTACAAATTAACATCAC 
3xseed-miR-34a-
5p_III-r 
TCGAGTGATGTTAATTTGTAAACACTGCCAA 
DDR1-UTR_SpeI-f ctcttcACTAGTCCTCTCCACCCTCCTCTAGC 
DDR1-UTR_HindIII-r ctcttcAAGCTTGGGGTGACTGAGGGCTG 
Cav2-UTR_SpeI-f ctcttcACTAGTGAATACTTGGACCCCAGGTCTGGAG  
Cav2-UTR_HindIII-r 
ctcttcAAGCTTAAGCAATCTGATTAGAGCAACATTTATATTAACTACAAAAT
ATAC 
MET-UTR_SpeI-f ctcttcACTAGTTAGTGCTAGTACTATGTCAAAGCAACAGTCC 
MET-UTR_HindIII-r ctcttcAAGCTTACAAGATGTTGCATCACTTTACTTTAATTGCATG 
CD44-UTR_XhoI-f ctcttcCTCGAGTGATGTGATGAGACAAGGAACCTGCAGAATGTG 
CD44-UTR_HindIII-r 
ctcttcAAGCTTTCTGTTTCCTTTAGTCTTTTAATGTTAGCCTTTTAATATTTT
CC 
perfmat-mut-miR199-
3p-5p-126-f 
AGCTTGACCGTGACCGTGACCGTGACCGAGCT 
perfmat-mut-miR199-
3p-5p-126-r 
CGGTCACGGTCACGGTCACGGTCA 
2_3xseed random-f CGACCGTGACCGTGACCGTGACCA 
2_3xseed random-r CTAGTGGTCACGGTCACGGTCACGGTCGAGCT 
3_3xseed random-f CTAGTGACCGTGACCGTGACCGTGACCCATCAC 
3_3xseed random-r TCGAGTGATGGGTCACGGTCACGGTCACGGTCA 
Genomic integration 
Gen.int.199a(#2)-
BamHI-f 
cttctcGGATCCAGTCAGCGCAGCAGAATTCAG 
Gen.int.199a(#2)- 
SacI-r 
cttctcGAGCTCCTGTGAAGAAAAACACTGGATATGAGATTC 
SpeI-ins-f GATCTCTCTGAACTAGTCTCTGAAT 
SpeI-ins-r CGATTCAGAGACTAGTTCAGAGA 
TetR-polyA-SpeI-f ctcttCACTAGTGCGTCCGGGGACCTTG 
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TetR-polyA-ClaI-r ctcttCATCGATAATTCACCCCGGCCGC 
SV40prom-ClaI-f ctcttCATCGATTTGCAAAAGCCTAGGCCTCC 
SV40prom-SbfI-r ctcttCCCTGCAGGGCTGGCCTTTTGCTCACATGG 
5.5 Plasmids 
Table 5.11 List of plasmids employed in this work. 
Plasmid name Description Reference 
Plasmids for miRNA overexpression 
pCMV-MS 
Constructed from pGL4.75 for protein overexpression;  
empty MCS, CMVprom 
J. Weigand,  
TU Darmstadt 
pCMV-TetR 
Vector for TetR expression; 
CMVprom 
Doctoral thesis  
J. Langner,  
TU Darmstadt 
pCMV-miR-126 
Contains 100 nt natural context up- and downstream of the 
natural stem loop of miR-126; 
CMVprom 
F. Nies,  
lab course, TU 
Darmstadt  
pCMV-miR-
126_2 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-126_2; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
126_5 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-126_5; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
126_5l 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-126_5l; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
126_NL 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-126_NL; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-92a 
Contains 100 nt natural context up- and downstream of the 
natural stem loop of miR-92a; 
CMVprom 
F. Nies,  
lab course, 
TU Darmstadt 
pCMV-miR-
92a_1 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-92a_1; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
92a_2 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-92a_2; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-199a 
Contains 100 nt natural context up- and downstream of the 
natural stem loop of miR-199a; 
CMVprom 
F. Nies,  
lab course,  
TU Darmstadt 
pCMV-miR-
199a_1 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-199a_1; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
199a_2 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-199a_2; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-34a  
 
Contains 100 nt natural context up- and downstream of the 
natural stem loop of miR-34a; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
34a_1  
 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-34a_1; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
34a_2 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-34a_2; 
Doctoral thesis  
J. Atanasov, 
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 CMVprom TU Darmstadt 
pCMV-miR-
34a_3 
 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-34a_3; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-101-1 
 
Contains 100 nt natural context up- and downstream of the 
natural stem loop of miR-101-1; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
101_1 
 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-101_1; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pCMV-miR-
101_2 
Contains 100 nt natural context up- and downstream of the 
pre-miR switch miR-101_2; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
Plasmids for the reporter gene assay  
pMIR-Report 
Vector for firefly luciferase expression; 
CMVprom 
Thermo Fisher 
Scientific, USA 
pRL-SV40 
 
Vector for Renilla luciferase expression; 
SV40prom 
Promega, USA 
pMIR-perfect 
match-miR-126 
Contains the perfect match binding site for miR-126-3p 
downstream of the firefly luciferase; 
CMVprom 
F. Nies, 
lab course, 
TU Darmstadt 
pMIR-perfect 
match-miR-199a-
5p 
Contains the perfect match binding site for miR-199a-5p 
downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-perfect 
match-miR-199a-
3p 
Contains the perfect match binding site for miR-199a-3p 
downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-perfect 
match-miR-34a 
Contains the perfect match binding site for miR-34a-5p 
downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3xseed-
miR-126 
Contains the triplicate of a predicted miR-126-3p target site 
(5’-TTTAACTAAATGTAAGGTACGA-3’) of the 3’UTR of 
SPRED1 downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3xseed-
miR-199a-5p 
Contains the triplicate of a predicted miR-199a-5p target site 
(5’-AGAAATATAGGATAGACACTGGA-3’) of the 3’UTR of 
DDR1 downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3xseed-
miR-199a-3p 
Contains the triplicate of a predicted miR-199a-5p target site 
(5’-TAACAAGATGTTTCATTTTACTGTA-3’) of the 3’UTR of 
CAV2 downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3xseed-
miR-34a 
Contains the triplicate of a predicted miR-34a-5p target site of 
(5’-TTAATTTGTAAACACTGCCA-3’) the 3’UTR of E2F3 
downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3’UTR-
DDR1 
Contains a part of the 3’UTR (position 264-582) of DDR1 
downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3’UTR-
CAV2 
Contains a part of the 3’UTR (position 1-665) of CAV2 
downstream of the firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3’UTR-
MET 
Contains the 3’UTR of MET downstream of the firefly 
luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3’UTR-
CD44 
Contains the 3’UTR of CD44 downstream of the firefly 
luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
 Material and Methods 
- 79 - 
 
pMIR-random 
Contains one random site 
(5’GGTCACGGTCACGGTCACGGTC-3’) downstream of the 
firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pMIR-3xrandom 
Contains three random sites (3x 
5’GGTCACGGTCACGGTCACGGTC-3’) downstream of the 
firefly luciferase; 
CMVprom 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
Plasmids for the genomic integration  
pOG44 
Vector for Flp recombinase expression; 
CMVprom 
Thermo Fisher 
Scientific, USA 
pFRT-GFP 
Contains the eGFP CDS behind the CMVprom in the pFRT- 
vector for genomic integration 
K. Beilstein173 
pFRT-CD20 
Contains the CD20 CDS behind the CMVprom in the pFRT- 
vector for genomic integration 
K. Beilstein, 
Goethe 
Universität, 
Frankfurt 
pFRT-miR-199a 
Contains the natural stem loop of miR-199a surrounded by 
100 nt of natural context up- and downstream behind the 
CMVprom in the pFRT- vector for genomic integration 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pFRT-miR-
199a_2 
Contains the pre-miR switch miR-199a_2 surrounded by 100 
nt of natural context up- and downstream behind the CMVprom 
in the pFRT- vector for genomic integration 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pFRT-miR-199a-
TetR 
Contains the natural stem loop of miR-199a surrounded by 
100 nt of natural context up- and downstream behind the 
CMVprom and the TetR CDS behind a SV40prom  in the pFRT- 
vector for genomic integration 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
pFRT-miR-
199a_2-TetR 
Contains the pre-miR switch miR-199a_2 surrounded by 100 
nt of natural context up- and downstream behind the CMVprom 
and the TetR CDS behind a SV40prom  in the pFRT- vector for 
genomic integration 
Doctoral thesis  
J. Atanasov, 
TU Darmstadt 
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5.5.1 Basic plasmids 
All plasmids exhibiting the β-lactamase (bla) gene as a resistance marker for plasmid multiplication in 
bacteria also contain a bla promoter and an SV40 poly(A) signal downstream of the β-lactamase gene. 
5.5.1.1 pCMV-MS 
The plasmid pCMV-MS was used as the basic plasmid for the generation of the miRNA 
overexpression plasmids or as an empty plasmid for transfection. The plasmid map is presented in 
Figure 5.1. The plasmid contains a CMV promoter (including the CMV early enhancer) and a multiple 
cloning site (MCS) harboring restriction sites for XhoI and XbaI that were employed for the generation 
of the pre-miR switch constructs. The transcription start site (TSS) is located at the end of the CMV 
promoter. For transcription termination a SV40 poly(A) signal is present downstream of the MCS. 
Furthermore the plasmid encodes for a β-lactamase gene (AmpR) that confers ampicillin resistance to 
the bacterial host organism.  
 
Figure 5.1 Plasmid map of pCMV-MS. 
The plasmid map of pCMV-MS shows the CMV promoter (blue) located in front of the MCS (grey). Two restriction 
sites for XhoI and XbaI are present within the MCS. An SV40 poly(A) signal (purple) is placed downstream of the 
MCS. Additionally the plasmid harbors an ampicillin resistance gene (AmpR, red). 
5.5.1.2 pCMV-TetR 
The plasmid pCMV-TetR was used for the overexpression of TetR from a CMV promoter (including a 
CMV early enhancer). The plasmid map in Figure 5.2 shows the composition of the plasmid pCMV-
TetR. The transcription of the TetR coding sequence (CDS) is terminated by an SV40 poly(A) signal. 
Furthermore the plasmid encodes for a β-lactamase gene that equips the bacterial host organism with 
an ampicillin resistance.  
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Figure 5.2 Plasmid map of pCMV-TetR. 
Indicated are the CMV promoter (blue), the TetR CDS (light green) and the SV40 poly(A) signal (purple) for 
transcription termination (purple). A linker region (light blue) is present downstream of the TetR sequence. The 
ampicillin resistance conferring gene (AmpR) is shown in red. 
5.5.1.3 pMIR-Report 
The plasmid pMIR-Report was produced by Thermo Fisher Scientific for the insertion of putative 
miRNA binding sites to investigate the interaction of a miRNA with its target region. The related 
plasmid map is given in Figure 5.3. A MCS was positioned downstream of a firefly luciferase CDS that 
is expressed from a CMV promoter. For transcription termination an SV40 poly(A) signal is present 
downstream of the MCS region. Furthermore the plasmid encodes for a β-lactamase that confers 
ampicillin resistance to the bacterial host organism. The plasmid was employed for the construction of 
the plasmids for performing the reporter gene assay. The restriction sites XhoI, SpeI, SacI and HindIII 
located in the MCS were utilized for the insertion of either the perfect match target sites, triplicates of 
miRNA target sequences or (parts of) the 3’UTR of validated target genes.  
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Figure 5.3 Plasmid map of pMIR-Report. 
The plasmid pMIR-Report contains a CMV promoter (blue) upstream of the firefly luciferase CDS (green). An 
SV40 poly(A) signal (purple) is located downstream of the MCS (grey). In the MCS the restriction sites for XhoI, 
SpeI, SacI and HindIII are shown. Additionally, the plasmid harbors an ampicillin resistance gene (AmpR, red).  
5.5.1.4 pFRT-CD20 
Plasmid pFRT-CD20 was used as the basis for the generation of the plasmids used for genomic 
integration of the natural miR-199a precursor and the pre-miR switch miR-199a_2 (together with 
TetR). As shown in Figure 5.4, it contains an hCMV promoter in front of the CD20 CDS and an SV40 
poly(A) and BGH poly(A) signal for transcription termination downstream of the CD20 CDS. An Flp 
Recombination Target (FRT)-site that serves as recognition and cleavage site for the Flp recombinase 
is present in the plasmid. The FRT-site is located upstream of a hygromycin resistance gene that lacks 
a promoter and a start codon. The required promoter as well as the start codon are, in turn, integrated 
into the host cell genome and are brought into correct proximity and frame with the hygromycin 
resistance gene upon genomic integration of the plasmid at the FRT-site. Successful integration then 
confers hygromycin resistance to the cells and enables selection of the cells bearing the integrated 
constructs. The restriction sites for ClaI, SbfI, BamHI and SacI, which were employed for the 
integration of the respective constructs and the TetR expression determinant, are also indicated in the 
map.  
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Figure 5.4 Plasmid map of pFRT-CD20. 
The plasmid pFRT-CD20 contains an hCMV promoter (blue) in front of the CD20 CDS (yellow). An SV40 poly(A) 
signal (purple) and a BGH poly(A) (purple) is located downstream to the CD20 expression sequence. Furthermore 
the FRT site (orange) and a hygromycin resistance conferring CDS missing the start codon (Hygro(R) (no ATG), 
red) are indicated. A further SV40 poly(A) signal (purple) is provided downstream of the hygromycin resistance 
CDS to terminate transcription. Additionally, the plasmid harbors an ampicillin resistance gene (AmpR, red).  
5.5.2 Construction of plasmids 
All established constructs were precipitated with butanol after ligation and transformed into E.coli 
Top10. Then, the bacterial clones were tested in a colony-PCR and sequenced to confirm construct 
integrity. In the section below, one cloning history to generate a plasmid employed in a specific assay 
is exemplified, respectively. The other plasmids used in the same assay were created in analog to the 
presented example.   
5.5.2.1 pCMV-miR-34a 
Due to the fact that plasmid pCMV-miR-126, -199a and -92a were cloned by F. Nies, the construction 
of the plasmid pCMV-miR-34a is described here.  
For the generation of a plasmid to express the natural miRNA-34a precursor, the miRNA-34a stem 
loop region surrounded by 100 nt of natural context was amplified from genomic HeLa DNA with the 
oligonucleotides pri-miR-34a_XhoI-f and pri-miR-34a_XbaI-r. The restriction sites for XhoI and XbaI 
together with an additional 5’-cttctc-3’ sequence to enhance restriction efficiency were attached to the 
respective 5’ ends of the oligonucleotides. After amplification, the PCR product was purified by gel 
extraction. Subsequently, the backbone plasmid pCMV-MS and the amplicon were digested with the 
restriction endonucleases XhoI and XbaI and the restricted backbone was purified through gel 
extraction, whereas the insert was purified via column purification. Then, the insert was ligated with the 
backbone resulting in plasmid pCMV-miR-34a (Fig. 5.5).  
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Figure 5.5 Plasmid map of pCMV-miR-34a. 
The plasmid map schematically shows the composition of the expression plasmid pCMV-miR-34a. The natural 
miRNA-34a stem loop surrounded by 100 nt of natural context up- and downstream (grey) is expressed under 
control of a CMV promoter (blue). Within the miR-34a stem loop the miR-34a-5p (=miR-34a) highlighted in green 
and miR-34a-3p (=miR-34a*) illustrated in red are located. For transcription termination an SV40 poly(A) signal 
(purple) is present downstream of the natural miRNA precursor CDS. The restriction sites for XbaI and XhoI that 
were used for the insertion of the miRNA precursor surrounded by 100 nt of natural context are also shown. 
5.5.2.2 pCMV-miR-34a_2 
To generate pre-miR switch miR-34a_2 on the basis of plasmid pCMV-miR-34a, the replacement of 
the natural terminal loop with the TetR aptamer is illustrated below. A two-step overlap extension (OE) 
PCR was used to create the plasmid. The first PCR (pre-fusion PCR) was performed to amplify two 
PCR products each containing a part of the TetR aptamer from the template pCMV-miR-34a using the 
oligonucleotide combinations CMV prom fwd/miR-34a-#2_1-r and miR-34a-#2_2-f/SV40 poly(A) rev. 
For that purpose, a respective part of the TetR aptamer was attached to the 5’ ends of the 
oligonucleotides miR-34a-#2_1-r and miR-34a-#2_2-f creating a 30 nt overlap of the TetR aptamer 
sequence (Fig. 5.6). After DpnI digestion of the template and column purification of the amplicons, the 
two PCR products and primers CMV prom fwd and SV40 polyA rev were used to perform the fusion 
PCR. Then, the produced amplicon was purified through gel extraction and digested together with the 
backbone plasmid pCMV-miR-34a using the restriction endonucleases XhoI and XbaI. After 
purification of the backbone using gel extraction and the column purification of the insert both parts 
were ligated resulting in plasmid pCMV-miR-34_2 (Fig. 5.7).                                                                                                                         
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Figure 5.6 Schematic section of map pCMV-miR-34a_2. 
The plasmid map schematically shows a section of plasmid pCMV-miR-34a_2. Indicated are the annealing 
positions of the respective primer pairs used to amplify the first two PCR products. The oligonucleotides miR-
34a_#2_2-f and miR-34a_#2_1-r possess 5’ overhangs containing parts of the TetR aptamer sequence, 
respectively. These overhangs produce a 30 nt overlap region necessary for overlap extension PCR.  
 
Figure 5.7 Plasmid map of pCMV-miR-34a_2. 
The plasmid map schematically shows the composition of the pCMV-miR-34a_2 expression plasmid. The pre-miR 
switch miRNA-34a_2 construct is expressed under control of a CMV promoter (blue) and surrounded by 100 nt of 
natural context up- and downstream (grey). Within this natural context the pre-miR-34a stem loop that harbors 
miR-34a-5p highlighted in red and miR-34a-3p illustrated in green is located. The TetR aptamer (TetR apt, light 
blue) was inserted in between both miRNAs. For transcription termination an SV40 poly(A) signal (purple) is 
present downstream of the natural precursor CDS. 
5.5.2.3 pMIR-perfect match-miR-199a-5p 
For the construction of the reporter gene plasmids for performing the luciferase assay, plasmid pMIR-
Report served as the basic plasmid. The MCS of pMIR-Report was used to insert either the perfect 
complementary sequence, a triplicate of a predicted target sequence or (a part of) the 3’UTR of a 
validated target gene. 
To create pMIR-perfect match miR-199a-5p harboring the perfect match target site for miR-199a-5p 
the two oligonucleotides perfectmatch-miR-199a-5p-f and perfectmatch-miR-199a-5p-r equipped with 
the processed restriction ends of HindIII and SacI at both ends were ordered, 5’-phosphorylated and 
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hybridized. The plasmid pMIR-Report was digested employing the restriction enzymes HindIII and 
SacI and purified by gel extraction. After column purification, the insert was ligated with the pMIR-
Report backbone resulting in the plasmid pMIR-perfect match miR-199a-5p (Fig. 5.8).  
For the generation of plasmid pMIR-3xseed-miR-199a-5p bearing a triplicate of a target sequence 
downstream of the firefly luciferase CDS the respective primer pairs 3xseed-miR-199a-5p_I-f and 
3xseed-miR-199a-5p_I-r, 3xseed-miR-199a-5p_II-f and 3xseed-miR-199a-5p_II-r as well as 3xseed-
miR-199a-5p_III-f and 3xseed-miR-199a-5p_III-r were used. The oligonucleotides bearing the target 
sites were phosphorylated, hybridized and inserted stepwise into the backbone pMIR-Report 
employing the restriction sites for XhoI and SpeI, SpeI and SacI as well as SacI and HindIII.  
The construction of plasmid pMIR-3’UTR-DDR1 that contains a larger part of the 3’UTR of DDR1 
downstream of the firefly luciferase CDS was accomplished using the primer pair DDR1-UTR_SpeI-f 
and DDR1-UTR_HindIII-r. This primer pair possesses the restriction sites for HindIII and SpeI at the 
respective 5’ end and was used to amplify a part of the 3’UTR from genomic HeLa DNA. Then, the 
amplicon was purified through gel extraction and together with the pMIR-Report restricted using the 
restriction endonucleases HindIII and SpeI. Afterwards the prepared backbone and the insert were 
ligated.       
 
Figure 5.8 Plasmid map of pMIR-perfect match miR-199a-5p.  
Indicated is the CMV promoter (blue) that regulates the expression of the firefly luciferase gene (green). 
Furthermore, the MCS (grey) containing the perfect match target site for miR-199a-5p binding (light green) and 
the SV40 poly(A) signal (purple) are shown. The plasmid contains the CDS of the β-lactamase (AmpR) that 
confers ampicillin resistance to the bacterial host organism. The restriction sites used for the insertion of all target 
regions are indicated within the MCS. 
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5.5.2.4 pFRT-miR-199a 
To generate plasmid pFRT-miR-199a for the first genomic integration, the primer pair 
Gen.int.199a(#2)-BamHI-f and Gen.int.199a(#2)-SacI-r was used to amplify the natural pre-miR-199a 
surrounded by 100 nt of natural context from the template plasmid pCMV-miR-199a. The primers 
contained the restriction sites for BamHI or SacI attached to the 5’ ends to enable the insertion of the 
amplified sequence into the backbone. After amplification, the insert was purified via column 
purification and backbone pFRT-CD20 and insert were restricted using the restriction endonucleases 
BamHI or SacI. After purification by gel extraction, both components were ligated to yield plasmid 
pFRT-miR-199a (Fig. 5.9). 
 
Figure 5.9 Plasmid map of pFRT-miR-199a. 
The plasmid pFRT-miR-199a contains an hCMV promoter (blue) in front of the natural miR-199a precursor that is 
surrounded by 100 nt of natural context (grey). An SV40 poly(A) signal (purple) and a BGH poly(A) (purple) is 
located downstream of the pre-miR-199a expression sequence. Furthermore the FRT site (orange) and a 
hygromycin resistance conferring CDS missing the start codon (Hygro(R) (no ATG), red) are indicated. The 
plasmid harbors an ampicillin resistance gene (AmpR, red).  
5.5.2.5 pFRT-miR-199a-TetR 
In the second genomic integration, a co-integration of the natural miR-199a precursor surrounded by 
100 nt natural context and a TetR expression determinant was performed. First, an additional 
restriction site for SpeI was inserted into the plasmid pFRT-miR-199a using the primer pair SpeI-ins-f 
and SpeI-ins-r that was later employed for the insertion of the TetR-poly(A) sequence.  
The TetR-poly(A) sequence was amplified from the template plasmid pCMV-TetR using primers TetR-
polyA-SpeI-f and TetR-polyA-ClaI-r. The SV40 promoter was amplified from the pRL-SV40 plasmid 
using SV40prom-ClaI-f and SV40prom-SbfI-r. After DpnI digestion and column purification, backbone 
pFRT-miR-199a as well as the inserts were restricted by SpeI and ClaI to insert the TetR-poly(A) as 
well as ClaI and SbfI to insert the SV40 promoter. After restriction digest, the single compounds were 
purified through gel extraction and ligated to produce plasmid pFRT-miR-199a-TetR (Fig. 5.10).  
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Figure 5.10 Plasmid map of pFRT-miR-199a-TetR. 
The plasmid pFRT-miR-199a-TetR contains an hCMV promoter (blue) in front of the natural miR-199a precursor 
(grey) and an SV40 promoter (dark blue) in front of the TetR CDS (green). An SV40 poly(A) signal (purple) and a 
BGH poly(A) (purple) is located downstream of the pre-miR-199a expression sequence. Another SV40 poly(A) 
signal (purple) is located downstream of the TetR CDS. Furthermore the FRT site (orange) and a hygromycin 
resistance conferring CDS missing the start codon (Hygro(R) (no ATG), red) are indicated. The plasmid harbors 
an ampicillin resistance gene (AmpR, red).  
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5.6 Methods 
5.6.1 Treatment of prokaryotic cells 
5.6.1.1 Preparation of electrocompetent cells 
One day before starting the preparation, two overnight cultures of 4 ml LB-medium containing tubes 
were inoculated with E.coli Top10 cells and grown at 37°C at 150 rpm overnight. At the following day, 
the overnight cultures were transferred to 600 ml of LB-medium in a 2 L baffle flask to yield a start 
OD600 of 0.1. The cell suspension was incubated at 37°C at 200 rpm. After reaching an OD600 between 
0.6 - 0.8 cells were chilled on ice for 0.5 h on a slowly shaking rocking shaker, harvested by 
centrifugation for 20 min at 7,000 rpm and washed twice with 10% (v/v) of sterile glycerol. In the last 
step, all cells were suspended in 4 ml of 10% (v/v) of sterile glycerol and split into aliquots of 100 µl in 
1 ml reaction tubes. 
5.6.1.2 Electroporation of E.coli 
Electroporation was used to transform E.coli cells. SOC-medium as well as cell culture plates were 
pre-warmed at 37°C, electroporation cuvettes pre-chilled and 50 µl of electrocompetent bacteria slowly 
thawed on ice. Then, 0.5 µl of DNA were gently mixed with the bacteria and the mixture transferred 
into the slit of the cuvette. The bacteria were electro-shocked with 1,800 V for 5 ms. Immediately after 
applying the electric field to the cells, cells were extracted from the cuvette and mixed with 450 µl 
SOC-medium. After a 10 min recovery phase at 37°C and 1,000 rpm in the shaker, 80 µl (re-
transformation)-200 µl (ligation) of cells were plated onto agar plates containing ampicillin. 
Subsequently cells were incubated at 37°C overnight.  
5.6.2 Treatment of eukaryotic cells 
5.6.2.1 Cultivation, harvest and storage 
For performing cell culture with human cells, a laminar flow cabinet was employed. HeLa cells and 
HeLa HF1-3 cells 172 were cultivated in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% (v/v) fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin and 1 mM sodium 
pyruvate. For the cultivation of HeLa HF1-3 cells, the medium was additionally supplemented with 100 
µg/ml zeocin. For maintenance an incubator was adjusted to 37°C, 5% CO2 and 100% humidity. 1 x 
106 cells were seeded in 20 ml of medium into a T75 cell culture flask and splitted every 3 to 4 d. For 
splitting the cells, the medium was removed and cells were washed with 3 ml 1x PBS. Then, cells 
were detached from the flask surface through the addition of 3 ml of Trypsin/EDTA and incubation for 
5 min at 37°C. Afterwards, 7 ml of medium were added and the cell count determined with the cell 
counter. For 12-well plates, 1.4 x 105 HeLa cells or 0.9 x 105 HF1-3 cells were seeded per well in 2 ml 
of medium. For 24-well plates, 0.55 x 105 HeLa cells were seeded per well in 1 ml of medium. For 
long-term storage, the harvested cells were centrifuged and re-suspended in DMEM supplemented 
with 10% (v/v) FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 1 mM sodium pyruvate and 10% (v/v) 
DMSO to yield a concentration of 1.5–2 x 106 cells/ ml. 1 ml of the cell suspension was then 
transferred into a cryo-vial and frozen in a 2-propanol containing freezing device at -80°C. After two 
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days, the cryo-vials were removed from the freezing device and stored in the liquid nitrogen phase of a 
container filled with liquid nitrogen.    
5.6.2.2 Transient transfection 
Cells were transiently transfected with Lipofectamine® 2000 according to the manufacturer`s protocol. 
For 12-well plates, 1.4 x 105 HeLa cells were seeded in 2 ml of medium one day before transfection. 
Cells were grown to 90-95% of confluency for transfection. A total amount of 800 ng DNA per well 
(ratio of miRNA precursor or pre-miR switch expression plasmid:TetR expression plasmid 1:1) was 
used for transfection. For each sample, 2 µl of Lipofectamine and 48 µl Opti-MEM were mixed and 
incubated for 5 min at room temperature. Furthermore, the DNA was diluted in 50 µl of Opti-MEM. The 
DNA- and Lipofectamine dilutions were mixed in a 1:1 ration and incubated for 20 min at room 
temperature. Meanwhile, the medium was removed from the cells and replaced with 500 µl Opti-MEM 
per well. Then, the DNA-Lipofectamine mixture was added to the cells and the cells were incubated for 
3.5 h at 37°C. Afterwards, the lipofection medium was replaced with complete growth medium possibly 
supplemented with 1 µg/ml dox and cells were incubated at 37°C to the next day.         
For 24-well plates, 0.55 x 105 HeLa cells per well were seeded in 1 ml of complete medium. A total 
DNA amount of 500 ng DNA per well (ratio of reporter gene plasmid: miRNA precursor or pre-miR 
switch expression plasmid:TetR expression plasmid:normalization plasmid 4:7:7:2) was used for 
transfection. For a 24-well-based transfection the respective amounts of Lipofectamine and Opti-MEM 
were scaled down: 1 µl of Lipofectamine was mixed with 24 µl of Opti-MEM per sample, and the DNA 
was diluted in 25 µl Opti-MEM.  
5.6.2.3 Genomic integration 
For genomic integration the Flp-In™ System in combination with HeLa HF1-3 cells harboring a single 
stably integrated FRT-site at a transcriptional active genomic locus was used. For the first integration, 
the miR-199a and miR-199a_2 constructs were cloned into the multiple cloning site of the pFRT-CD20 
plasmid using BamHI and SacI and constitutively expressed from an hCMV immediate-early enhancer 
and promoter. For the second integration, the TetR expression sequence with an SV40 poly(A) tail as 
well as the SV40 promoter were additionally inserted into the plasmid pFRT-miR-199a(_2) using ClaI 
and SpeI and ClaI and SbfI in addition to the constructs miR-199a and miR-199a_2. The expression of 
miRNA and TetR from the integration plasmids was tested and after the confirmation of their 
functionality transfected into HF1-3 cells. As controls, a plasmid harboring no FRT-site for 
recombination constituting the negative selection control and a pFRT-GFP vector harboring the GFP 
gene for monitoring transfection and integration under the microscope were also transfected in parallel 
to the constructs. For transfection, 0.9 x 105 HF1-3 cells were seeded in 2 ml of complete medium 
without antibiotics per well in a 12-well plate. Then, 1,800 ng of the Flp-recombinase expression vector 
pOG44 and 200 ng of the construct vector or the control vectors (ratio 9:1) were transfected into the 
cells (5.6.2.2 transient transfection). After 4 h of incubation the lipofection mix was removed and 2 ml 
of complete medium without antibiotics were added to each well. At the following day, the medium was 
exchanged and the transfection efficiency was checked using fluorescence microscopy. The 
transfection efficiency was roughly approximated to be at 60-70%. After two days, the medium was 
removed and the selection medium supplemented with 150 µg/ml hygromycin B was added. During 
 Material and Methods 
- 91 - 
 
the selection for integrated clones, the selection medium was exchanged all 2 to 3 d. After some 
weeks, the negative control cells were completely dead and, in case of the first integration, the 
successfully selected cells were split into single clones through dilution in 96-well plates. Cells derived 
from a single clone were raised and cultured in selection medium in T75 cell culture flasks. At the end 
of selection, cells were tested for miRNA and TetR expression and the integration sites were 
sequenced. For sequencing, the genomic DNA was isolated with the DNeasy® Blood & Tissue kit, the 
target sequence was amplified by PCR and the PCR product was sequenced.          
5.6.2.4 Dual Luciferase reporter gene assay 
For the performance of the dual luciferase assay, the pMIR-REPORT vector was used that 
constitutively expresses the firefly luciferase gene from the CMV promoter. The pRL-SV40 that 
provides constitutive expression of the wild-type Renilla luciferase gene through an SV40 promoter 
was co-transfected with the pMIR-REPORT vector and used as an internal control for normalization of 
the firefly luciferase reporter gene-derived luminescence values. The respective miRNA target 
sequences and control sequences or (larger parts of) the target gene 3’UTRs were introduced 
downstream of the firefly luciferase reporter gene. The plasmids were co-transfected into HeLa cells 
together with the respective pre-miR switch and TetR expression plasmids as well as the pRL-SV40 
and cultivated in the absence or presence of 1 µg/ml dox. Luminescence measurements were 
performed 24 h post transfection with the Dual-Glo® Luciferase Assay System according to the 
manufacturer’s protocol. Before cell lysis, the cells were washed twice with 1x PBS and 100 µl of 
complete medium without phenol red indicator were added to each well. Then, 100 µl of the Dual Glo® 
Luciferase reagent were mixed to each well and incubated for 10 min at room temperature. 
Afterwards, the 200 µl lysate was transferred into white, 96-well Nunc™ MicroWell™ plates and firefly 
luciferase luminescence was measured with the Infinite®M200 plate reader using one second 
integration time. After that, 100 µl of the freshly prepared Dual Glo® Stop&Glo® reagent were added, 
incubated for 10 min at room temperature and Renilla luciferase luminescence was monitored. For 
normalization, the ratio between Renilla and firefly luciferase values was calculated for each well. 
Then, mean values as well as standard deviation were calculated from duplicates and normalized to 
the value derived from the empty plasmid pCMV-MS.  
5.6.2.5 Time course experiments 
The time course experiments were performed using construct miR-199a_2 for transient transfection 
(5.6.2.2 transient transfection). To gain information about the processing of the modified precursor in 
the course of time, also additional control transfections were performed with the pre-miR switch 
bearing plasmid, but without the TetR expression plasmid or dox. After transfection, cells were 
incubated in complete medium for one day. At the next day, dox was added to the medium per wells 
and cells were harvested after 0, 4, 8, 16 and 24 h of incubation at 37°C. Then, RNA was isolated 
from the samples and the amount of mature miRNA was determined using qPCR. The amount of 
mature miRNA measured by qPCR was normalized to the amount of miRNA that was obtained from 
the above mentioned controls.   
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5.6.3 Treatment of proteins 
5.6.3.1 Protein preparation from eukaryotic cells 
After transfection and incubation, cells were washed with 1xPBS and harvested from 12-well plates or 
T75 cell culture flasks using either 500 µl or 3 ml of Trypsin/EDTA per well. After 5 min of incubation at 
37°C, 1 ml or 7 ml of complete medium were added to each well or flask and the respective cell 
suspension was transferred to an either an 2 ml reaction tube or a 50 ml tube. Then, the cell 
suspensions were centrifuged at 9 x 103 rpm or 4.5 x 103 rpm for 5 min and the supernatant was 
removed. Subsequently, cells were re-suspended in 80 µl or 3 ml of protein lysis buffer and incubated 
for at least 30 min on ice. To separate supernatant and cell debris, the tubes were centrifuged for 5 
min at 9 x 103 rpm and the supernatant was transferred into a fresh tube. 
5.6.3.2 Protein concentration determination 
For the determination of the protein concentration the Bradford protein assay was used. A standard 
curve was developed by using 0, 2, 6, 10, 15 and 20 µg of BSA. The amount of BSA was diluted with 
water ad 20 µl and 980 µl of a 1:5 dilution of the Bradford reagent were added, mixed and incubated 
for 10 min at room temperature. Then, the mixture was transferred into a cuvette and absorption was 
measured at 595 nm with a spectrophotometer. 
2-3 µl of the protein extract were diluted with 17-18 µl of MQ and 980 µl of a 1:5 dilution of the 
Bradford reagent were added. The mixture was mixed and incubated for 10 min at room temperature. 
Afterwards, the measurement was performed the same way as described above. With the help of the 
standard curve, the concentration of each sample was determined and the required concentration was 
adjusted.  
5.6.3.3 SDS-PAGE and western blotting 
To investigate the effect caused by the miRNA switches at the protein level, western blotting was 
performed. For performing an SDS-PAGE, the Mini-PROTEAN® TGX Stain-Free™ precast gels with 
10 wells or 8+1 wells and either any kDa or 7.5% dependent on protein size were employed. The 
protein amount was adjusted to 20-40 µg of protein per sample, mixed with 4x protein loading buffer 
and heated for 5–10 min to 95°C. The SDS-PAGE gels were run with 140 V in 1x running buffer.   
For western blotting, the Trans-Blot® Turbo™ Transfer system was used according to the 
manufacturer`s protocol. The gel was removed from the gel chamber and washed with MQ water. 
Subsequently, the prepared stacks and the 0.2 µm PVDF membrane from the Transfer Pack were 
lifted from the tray and positioned in the centre of the cassette. The gel was placed onto the 
membrane and covered with the Top ion reservoir stack. After removing bubbles, the blotting cassette 
was closed and put into the Trans-Blot® Turbo™ apparatus. The transfer programs were chosen 
according to the size of the selected protein. For blotting the proteins SMAD4 with 65 kDa and DDR1 
with 100–125 kDa, the “mixed MW” pre-programmed protocol was applied, whereas for blotting of 
CAV1 with 22 kDa the pre-programmed protocol “low MW” was used according to the manufacturer`s 
recommendations. After blotting the proteins onto the membrane, the membrane was blocked with 
either 2% (w/v) ECL-reagent (SMAD4, CAV1, TetR) or skimmed milk powder (DDR1) in 1x TBST for 
1.5 h gently shaking on a rocking shaker at room temperature. Then, the membrane was incubated 
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with the first antibody for either 1-2 h (SMAD4) or overnight (DDR1, CAV1). The anti-SMAD4, anti-
DDR1 and anti-CAV1 antibodies were diluted 1:1,000 with the respective blocking reagent for usage. 
The anti-TetR antibody was diluted 1:5,000, the anti-β-actin and anti-HSP-60 antibody 1:7,000 and 
1:2,000 for application. Afterwards, the membrane was washed three times with 1x TBST for 15 min 
and the secondary antibody was added. The secondary antibodies were used in a 1:7,000 dilution with 
the respective blocking reagent and incubated for 1 h at room temperature. After washing the 
membranes three times for 15 min, the detection was performed with the Clarity™ and the Clarity 
Max™ Western ECL Blotting substrate dependent on signal intensity at the ChemiDoc™ MP system. 
For protein detection the Clarity Western Peroxid Reagent and the Clarity Luminol/Enhancer Reagent 
were mixed in a 1:1 ratio and incubated on the membrane for 5 min.       
5.6.4 Treatment of nucleic acids  
5.6.4.1 Agarose gel electrophoresis 
The analysis of size and quality of DNA and RNA as well as the DNA fragment purification was 
performed through applying agarose gel electrophoresis. Dependent on fragment size, 1% - 3% (w/v) 
agarose gels were used. For their fabrication, the respective amount of agarose was dissolved in 1x 
TAE and dissolved by heating in the microwave. The samples were mixed with 6x DNA or 2x RNA 
loading dye, the gel was run in 1x TAE and an electric field strength of 6 V/cm. Afterwards, the gels 
were stained in 0.5 µg/ml ethidium bromide for 10 min and DNA or RNA was visualized under UV light. 
For analytical gels a wave length of 254 nm, for preparative gels a wave length of 366 nm was 
employed to prevent the extracted DNA from damage.      
5.6.4.2 DNA precipitation with 1-butanol 
To concentrate DNA, 10 volumes of 1-butanol were added to the DNA solution and the mix was 
vortexed for 10 s. Then, it was centrifuged for 10 min at 13,000 rpm, washed with 70% (v/v) ethanol 
and centrifuged for 5 min at 13,000 rpm, again. After removing the supernatant, the pellet was dried 
for 5 min at room temperature and subsequently dissolved in 8 µl water.  
5.6.4.3 DNA purification 
DNA purification was conducted by using column purification or gel extraction methods. To purify DNA 
from proteins, salt, RNA and small DNA fragments, the QIAquick PCR Purification kit was used. To 
isolate DNA fragments of defined size, the DNA sample was run on a gel and the band of interest was 
excised from the gel. Gel extraction was performed employing the Zymoclean® Gel DNA Recovery kit 
according to the manufacturer`s protocol. The pellet was dissolved in water instead of the 
recommended buffer. After purification, the concentration of the sample was determined with the 
NanoDrop® ND-1000 Spectrophotometer.  
5.6.4.4 Determination of the concentration of nucleic acids 
The concentration of DNA and RNA sample was determined at 260 nm wave length using the 
NanoDrop® ND-1000 Spectrophotometer. As reference the respective solvent was employed. 
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5.6.4.5 Plasmid preparation 
For the propagation of a plasmid in bacteria, the cells containing the desired plasmid were inoculated 
in 4 ml of LB-medium supplemented with the respective antibiotic and grown at 37°C shaking at 150 
rpm overnight. For plasmid isolation the QIAprep®Spin Miniprep kit was used according to the 
manufacturer`s protocol. The pellet was dissolved in water instead of the recommended buffer. After 
plasmid isolation, the concentration of the sample was determined with the NanoDrop® ND-1000 
Spectrophotometer.  
5.6.4.6 Polymerase Chain Reaction (PCR) 
PCR was employed to delete, insert or amplify defined sequence parts and to screen for desired 
sequences. Here, plasmid- and genomic DNA, PCR amplicons or whole cells were applied as 
template.      
For constructing the plasmids bearing the miRNA precursor, the respective miRNA stem loop 
structures flanked by 100 nt up- and downstream of the stem loop region were amplified from genomic 
HeLa DNA and introduced into the multiple cloning site of pCMV-MS. Afterwards, a two-step overlap 
extension-PCR was applied. The first PCR (pre-fusion PCR) served to introduce additional sequence 
parts that were attached to the 5’ end of the respective primer into selected positions of the plasmid. 
By the creation of an overlap region in the PCR used to prime amplification, the second step (fusion 
PCR) was used to fuse the respective single fragments to one insert. The respective template amount 
was adjusted to result in equimolar amounts of template. The programs as well as the reaction 
mixtures for the two-step OE-PCR are depicted in Table 5.12-15. 
Table 5.12 Reaction mixture for the performance of the pre-fusion PCR. 
Concentration Reagent Reagent volume [µL] End concentration 
5x Q5® Reaction Buffer 20 1x 
10 µM primer fwd 3 300 nM 
10 µM primer rev 3 300 nM 
100% DMSO 3 3% 
25 ng/µL template 4 1 ng/µl 
10 mM dNTPs 2 200 µM 
2 U/µL 
Q5® High-Fidelity DNA 
Polymerase 
1 0.02 U/µl 
 MQ ad 100  
 total 100  
Table 5.13 PCR program applied for the pre-fusion PCR.  
 Temperature [°C] Time 
Initial 
denaturation 98 
30 s 
Denaturation 98 7 s 
Annealing 50 20 s 
Extension 72 20 s/kb 
Final extension 72 4 min 
 
 
35 cycles 
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Table 5.14 Reaction mixture for the performance of the fusion PCR. 
Concentration Reagent Reagent volume [µL] End concentration 
5x Q5® Reaction Buffer 20 1x 
10 µM primer fwd 3 300 nM 
10 µM primer rev 3 300 nM 
100% DMSO 3 3% 
 template 1 x 50 – 150 ng 
 template 2 x 50 – 150 ng 
10 mM dNTPs 2 200 µM 
2 U/µL 
Q5® High-Fidelity DNA 
Polymerase 
1 0.02 U/µl 
 MQ ad 100  
 total 100  
Table 5.15 PCR program applied for the fusion PCR. 
 Temperature [°C] Time 
Initial 
denaturation 98 
1 min 
Annealing 45 1 m 
Extension 72 20 s/kb 
Denaturation 98 10 s 
Annealing 56 30 s 
Extension 72 20 s/kb 
Final extension 72 4 min 
The reaction mixture contents as well as the program for standard PCR amplification was absolutely 
conform to that of the Pre-Fusion-PCR. Merely, the annealing temperature was adapted to the melting 
temperature of the applied primers. 
By means of colony-PCR, several bacterial clones were screened for harboring a plasmid with the 
correct insert by the amplification of a defined sequence. The band pattern obtained from PCR-based 
amplification was visualized on an agarose gel. The appearance of the desired band in the gel implied 
the correct insertion or deletion of a particular sequence in the plasmid. A bacterial colony was picked 
from an LB-plate and suspended in 50 µl of water. 1 µl was used for the analysis by PCR. The 
programs as well as the reaction mixture for colony PCR are shown in Table 5.16 and 5.17. 
Table 5.16 Reaction mixture for the performance of the colony PCR. 
Concentration Reagent Reagent volume [µL] End concentration 
10x Taq DNA Buffer 10 1x 
10 µM primer fwd 0.3 300 nM 
10 µM primer rev 0.3 300 nM 
 bacterial cell 1  
10 mM dNTPs 0.2 200 µM 
5 U/µL Taq DNA Polymerase 0.2 0.1 U/µl 
 MQ 6.8  
 total 10  
 
30 cycles 
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Table 5.17 PCR program applied for colony PCR. 
 Temperature [°C] Time 
Initial 
denaturation 95 
10 s 
Denaturation 95 5 s 
Annealing 50 30 s 
Extension 72 1 min/kb 
Final extension 72 4 min 
5.6.4.7 Oligonucleotide annealing and 5’ end phosphorylation 
To produce short oligonucleotide-based stretches without using a template for cloning, the 
complementary single strands were ordered pre-cut to match the restriction site of the target vector. 
For efficient sticky end ligation into a plasmid, the double-stranded products were phosphorylated at 
the 5’ end. The reaction mix for 5’ end phosphorylation is displayed in Table 5.18.   
Table 5.18 Oligonucleotide-annealing reaction mix.  
Concentration Reagent Reagent volume [µL] End concentration 
10x 
T4-Polynucleotide 
Kinase Buffer 
5 1x 
100 µM oligonucleotide fwd 1.5 3 µM 
100 µM oligonucleotide rev 1.5 3 µM 
10 mM ATP 5 1 mM 
10 U/µL 
T4-Polynucleotide 
Kinase (T4-PNK) 
1 0.2 U/µl 
 MQ ad 50  
 total 50  
The mix without T4-PNK was incubated 2 min at 98 °C and then cooled with 0.1°C/s to 25°C. T4-PNK 
was added, the reaction mix was mixed and incubated at 37 °C for 1 h. 
5.6.4.8 Restriction digest  
For DNA restriction digest, type IIP restriction endonucleases were used with the manufacturer`s 
buffer systems according to the manufacturer`s recommendations. Up to 4 µg of DNA were applied for 
digestion in a volume of 50 µl. The reaction mixture for restriction digest is shown in Table 5.19.   
Table 5.19 Reaction mix for restriction digest.  
Concentration Reagent Reagent volume [µl] End concentration 
10x buffer system 5 1x 
20 U/µl restriction enzyme 1-2 0.4-0.8 U/µl 
 DNA x 2-4 µg/50 µl 
 H2O ad 50  
 total 50  
The restricted plasmid backbones were purified by gel extraction, whereas the restricted PCR-
products were purified through column purification, gel extraction or alcohol precipitation dependent on 
size.    
 
 
25 cycles 
 Material and Methods 
- 97 - 
 
5.6.4.9 DpnI digestion 
After the amplification of a PCR product from a bacteria-derived plasmid, the PCR product was treated 
with 1 µl of DpnI for 45 minutes at 37°C to destroy the DNA template. Meanwhile, the amplified 
product stayed unaffected due to DpnI`s property to recognize and digest merely (hemi-)methylated 
DNA. Afterwards, the PCR product was purified by column purification. 
5.6.4.10  Ligation 
For ligation of backbone and insert a molar ratio of 1:6 was used. After 1-2 h of ligation at room 
temperature, the plasmid was precipitated using 1-butanol before transformation and the pellet was 
resupended in 8 µl of MQ water. The reaction mixture for ligation is depicted in Table 5.20. 
Table 5.20 Reaction mixture for ligation.  
Concentration Reagent Reagent volume [µl] End concentration 
10x T4 DNA Ligase Buffer 2 1x 
x ng/µl backbone x 25 ng/20 µl 
x ng/µl insert x x ng/20 µl 
10 mM ATP 2 1 mM 
400 U/µl T4 DNA ligase 1 400 U 
 MQ ad 20  
 total 20  
5.6.4.11  Total RNA extraction from human cells and digestion of DNA 
The whole extraction process was performed on ice to prevent degradation of RNA through RNases. 
After transfection and incubation, cells were washed with 500 µl 1x PBS per well, respectively 400 µl 
of Trizol were added to the cells and the mixture was incubated for 5 min at room temperature. Then, 
the lyates were transferred to 2 ml reaction tubes and 80 µl of chloroform per sample were added, the 
samples were vortexed for 15 s and incubated for 3 min at room temperature. The samples were 
centrifuged for 15 min at 13,000 rpm and 4°C. Afterwards, the upper aqueous phase was transferred 
into a fresh 2 ml reaction tube and 200 µl of chloroform were mixed to the solution. Subsequently, the 
samples were vortexed for 15 s again and centrifuged for 15 min at 13,000 rpm and 4°C. Again, the 
upper aqueous phase was transferred into a fresh reaction tube and 0.75 µl of GlycoBlue™ as well as 
200 µl of cold 2-isopropanol were added to the samples. After mixing, the samples were incubated for 
10 min at room temperature and centrifuged for 45 min at 13000 rpm and 4°C. The supernatant was 
removed, samples were washed with 180 µl of 70% (v/v) ethanol and centrifuged for 10 min at 13,000 
rpm and 4°C. The pellets were dried for 5 min at room temperature and dissolved in 35 µl of water.  
To remove DNA from the samples, 4 µl of 10x TURBO DNase buffer and 0.5 µl TURBO DNase per 
sample were used. After 15 min incubation at room temperature, 4 µl of 3 M sodium acetate (pH=6.5) 
and 200 µl of cold 100% (v/v) ethanol were added for RNA precipitation and the samples were 
incubated for 45 min at - 80°C. Afterwards, RNAs were washed with 70% (v/v) ethanol and dried for 5 
min at room temperature. The RNA pellets were dissolved in 20 µl of water, RNA concentration was 
determined by using the NanoDrop spectrophotometer and RNA integrity of each RNA sample was 
analyzed on a 1% (w/v) agarose gel. Isolated RNAs were stored at -80°C. 
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5.6.4.12 Reverse transcription 
To transcribe the complete isolated RNA pool for qPCR detection with SYBR Green, random hexamer 
primers were employed. Random hexamer primers consist of a mixture of oligonucleotides 
representing all possible hexamer sequences. Random priming during cDNA generation results in a 
random coverage of all regions of the RNAs and generates cDNAs of different lengths. In total, 1 µg of 
RNA was transcribed into cDNA. The reaction mixture and the PCR program are depicted in Table 
5.21 and 5.22. 
Table 5.21 Reaction mix for reverse transcription with random hexamer primers. 
Concentration Reagent Reagent volume [µL] End concentration 
25 mM MgCl2 Solution 8 5 mM 
10x PCR Buffer II 4 1x 
100 mM dNTPs 0.4 1 mM 
20x 
random hexamer 
primer 
2 1x 
40 U/µl RiboLock RNase 1 0.025 U/µl 
50 U/µL 
MuLV Reverse 
Transcriptase 
2 2.5 U/µl 
 MQ ad 40  
 total (with RNA) 40  
Table 5.22 PCR program for reverse transcription with random hexamer primers. 
Temperature 
[°C] 
Time 
20 10 min 
42 15 min 
99 5 min 
4 ∞ 
Afterwards, the samples were filled with water ad 200 µl (1:5 dilution).  
To rewrite miRNAs into complementary DNA (cDNA) for qPCR detection employing the TaqMan® 
method, sequence-specific stem-loop (SL) primers were used to make target-specific reverse 
transcription. In total, 100 ng of RNA were transcribed into cDNA. For normalization in qPCR, the 
small nucleolar RNA (snoRNA) U48 was co-transcribed to cDNA. In Table 5.23 and 5.24 the reaction 
mixture and the used PCR program are shown.  
  Table 5.23 Reaction mix for reverse transcription with SL-primers.  
Concentration Reagent Reagent volume [µL] End concentration 
5x First-Strand Buffer 2 1x 
500 nM SL-primer U48 1 50 nM 
500 nM SL-primer miR-X 1 50 nM 
10 mM dNTPs 0.25 0.25 mM 
0.1 M DTT 1 10 mM 
25 ng/µl RNA 4 100 ng/10 µl 
200 U/µL 
Super-Script™ II 
Reverse Transcriptase 
0.25 5 U/µl 
 MQ 0.5  
 total 10  
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Table 5.24 PCR program for reverse transcription with SL-primers. 
Temperature 
[°C] 
Time 
16 30 min 
30 30 s 
42 30 s 
50 1 min 
70 15 min 
4 ∞ 
After cDNA synthesis, the samples were diluted 1:5 with 40 µl of water. 
5.6.4.13  qPCR 
Quantitative Real-Time PCR (qPCR) was performed using the StepOnePlus™ Real-Time PCR 
System. During amplification of the target cDNA, the increase in amplification product is monitored by 
fluorescence measurement. The cycle threshold (Ct) value indicates the number of cycles that are 
required for the fluorescence signal to cross the threshold and constitutes a relative measure of the 
respective target concentration in the reaction sample.   
During SYBR Green-based qPCR, the SYBR Green I dye efficiently intercalates into present ds DNA 
and fluoresces in that bound state. 5 µl of the diluted cDNA solution were employed for measurements 
and a primer mix of the respective two gene specific primers was mixed in advance. The reaction mix 
was pipetted into an optical 96-well reaction plate followed by the cDNA, the plate was covered with an 
optical membrane and shortly centrifuged at 1,500 rpm. The applied reaction mix and the qPCR 
program are depicted in Table 5.25 and 5.26.   
Table 5.25 Reaction mix for reverse transcription. 
Concentration Reagent Reagent volume [µL] End concentration 
2x 
SYBR Green 
Master Mix 
10 1x 
10 µM each Primer Mix 1 0.5 µM each 
 cDNA 5  
 MQ 4  
 total 20  
Table 5.26 PCR program for SYBR Green-based qPCR. 
Temperature [°C] Time 
95 20 s 
95 3 s 
60 30 s 
95 15 s 
60 1 min 
95 15 s 
Each primer pair was tested to produce no unspecific by-products. Specific amplification was verified 
with melting curves and by visualization of the amplicon in an agarose gel.  
All reactions for miRNAs and endogenous controls were run in duplicates. Relative gene expression 
was analyzed using the 2-ΔΔCt  method 174. 
60 cycles 
40 cycles 
melting curve program 
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TaqMan qPCR was performed according to Chen et al. 175. For this method, a TaqMan probe was 
used that harbors a fluorescence reporter dye at the 5’ end as well as a quencher at the 3’ end that 
quenches dye emission through its direct position next to the reporter dye. During amplification, the 
DNA polymerase cleaves the reporter dye from the quencher resulting in the reporter dye`s 
characteristic emission of the fluorescence signal. 5 µl of the cDNA mixture were used for qPCR. 
During cDNA synthesis, the applied SL-primer introduced a stem-loop structure which harbors a 
TaqMan probe binding site as well as a Universal Primer binding site required for qPCR. The presence 
of both binding sites enables the quantification of several miRNAs with one stem-loop sequence. The 
reaction mix was pipetted into an optical 96-well reaction plate followed by the cDNA, the plate was 
covered with an optical membrane and shortly centrifuged at 1,500 rpm. The composition of the 
reaction mix and the qPCR program are shown in Table 5.27 and 5.28.   
Table 5.27 Reaction mixture for the TaqMan-based qPCR. 
Concentration Reagent Reagent volume [µL] End concentration 
2x 
TaqMan® Fast 
Universal  Master 
Mix 
10 1x 
10 µM Universal Primer 1 0.5 µM 
10 µM qPCR Primer fwd 1 0.5 µM 
 
Universal 
ProbeLibrary Probe 
#21 
1  
 cDNA 5 100 ng/10 µl 
200 U/µL 
Super-Script™ II 
Reverse 
Transcriptase 
0.25 5 U/µl 
 MQ 2  
 total 20  
Table 5.28 PCR program for the TaqMan-based qPCR. 
Temperature [°C] Time 
50 2 min 
95 10 min 
95 15 s 
60 1 min 
All reactions for miRNAs and endogenous control were run in duplicates. The ratio of two cDNAs was 
calculated through the exponential increase with the formula 2-ΔCt. The ΔCt value represents the 
difference between Ctreference gene and Cttarget gene. 
 
 
 
 
 
 
 
40 cycles 
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6 Appendix 
6.1 Abbreviations 
Table 6.1 List of abbreviations. 
Abbreviations Abbreviations 
% (v/v) % (volume/volume) Prom promoter 
% (w/v) % (weight/volume) qPCR quantitative PCR 
Amp ampicillin rev/r reverse 
bp base pair RNA ribonucleic acid 
BSA bovine serum albumin RNAi RNA interference 
cDNA complementary DNA RISC 
RNA induced silencing 
complex 
CDS coding sequence SD Shine-Dalgarno  
CMV cytomegalovirus SDS Sodium dodecyl sulfate 
dNTP  
deoxynucleoside 
triphosphate 
shRNA small hairpin RNA 
DMSO  dimethylsufoxide siRNA small interfering RNA 
DNA deoxyribonucleic acid SL stem loop 
dox doxycycline ss single strand 
ds double stranded SV40 Simian vacuolating virus 40 
et al. et alii TBS tris buffered saline 
EtOH ethanol tc tetracycline 
FBS fetal bovine serum TF transcription factor 
fwd/f forward UTR untranslated region 
gDNA genomic DNA UTR untranslated region 
LB lysogeny broth 
MCS multiple cloning site 
miRNA/ miR micro RNA 
mRNA messenger RNA 
nt nucleotides 
PAGE 
polyacrylamide gel 
electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
pre-miRNA precursor miRNA 
pri-miRNA primary miRNA 
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6.2 Units 
Table 6.2 List of units. 
Units 
°C degree Celsius 
Da Dalton 
g gram 
h hours 
l liter 
M molar 
min minutes 
rpm  rounds per minute 
sec seconds 
U unit 
V volt 
v/v volume per volume 
w/v weight per volume 
6.3 Prefixes 
Table 6.3 List of used prefixes. 
Dimensions 
k kilo (103) 
m milli (10-3) 
µ micro (10-6) 
n nano (10-9) 
p pico (10-12) 
6.4 Nucleobases 
Table 6.4 Abbreviations for nucleobases. 
Nucleobases 
A adenine 
C cytosine 
G guanine 
T thymine 
U uracil 
N A, C, G, T, U 
 References 
- 103 - 
 
7 References 
(1) de Vriend, H. (2006) Constructing Life. Early social reflections on the emerging field of synthetic 
biology. The Hague: Rathenau Institute. 
(2) Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D., and Keasling, J. D. (2003) Engineering 
a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotechnol. 21, 796–802. 
(3) Lindahl, A.-L., Olsson, M. E., Mercke, P., Tollbom, Ö., Schelin, J., Brodelius, M., and Brodelius, P. 
E. (2006) Production of the Artemisinin Precursor Amorpha-4,11-diene by Engineered Saccharomyces 
cerevisiae. Biotechnol. Lett. 28, 571–580. 
(4) Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., 
Eachus, R. A., Ham, T. S., Kirby, J., Chang, M. C. Y., Withers, S. T., Shiba, Y., Sarpong, R., and 
Keasling, J. D. (2006) Production of the antimalarial drug precursor artemisinic acid in engineered 
yeast. Nature 440, 940–943. 
(5) Berens, C., and Suess, B. (2015) Riboswitch engineering - making the all-important second and 
third steps. Curr. Opin. Biotechnol. 31, 10–15. 
(6) van Steensel, B. (2011) Chromatin: constructing the big picture. EMBO J. 30, 1885–95. 
(7) Brown, T. A. (2002) Genomes. 2nd ed. Wiley-Liss. 
(8) Woodcock, C. L., and Ghosh, R. P. (2010) Chromatin Higher-order Structure and Dynamics. Cold 
Spring Harb Perspect Biol 2, 1–26. 
(9) Li, B., Carey, M., and Workman, J. L. (2007) The Role of Chromatin during Transcription. Cell 128, 
707–719. 
(10) Iyer, B. V., Kenward, M., and Arya, G. (2011) Hierarchies in eukaryotic genome organization: 
Insights from polymer theory and simulations. BMC Biophys. 4, 8. 
(11) Struhl, K. (1999) Fundamentally Different Logic of Gene Regulation in Eukaryotes and 
Prokaryotes. Cell 98, 1–4. 
(12) Orphanides, G., Lagrange, T., and Reinberg, D. (1996) The general transcription factors of RNA 
polymerase II. Genes Dev. 10, 2657–83. 
(13) Maston, G. a, Evans, S. K., and Green, M. R. (2006) Transcriptional regulatory elements in the 
human genome. Annu. Rev. Genomics Hum. Genet. 7, 29–59. 
(14) Narlikar, G. J., Fan, H.-Y., and Kingston, R. E. (2002) Cooperation between complexes that 
regulate chromatin structure and transcription. Cell 108, 475–87. 
(15) Purcell, O., Peccoud, J., and Lu, T. K. (2014) Rule-Based Design of Synthetic Transcription 
Factors in Eukaryotes. ACS Synth. Biol. 3, 737–744. 
(16) Klug, A. (2010) The Discovery of Zinc Fingers and Their Applications in Gene Regulation and 
Genome Manipulation. Annu. Rev. Biochem. 79, 213–231. 
(17) Khalil, A. S., Lu, T. K., Bashor, C. J., Ramirez, C. L., Pyenson, N. C., Joung, J. K., and Collins, J. 
 References 
- 104 - 
 
J. (2012) A synthetic biology framework for programming eukaryotic transcription functions. Cell 150, 
647–658. 
(18) Jankele, R., and Svoboda, P. (2014) TAL effectors: tools for DNA Targeting. Brief. Funct. 
Genomics 13, 409–419. 
(19) Moscou, M. J., and Bogdanove, A. J. (2009) A Simple Cipher Governs DNA Recognition by TAL 
Effectors. Science. 326, 1501–1501. 
(20) Zhang, F., Cong, L., Lodato, S., Kosuri, S., Church, G. M., and Arlotta, P. (2011) Efficient 
construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. 
Biotechnol. 29, 149–153. 
(21) Morbitzer, R., Romer, P., Boch, J., and Lahaye, T. (2010) Regulation of selected genome loci 
using de novo-engineered transcription activator-like effector (TALE)-type transcription factors. Proc. 
Natl. Acad. Sci. 107, 21617–21622. 
(22) Mercer, A. C., Gaj, T., Sirk, S. J., Lamb, B. M., and Barbas, C. F. (2014) Regulation of 
Endogenous Human Gene Expression by Ligand- Inducible TALE Transcription Factors. ACS Synth. 
Biol. 3, 723–730. 
(23) Maeder, M. L., Linder, S. J., Cascio, V. M., Fu, Y., Ho, Q. H., and Joung, J. K. (2013) CRISPR 
RNA-guided activation of endogenous human genes. Nat Methods 10, 977–979. 
(24) Gilbert, L. a, Larson, M. H., Morsut, L., Liu, Z., Gloria, A., Torres, S. E., Stern-ginossar, N., 
Brandman, O., Whitehead, H., Doudna, J. a, Lim, W. a, and Jonathan, S. (2013) CRISPR-Mediated 
Modular RNA-Guided Regualtion of Transcription in Eukaryotes. Cell 154, 442–451. 
(25) Berg, J. M., Tymoczko, J. L., and Stryer, L. (2002) Biochemistry. W.H. Freeman. 
(26) Keegan, L. P., Leroy, A., Sproul, D., and O’Connell, M. A. (2004) Adenosine deaminases acting 
on RNA (ADARs): RNA-editing enzymes. Genome Biol. 5, 209. 
(27) Glisovic, T., Bachorik, J. L., Yong, J., and Dreyfuss, G. (2008) RNA-binding proteins and post-
transcriptional gene regulation. FEBS Lett. 582, 1977–86. 
(28) Palazzo, A. F., and Lee, E. S. (2015) Non-coding RNA: What is functional and what is junk? 
Front. Genet. 5, 1–11. 
(29) Mattick, J. S., and Makunin, I. V. (2006) Non-coding RNA. Hum. Mol. Genet. 15 Spec No, 17–29. 
(30) Carthew, Richard W. and Sontheimer, E. J. (2009) Origins and Mechanisms of miRNAs and 
siRNAs. Cell 136, 642–655. 
(31) Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 
encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–54. 
(32) Mello, C. C., and Conte, D. (2004) Revealing the world of RNA interference. Nature 431, 338–
342. 
(33) Shabalina, S., and Koonin, E. (2008) Origins and evolution of eukaryotic RNA interference. 
Trends Ecol. Evol. 23, 578–587. 
(34) Wilson, R. C., and Doudna, J. A. (2013) Molecular Mechanisms of RNA Interference. Annu. Rev. 
Biophys 42, 217–39. 
 References 
- 105 - 
 
(35) Seto, A. G., Kingston, R. E., and Lau, N. C. (2007) The Coming of Age for Piwi Proteins. Mol. Cell 
26, 603–609. 
(36) Meister, G. (2013) Argonaute proteins: functional insights and emerging roles. Nat. Rev. Genet. 
14, 447–459. 
(37) He, L., and Hannon, G. J. (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. 
Rev. Genet. 5, 522–531. 
(38) Hammond, S. M., Boettcher, S., Caudy, A. A., Kobayashi, R., and Hannon, G. J. (2001) 
Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAi. Science. 293, 1146–1150. 
(39) Friedman, R. C., Farh, K. K. H., Burge, C. B., and Bartel, D. P. (2009) Most mammalian mRNAs 
are conserved targets of microRNAs. Genome Res. 19, 92–105. 
(40) Filipowicz, W., Bhattacharyya, S. N., and Sonenberg, N. (2008) Mechanisms of post-
transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9, 102–114. 
(41) Lee, Y., Jeon, K., Lee, J.-T., Kim, S., and Kim, V. N. (2002) MicroRNA maturation: stepwisee 
processing and subcellular localization. EMBO J. 21, 4663–4670. 
(42) Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by 
adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20. 
(43) Kiriakidou, M., Nelson, P. T., Kouranov, A., Fitziev, P., Bouyioukos, C., Mourelatos, Z., and 
Hatzigeorgiou, A. (2004) A combined computational-experimental approach predicts human microRNA 
targets. Genes Dev. 18, 1165–1178. 
(44) Kloosterman, W. P., Wienholds, E., Ketting, R. F., and Plasterk, R. H. A. (2004) Substrate 
requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res. 32, 6284–6291. 
(45) Huntzinger, E., and Izaurralde, E. (2011) Gene silencing by microRNAs: contributions of 
translational repression and mRNA decay. Nat. Rev. Genet. 12, 99–110. 
(46) Fabian, M. R., Mathonnet, G., Sundermeier, T., Zipprich, J. T., Svitkin, Y. V, Rivas, F., Jinek, M., 
Doudna, J. A., Chen, C. A., Shyu, A., Yates, J. R., Hannon, G. J., Filipowicz, W., and Duchaine, T. F. 
(2010) Mammalian miRNA RISC Recruits CAF1 and PABP to Affect PABP- Dependent 
Deadenylation. Mol cell. 35, 868–880. 
(47) Zdanowicz, A., Thermann, R., Kowalska, J., Jemielity, J., Duncan, K., Preiss, T., Darzynkiewicz, 
E., and Hentze, M. W. (2009) Drosophila miR2 Primarily Targets the m7GpppN Cap Structure for 
Translational Repression. Mol. Cell 35, 881–888. 
(48) Wilczynska, A., and Bushell, M. (2015) The complexity of miRNA-mediated repression. Cell Death 
Differ. 22, 22–33. 
(49) Bartel, D. P., and Chen, C.-Z. (2004) Opinion: Micromanagers of gene expression: the potentially 
widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5, 396–400. 
(50) Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., 
and Kim, V. N. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415–
419. 
(51) Ma, H., Wu, Y., Choi, J.-G., and Wu, H. (2013) Lower and upper stem-single-stranded RNA 
junctions together determine the Drosha cleavage site. Proc. Natl. Acad. Sci. U. S. A. 110, 20687–92. 
 References 
- 106 - 
 
(52) Han, J., Lee, Y., Yeom, K., Kim, Y., Jin, H., and Kim, V. N. (2004) The Drosha – DGCR8 complex 
in primary microRNA processing. Genes Dev. 3016–3027. 
(53) Zeng, Y., and Cullen, B. R. (2003) Sequence requirements for micro RNA processing and 
function in human cells. RNA 9, 112–23. 
(54) Roden, C. A., Gaillard, J., Kanoria, S., Rennie, W., Barish, S., Cheng, J., Pan, W., Liu, J., 
Cotsapas, C., Ding, Y., and Lu, J. (2017) Novel determinants of mammalian primary microRNA 
processing revealed by systematic evaluation of hairpin-containing transcripts and human genetic 
variation. Genome Res. gr.208900.116. 
(55) Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E., and Kutay, U. (2004) Nuclear Export of 
MicroRNA Precursors. Science. 303, 95–98. 
(56) Gregory, R. I., Yan, K., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., and Shiekhattar, 
R. (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235–240. 
(57) Basyuk, E., Suavet, F., Doglio, A., Bordonné, R., and Bertrand, E. (2003) Human let-7 stem-loop 
precursors harbor features of RNase III cleavage products. Nucleic Acids Res. 31, 6593–6597. 
(58) Macrae, I. J., Zhou, K., Li, F., Repic, A., Brooks, A. N., Cande, W. Z., Adams, P. D., and Doudna, 
J. A. (2006) Structural Basis for Double-Stranded RNA Processing by Dicer. Science. 311. 
(59) Park, J.-E., Heo, I., Tian, Y., Simanshu, D. K., Chang, H., Jee, D., Patel, D. J., and Kim, V. N. 
(2011) Dicer recognizes the 5’ end of RNA for efficient and accurate processing. Nature 475, 201–205. 
(60) Tsutsumi, A., Kawamata, T., Izumi, N., Seitz, H., and Tomari, Y. (2011) Recognition of the pre-
miRNA structure by Drosophila Dicer-1. Nat. Struct. Mol. Biol. 18, 1153–1158. 
(61) Starega-Roslan, J., Galka-Marciniak, P., and Krzyzosiak, W. J. (2015) Nucleotide sequence of 
miRNA precursor contributes to cleavage site selection by Dicer. Nucleic Acids Res. 43, 10939–
10951. 
(62) Zhang, X., and Zeng, Y. (2010) The terminal loop region controls microRNA processing by 
Drosha and Dicer. Nucleic Acids Res. 38, 7689–7697. 
(63) Bernstein, E., Caudy, A. A., Hammond, S. M., and Hannon, G. J. (2001) Role for a bidentate 
ribonuclease in the initiation step of RNA interference. Nature 409, 363–366. 
(64) Daniels, S. M., Melendez-Peña, C. E., Scarborough, R. J., Daher, A., Christensen, H. S., El Far, 
M., Purcell, D. F. J., Lainé, S., and Gatignol, A. (2009) Characterization of the TRBP domain required 
for dicer interaction and function in RNA interference. BMC Mol. Biol. 10, 38. 
(65) Lee, H. Y., and Doudna, J. A. (2012) TRBP alters human precursor microRNA processing in vitro. 
RNA 18, 2012–9. 
(66) Fukunaga, R., Han, B. W., Hung, J.-H., Xu, J., Weng, Z., and Zamore, P. D. (2012) Dicer Partner 
Proteins Tune the Length of Mature miRNAs in Flies and Mammals. Cell 151, 533–546. 
(67) Wang, H., Noland, C., Siridechadilok, B., Taylor, D. W., Ma, E., Felderer, K., Doudna, J. a, and 
Nogales, E. (2010) Structural insights into RNA Processing by the Human RISC- Loading Complex. 
Nat Struct Mol Biol. 16, 1148–1153. 
(68) Hutvagner, G., and Simard, M. J. (2008) Argonaute proteins: key players in RNA silencing. Nat. 
Rev. Mol. Cell Biol. 9, 22–32. 
 References 
- 107 - 
 
(69) Wilson, R. C., and Doudna, J. A. (2013) Molecular Mechanisms of RNA Interference. Annu. Rev. 
Biophys. 42, 217–239. 
(70) Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., and Zamore, P. D. (2003) Asymmetry in 
the assembly of the RNAi enzyme complex. Cell 115, 199–208. 
(71) O’Toole, A. S., Miller, S., Haines, N., Zink, M. C., and Serra, M. J. (2006) Comprehensive 
thermodynamic analysis of 3’ double-nucleotide overhangs neighboring Watson-Crick terminal base 
pairs. Nucleic Acids Res. 34, 3338–3344. 
(72) Johnston, R. J., Chang, S., Etchberger, J. F., Ortiz, C. O., and Hobert, O. (2005) MicroRNAs 
acting in a double-negative feedback loop to control a neuronal cell fate decision. Proc. Natl. Acad. 
Sci. U. S. A. 102, 12449–54. 
(73) Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Cooch, N., Nishikura, K., and Shiekhattar, 
R. (2010) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. 
Nature 436, 740–744. 
(74) Viswanathan, S. R., and Daley, G. Q. (2010) Lin28: A MicroRNA Regulator with a Macro Role. 
Cell 140, 445–449. 
(75) Kawahara, Y., Zinshteyn, B., Chendrimada, T. P., Shiekhattar, R., and Nishikura, K. (2007) RNA 
editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 8, 
763–9. 
(76) Di Leva, G., Garofalo, M., and Croce, C. M. (2014) MicroRNAs in Cancer. Annu. Rev. Pathol. 
Mech. Dis. 9, 287–314. 
(77) Mishra, P. J. (2014) MicroRNAs as promising biomarkers in cancer diagnostics. Biomark. Res. 2, 
4–7. 
(78) Thiery, J., Ralph, P., Häntzsch, M., and Leipzig, U. (2015) Zirkulierende MicroRNAs Neuartige 
Biomarker am Horizont ? Medizin von Morgen 46, 29–32. 
(79) Welch, C., Chen, Y., and Stallings, R. L. (2007) MicroRNA-34a functions as a potential tumor 
suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017–22. 
(80) Agostini, M., and Knight, R. A. (2014) miR-34 : from bench to bedside. Oncotarget. 5, 872–81. 
(81) Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., and 
Hermeking, H. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel 
sequencing: miR-34a is a p53 target that induces apoptosis and G 1-arrest. Cell Cycle 6, 1586–1593. 
(82) Hermeking, H. (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193–9. 
(83) Yamakuchi, M., and Lowenstein, C. J. (2009) MiR-34, SIRT1 and p53: The feedback loop. Cell 
Cycle 8, 712–715. 
(84) Yamakuchi, M., Ferlito, M., and Lowenstein, C. J. (2008) miR-34a repression of SIRT1 regulates 
apoptosis. Proc. Natl. Acad. Sci. 105, 13421–13426. 
(85) Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y., and Zheng, X. (2009) miR-34a inhibits migration 
and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer 
Lett. 275, 44–53. 
 References 
- 108 - 
 
(86) Tazawa, H., Tsuchiya, N., Izumiya, M., and Nakagama, H. (2007) Tumor-suppressive miR-34a 
induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer 
cells. Proc. Natl. Acad. Sci. U. S. A. 104, 15472–7. 
(87) Concepcion, C. P., Bonetti, C., and Ventura, A. (2012) The MicroRNA-17-92 Family of MicroRNA 
Clusters in Development and Disease. Cancer J. 18, 262–267. 
(88) Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., 
Peterson, A., Noteboom, J., O’Briant, K. C., Allen, A., Lin, D. W., Urban, N., Drescher, C. W., 
Knudsen, B. S., Stirewalt, D. L., Gentleman, R., Vessella, R. L., Nelson, P. S., Martin, D. B., and 
Tewari, M. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. 
Natl. Acad. Sci. U.S.A. 105, 10513–10518. 
(89) Li, M., Guan, X., Sun, Y., Mi, J., Shu, X., Liu, F., and Li, C. (2014) MiR-92a family and their target 
genes in tumorigenesis and metastasis. Exp. Cell Res. 323, 1–6. 
(90) Ohyagi-Hara, C., Sawada, K., Kamiura, S., Tomita, Y., Isobe, A., Hashimoto, K., Kinose, Y., 
Mabuchi, S., Hisamatsu, T., Takahashi, T., Kumasawa, K., Nagata, S., Morishige, K. I., Lengyel, E., 
Kurachi, H., and Kimura, T. (2013) MiR-92a inhibits peritoneal dissemination of ovarian cancer cells by 
inhibiting integrin alpha5 expression. Am. J. Pathol. 182, 1876–1889. 
(91) Liao, W., Zhang, H., Feng, C., Wang, T., Zhang, Y., and Tang, S. (2014) Downregulation of TrkA 
protein expression by miRNA-92a promotes the proliferation and migration of human neuroblastoma 
cells. Mol. Med. Rep. 10, 778–784. 
(92) Zhang, L., Zhou, M., Qin, G., Weintraub, N. L., and Tang, Y. (2014) MiR-92a regulates viability 
and angiogenesis of endothelial cells under oxidative stress. Biochem. Biophys. Res. Commun. 446, 
952–958. 
(93) Erdmann, K., Kaulke, K., Thomae, C., Huebner, D., Sergon, M., Froehner, M., Wirth, M. P., and 
Fuessel, S. (2014) Elevated expression of prostate cancer-associated genes is linked to down-
regulation of microRNAs. BMC Cancer 14, 82. 
(94) Zheng, F., Liao, Y. J., Cai, M. Y., Liu, T. H., Chen, S. P., Wu, P. H., Wu, L., Bian, X. W., Guan, X. 
Y., Zeng, Y. X., Yuan, Y. F., Kung, H. F., and Xie, D. (2015) Systemic delivery of microRNA-101 
potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets. PLoS Genet. 11, 
e1004873. 
(95) Lei, Y., Li, B., Tong, S., Qi, L., Hu, X., Cui, Y., Li, Z., He, W., Zu, X., Wang, Z., and Chen, M. 
(2015) MiR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion 
and enhances cisplatin chemosensitivity of bladder cancer cells. PLoS One 10, 1–14. 
(96) Liu, N., Xia, W.-Y., Liu, S.-S., Chen, H.-Y., Sun, L., Liu, M.-Y., Li, L.-F., Lu, H.-M., Fu, Y.-J., 
Wang, P., Wu, H., and Gao, J.-X. (2016) MicroRNA-101 targets von Hippel-Lindau tumor suppressor 
(VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition. Sci. Rep. 6, 
20489. 
(97) Lin, C., Huang, F., Shen, G., and Yiming, A. (2015) MicroRNA-101 regulates the viability and 
invasion of cervical cancer cells. Int J Clin Exp Pathol 8, 10148–10155. 
(98) Yan, D., Zhou, X., Chen, X., Hu, D. N., Dong, X. Da, Wang, J., Lu, F., Tu, L. L., and Qu, J. (2009) 
MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-
Met. Investig. Ophthalmol. Vis. Sci. 50, 1559–1565. 
(99) Sun, Y., Zhang, F., Bai, Y., and Guo, L. (2010) miR-126 modulates the expression of epidermal 
 References 
- 109 - 
 
growth factor-like domain 7 in human umbilical vein endothelial cells in vitro. J South Med Univ 30, 
767–770. 
(100) Fitch, M. J., Campagnolo, L., Kuhnert, F., and Stuhlmann, H. (2004) Egfl7, a novel epidermal 
growth factor-domain gene expressed in endothelial cells. Dev. Dyn. 230, 316–324. 
(101) Meister, J., and Schmidt, M. H. H. (2010) miR-126 and miR-126*: New Players in Cancer. Sci. 
World J. 10, 2090–2100. 
(102) Ebrahimi, F., Gopalan, V., Smith, R. A., and Lam, A. K. Y. (2014) MiR-126 in human cancers: 
Clinical roles and current perspectives. Exp. Mol. Pathol. 96, 98–107. 
(103) Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T., and Lowenstein, C. J. (2008) MicroRNA-
126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 
105, 1516–1521. 
(104) Fish, J., Santoro, M., Morton, S., Yu, S., Yeh, R., Wythe, J., Ivey, K., Bruneau, B., Stainier, D., 
and Srivastava, D. (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15, 
272–84. 
(105) Mizuno, S., Bogaard, H. J., Gomez-Arroyo, J., Alhussaini, A., Kraskauskas, D., Cool, C. D., and 
Voelkel, N. F. (2012) MicroRNA-199a-5p is associated with hypoxia-inducible factor-1 alpha 
expression in lungs from patients with COPD. Chest 142, 663–672. 
(106) Gu, S., and Chan, W.-Y. (2012) Flexible and versatile as a chameleon-sophisticated functions of 
microRNA-199a. Int. J. Mol. Sci. 13, 8449–66. 
(107) Jia, X. Q., Cheng, H. Q., Qian, X., Bian, C. X., Shi, Z. M., Zhang, J. P., Jiang, B. H., and Feng, Z. 
Q. (2012) Lentivirus-Mediated Overexpression of MicroRNA-199a Inhibits Cell Proliferation of Human 
Hepatocellular Carcinoma. Cell Biochem. Biophys. 62, 237–244. 
(108) Rane, S., He, M., Sayed, D., Vashistha, H., Malhotra, A., Sadoshima, J., Vatner, D. E., Vatner, 
S. F., and Abdellatif, M. (2009) Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 
alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 104, 
879–886. 
(109) Tsukigi, M., Bilim, V., Yuuki, K., Ugolkov, A., Naito, S., Nagaoka, A., Kato, T., Motoyama, T., and 
Tomita, Y. (2012) Re-expression of miR-199a suppresses renal cancer cell proliferation and survival 
by targeting GSK-3. Cancer Lett. 315, 189–197. 
(110) Zhang, Y., Fan, K. J., Sun, Q., Chen, A. Z., Shen, W. L., Zhao, Z. H., Zheng, X. F., and Yang, X. 
(2012) Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator 
of TGF-ß signalling pathway. Nucleic Acids Res. 40, 9286–9297. 
(111) Shen, Q., Cicinnati, V. R., Zhang, X., Iacob, S., Weber, F., Sotiropoulos, G. C., Radtke, A., Lu, 
M., Paul, A., Gerken, G., and Beckebaum, S. (2010) Role of microRNA-199a-5p and discoidin domain 
receptor 1 in human hepatocellular carcinoma invasion. Mol. Cancer 9, 1–12. 
(112) Zhang, P., Cheng, J., Zou, S., D’Souza, A. D., Koff, J. L., Lu, J., Lee, P. J., Krause, D. S., Egan, 
M. E., and Bruscia, E. M. (2015) Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 
pathway ameliorates cystic fibrosis lung hyper-inflammation. Nat. Commun. 6, 6221. 
(113) Shatseva, T., Lee, D. Y., Deng, Z., and Yang, B. B. (2011) MicroRNA miR-199a-3p regulates 
cell proliferation and survival by targeting caveolin-2. J. Cell Sci. 124, 2826–2836. 
 References 
- 110 - 
 
(114) Kim, S., Ui, J. L., Mi, N. K., Lee, E. J., Ji, Y. K., Mi, Y. L., Choung, S., Young, J. K., and Choi, Y. 
C. (2008) MicroRNA miR-199a * regulates the MET proto-oncogene and the downstream extracellular 
signal-regulated kinase 2 (ERK2). J. Biol. Chem. 283, 18158–18166. 
(115) Henry, J. C., Park, J. K., Jiang, J., Kim, J. H., Nagorney, D. M., Roberts, L. R., Banerjee, S., and 
Schmittgen, T. D. (2010) miR-199a-3p targets CD44 and reduces proliferation of CD44 positive 
hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 403, 120–125. 
(116) Winkler, W. C. (2002) An mRNA structure that controls gene expression by binding FMN. Proc. 
Natl. Acad. Sci. 99, 15908–15913. 
(117) Tucker, B. J., and Breaker, R. R. (2005) Riboswitches as versatile gene control elements. Curr. 
Opin. Struct. Biol. 15, 342–348. 
(118) Barrick, J. E., and Breaker, R. R. (2007) The distributions, mechanisms, and structures of 
metabolite-binding riboswitches. Genome Biol. 8, R239. 
(119) Ellington, A. D., and Szostak, J. W. (1990) In vitro selection of RNA molecules that bind specific 
ligands. Nature 346, 818–822. 
(120) Tuerk, C., and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment: RNA 
ligands to bacteriophage T4 DNA polymerase. Science 249, 505–10. 
(121) Darmostuk, M., Rimpelova, S., Gbelcova, H., and Ruml, T. (2015) Current approaches in 
SELEX: An update to aptamer selection technology. Biotechnol. Adv. 33, 1141–1161. 
(122) Germer, K., Leonard, M., and Zhang, X. (2013) Review Article RNA aptamers and their 
therapeutic and diagnostic applications. Int. J. Biochem. Mol. Biol. 4, 27–40. 
(123) Song, S., Wang, L., Li, J., Fan, C., and Zhao, J. (2008) Aptamer-based biosensors. TrAC - 
Trends Anal. Chem. 27, 108–117. 
(124) Werstuck, G., and Green, M. R. (1998) Controlling Gene Expression in Living Cells Through 
Small Molecule – RNA Interactions. Science. 282, 296–298. 
(125) Schneider, C., and Suess, B. (2016) Identification of RNA aptamers with riboswitching 
properties. Methods 97, 44–50. 
(126) Weigand, J. E., Sanchez, M., Gunnesch, E.-B., Zeiher, S., Schroeder, R., and Suess, B. (2008) 
Screening for engineered neomycin riboswitches that control translation initiation. RNA 14, 89–97. 
(127) Suess, B., Hanson, S., Berens, C., Fink, B., Schroeder, R., and Hillen, W. (2003) Conditional 
gene expression by controlling translation with tetracycline-binding aptamers. Nucleic Acids Res. 31, 
1853–1858. 
(128) Weigand, J. E., and Suess, B. (2007) Tetracycline aptamer-controlled regulation of pre-mRNA 
splicing in yeast. Nucleic Acids Res. 35, 4179–4185. 
(129) An, C., Trinh, V. B., and Yokobayashi, Y. (2006) Artificial control of gene expression in 
mammalian cells by modulating RNA interference through aptamer − small molecule interaction 
Artificial control of gene expression in mammalian cells by modulating RNA interference through 
aptamer – small molecule i. Rna 12, 710–716. 
(130) Wang, S., and White, K. A. (2007) Riboswitching on RNA virus replication. Proc. Natl. Acad. Sci. 
104, 10406–10411. 
 References 
- 111 - 
 
(131) Suess, B., and Weigand, J. E. (2008) Engineered Riboswitches : Overview, problems and 
trends. RNA Biol. 5, 24–9. 
(132) Desai, S. K., and Gallivan, J. P. (2004) Genetic Screens and Selections for Small Molecules 
Based on a Synthetic Riboswitch That Activates Protein Translation. J. Am. Chem. Soc. 126, 13247–
13254. 
(133) Suess, B., Fink, B., Berens, C., Stentz, R., and Hillen, W. (2004) A theophylline responsive 
riboswitch based on helix slipping controls gene expression in vivo. Nucleic Acids Res. 32, 1610–
1614. 
(134) Famulok, M., Hartig, J. S., and Mayer, G. (2007) Functional aptamers and aptazymes in 
biotechnology, diagnostics, and therapy. Chem. Rev. 107, 3715–3743. 
(135) Kashida, S., Inoue, T., and Saito, H. (2012) Three-dimensionally designed protein-responsive 
RNA devices for cell signaling regulation. Nucleic Acids Res. 40, 9369–9378. 
(136) Hunsicker, A., Steber, M., Mayer, G., Meitert, J., Klotzsche, M., Blind, M., Hillen, W., Berens, C., 
and Suess, B. (2009) An RNA Aptamer that Induces Transcription. Chem. Biol. 16, 173–180. 
(137) Saenger, W., Hinrichs, W., Orth, P., Schnappinger, D., and Hillen, W. (2000) Structural basis of 
gene regulation by the tetracycline inducible Tet repressor-operator system. Nat. Struct. Biol. 7, 215–
219. 
(138) Ramos, J. L., Martı, M., Molina-henares, A. J., Tera, W., Brennan, R., and Tobes, R. (2005) The 
TetR family of transcriptional. Microbiol. Mol. Biol. Rev. 69, 1–31. 
(139) Orth, P., Saenger, W., and Hinrichs, W. (1999) Tetracycline-Chelated Mg 2+ Ion Initiates Helix 
Unwinding in Tet Repressor Induction. Biochemistry 38, 191–198. 
(140) Berens, C., and Hillen, W. (2003) Gene regulation by tetracyclines: Constraints of resistance 
regulation in bacteria shape TetR for application in eukaryotes. Eur. J. Biochem. 270, 3109–3121. 
(141) Gossen, M., and Bujard, H. (1992) Tight control of gene expression in mammalian cells by 
tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547–5551. 
(142) Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., and Bujard, H. (1995) 
Transcriptional Activation By Tetracyclines in Mammalian-Cells. Science. 268, 1766–1769. 
(143) Urlinger, S., Helbl, V., Guthmann, J., Pook, E., Grimm, S., and Hillen, W. (2000) The p65 domain 
from NF-κB is an efficient human activator in the tetracycline-regulatable gene expression system. 
Gene 247, 103–110. 
(144) Gatz, C., and Quail, P. H. (1988) Tn10-encoded tet repressor can regulate an operator-
containing plant promoter. Proc. Natl. Acad. Sci. U. S. A. 85, 1394–7. 
(145) Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., and Hillen, W. (2000) Exploring 
the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield 
expanded range and sensitivity. Proc. Natl. Acad. Sci. U. S. A. 97, 7963–8. 
(146) Resch, M., Striegl, H., Henssler, E. M., Sevvana, M., Egerer-sieber, C., Schiltz, E., Hillen, W., 
and Muller, Y. A. (2008) A protein functional leap: How a single mutation reverses the function of the 
transcription regulator TetR. Nucleic Acids Res. 36, 4390–4401. 
(147) Steber, M., Arora, A., Hofmann, J., Brutschy, B., and Suess, B. (2011) Mechanistic basis for 
 References 
- 112 - 
 
RNA aptamer-based induction of TetR. ChemBioChem 12, 2608–2614. 
(148) Goldfless, S. J., Belmont, B. J., De Paz, A. M., Liu, J. F., and Niles, J. C. (2012) Direct and 
specific chemical control of eukaryotic translation with a synthetic RNA-protein interaction. Nucleic 
Acids Res. 40, 1–12. 
(149) Goldfless, S. J., Wagner, J. C., and Niles, J. C. (2014) Versatile control of Plasmodium 
falciparum gene expression with an inducible protein-RNA interaction. Nat. Commun. 5, 5329. 
(150) Wieland, M., Ausländer, S., Tigges, M., and Fussenegger, M. (2011) Rational design of a small 
molecule-responsive intramer controlling transgene expression in mammalian cells. Nucleic Acids 
Res. 39, e155. 
(151) Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861–74. 
(152) Sayed, D., and Abdellatif, M. (2011) MicroRNAs in Development and Disease. Physiol. Rev. 91, 
827–887. 
(153) Saito, H., Fujita, Y., Kashida, S., Hayashi, K., and Inoue, T. (2011) Synthetic human cell fate 
regulation by protein-driven RNA switches. Nat. Commun. 2, 160–168. 
(154) Feng, Y., Zhang, X., Graves, P., and Zeng, Y. A. N. (2012) A comprehensive analysis of 
precursor microRNA cleavage by human Dicer. RNA 18 (11), 2083–2092. 
(155) Choudhury, N. R., and Michlewski, G. (2012) Terminal loop-mediated control of microRNA 
biogenesis: selectivity and mechanism. Biochem Soc Trans. 41, 789–793. 
(156) Michlewski, G., Guil, S., Semple, C. A., and Cáceres, J. F. (2008) Posttranscriptional Regulation 
of miRNAs Harboring Conserved Terminal Loops. Mol. Cell 32, 383–393. 
(157) Gu, S., Jin, L., Zhang, Y., Huang, Y., Zhang, F., Valdmanis, P. N., and Kay, M. A. (2012) The 
loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo. Cell 
151, 900–911. 
(158) Taylor, D. W., Shigematsu, H., Cianfrocco, M. A., Noland, C. L., Nagayama, K., Nogales, E., 
Jennifer, A., Wang, H., Biology, C., Division, S., Berkeley, L., Division, B., and Berkeley, L. (2013) 
Substrate-specific structural rearrangements of human Dicer. Nat. Struct. Mol. Biol. 20, 662–670. 
(159) Mayr, and Bartel. (2010) Widespread shortening of 3′UTRs by alternative cleavage and 
polyadenylation activates oncogenes in cancer cells. Cell 138, 673. 
(160) Ziebarth, J. D., Bhattacharya, A., and Cui, Y. (2012) Integrative Analysis of Somatic Mutations 
Altering MicroRNA Targeting in Cancer Genomes. PLoS One 7, 1–10. 
(161) Jin, H. Y., Gonzalez-Martin, A., Miletic, A. V., Lai, M., Knight, S., Sabouri-Ghomi, M., Head, S. 
R., Macauley, M. S., Rickert, R. C., and Xiao, C. (2015) Transfection of microRNA mimics should be 
used with caution. Front. Genet. 6, 1–23. 
(162) Cloonan, N. (2015) Re-thinking miRNA-mRNA interactions: Intertwining issues confound target 
discovery. BioEssays 37, 379–388. 
(163) Kulkarni, V., Naqvi, A. R., Uttamani, J. R., and Nares, S. (2016) MiRNA-Target interaction 
reveals cell-specific post-transcriptional regulation in mammalian cell lines. Int. J. Mol. Sci. 17. 
(164) Chou, C.-H., Chang, N.-W., Shrestha, S., Hsu, S.-D., Lin, Y.-L., Lee, W.-H., Yang, C.-D., Hong, 
 References 
- 113 - 
 
H.-C., Wei, T.-Y., Tu, S.-J., Tsai, T.-R., Ho, S.-Y., Jian, T.-Y., Wu, H.-Y., Chen, P.-R., Lin, N.-C., 
Huang, H.-T., Yang, T.-L., Pai, C.-Y., Tai, C.-S., Chen, W.-L., Huang, C.-Y., Liu, C.-C., Weng, S.-L., 
Liao, K.-W., Hsu, W.-L., and Huang, H.-D. (2016) miRTarBase 2016: updates to the experimentally 
validated miRNA-target interactions database. Nucleic Acids Res. 44, D239–D247. 
(165) Aranda, J. F., Canfran-Duque,  a., Goedeke, L., Suarez, Y., and Fernandez-Hernando, C. (2015) 
The miR-199-dynamin regulatory axis controls receptor-mediated endocytosis. J. Cell Sci. 128, 3197–
3209. 
(166) Lino Cardenas, C. L., Henaoui, I. S., Courcot, E., Roderburg, C., Cauffiez, C., Aubert, S., Copin, 
M. C., Wallaert, B., Glowacki, F., Dewaeles, E., Milosevic, J., Maurizio, J., Tedrow, J., Marcet, B., Lo-
Guidice, J. M., Kaminski, N., Barbry, P., Luedde, T., Perrais, M., Mari, B., and Pottier, N. (2013) miR-
199a-5p Is Upregulated during Fibrogenic Response to Tissue Injury and Mediates TGFbeta-Induced 
Lung Fibroblast Activation by Targeting Caveolin-1. PLoS Genet. 9. 
(167) Mukherji, S., Ebert, M. S., Zheng, G. X. Y., Tsang, J. S., Sharp, P. A., and van Oudenaarden, A. 
(2011) MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 43, 854–859. 
(168) Hydbring, P., and Badalian-Very, G. (2013) Clinical applications of microRNAs. F1000Research 
2, 136. 
(169) Choudhuri, S. (2010) Small noncoding RNAs: Biogenesis, function, and emerging significance in 
toxicology. J. Biochem. Mol. Toxicol. 24, 195–216. 
(170) Tuleuova, N., An, C. Il, Ramanculov, E., Revzin, A., and Yokobayashi, Y. (2008) Modulating 
endogenous gene expression of mammalian cells via RNA-small molecule interaction. Biochem. 
Biophys. Res. Commun. 376, 169–173. 
(171) Beisel, C. L., Bayer, T. S., Hoff, K. G., and Smolke, C. D. (2008) Model-guided design of ligand-
regulated RNAi for programmable control of gene expression. Mol. Syst. Biol. 4, 224. 
(172) Berens, C., Lochner, S., Löber, S., Usai, I., Schmidt, A., Drueppel, L., Hillen, W., and Gmeiner, 
P. (2006) Subtype Selective Tetracycline Agonists and their Application for a Two-Stage Regulatory 
System. ChemBioChem 7, 1320–1324. 
(173) Beilstein, K., Wittmann, A., Grez, M., and Suess, B. (2014) Conditional control of mammalian 
gene expression by tetracycline- dependent hammerhead ribozymes. ACS Synth. Biol. 4, 526–534. 
(174) Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-
time quantitative PCR and. Methods 25, 402–408. 
(175) Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., Nguyen, J. T., Barbisin, M., Xu, N. 
L., Mahuvakar, V. R., Andersen, M. R., Lao, K. Q., Livak, K. J., and Guegler, K. J. (2005) Real-time 
quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, 1–9. 
 
 
 
 
 Talks and Poster Presentations 
- 114 - 
 
8 Talks and Poster Presentations  
2014 
 Summer School, Pottenstein, Germany 
Talk: Kontrolle der miRNA Funktion durch Liganden-gesteuerte RNA-basierte 
Regulatorsysteme  
2015 
 Winter School SFB902, Obergurgl, Austria 
 Talk: Control of miRNA function by ligand dependent RNA-based regulators  
 
 International Synthetic and Systems Biology Summer School SFB902, Taormina, Sicily 
 Poster: Control of miRNA function by ligand-dependent RNA-based regulators  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Publications 
- 115 - 
 
9 Publications 
Klauser B, Atanasov J, Siewert LK, Hartig JS: Ribozyme-based aminoglycoside switches of gene 
expression engineered by genetic selection in S. cerevisiae. (2015) ACS Synth Biol. 4(5): 516-25 
Atanasov J, Weigand JE and Suess B: Design and implementation of a synthetic pre-miR switch 
for controlling miRNA biogenesis in mammals. (2017), manuscript submitted 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Curriculum Vitae 
- 116 - 
 
10 Curriculum Vitae 
Name   Janina Atanasov 
Date of birth  29.09.1987 in Nuremberg 
Address  Darmstädter Straße 35a 
   64807 Dieburg 
   Germany 
Professional    
experience 
01/2014 - present Institute for Biology | Synthetic genetic circuits |  
Technische Universität Darmstadt, Germany 
   Graduate student in the Lab of Prof. Dr. Beatrix Suess  
Doctoral thesis: Design and implementation of a synthetic pre-miR switch for 
controlling miRNA biogenesis in mammals 
Degree: Dr. rer. nat. 
Education   
10/2011-12/2013   Master of Science in Life Science   
   Universität Konstanz  
Master thesis: Design of Aptazymes with Novel Ligand Selectivity 
Degree: M. Sc.  
04/2008 - 03/2011  Bachelor of Science in Pharmaceutical Sciences 
   Ludwig-Maximilians-Universität München  
 Bachelor thesis: Detection of HCN3 surface expression 
Degree: B. Sc.  
09/1998 - 06/2007 Wolfram-von-Eschenbach-Germany, Schwabach, Germany 
    University-entrance diploma 
 
   
   
 
 
 Ehrenwörtliche Erklärung 
- 117 - 
 
11 Ehrenwörtliche Erklärung  
 
 
Ich erkläre hiermit ehrenwörtlich, dass ich die vorliegende Arbeit entsprechend den Regeln guter 
wissenschaftlicher Praxis selbstständig und ohne unzulässige Hilfe Dritter angefertigt habe.  
 
Sämtliche aus fremden Quellen direkt oder indirekt übernommenen Gedanken sowie sämtliche von 
Anderen direkt oder indirekt übernommenen Daten, Techniken und Materialien sind als solche 
kenntlich gemacht. Die Arbeit wurde bisher bei keiner anderen Hochschule zu Prüfungszwecken 
eingereicht.  
 
 
 
Darmstadt, den 06.03.2017  
 
 
 
..............................................................................  
(Janina Atanasov) 
